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Abstract  
The incorporation of a synthetic, catalytically competent metallocofactor into a protein 
scaffold to generate an artificial metalloenzyme (ArM) has been explored since the late 
1970s. Progress in the ensuing years was limited by the tools available for both 
organometallic synthesis and protein engineering. Advances in both of these areas, 
combined with increased appreciation of the potential benefits of combining attractive 
features of both homogeneous catalysis and enzymatic catalysis, led to a resurgence of 
interest in ArMs starting in the early 2000s. Perhaps the most intriguing of potential ArM 
properties is their ability to endow homogeneous catalysts with a genetic memory. 
Indeed, incorporating a homogeneous catalyst into a genetically-encoded scaffold offers 
the opportunity to improve ArM performance by directed evolution. This capability could, 
in turn, lead to improvements in ArM efficiency similar to those obtained for natural 
enzymes, providing systems suitable for practical applications and greater insight into 
the role of second coordination sphere interactions in organometallic catalysis.  
Since its renaissance in the early 2000s, different aspects of artificial metalloenzymes 
have been extensively reviewed and highlighted. Our intent is to provide a 
comprehensive overview of all work in the field up to December 2016, organized 
according to reaction class. Because of the wide range of non-natural reactions 
catalyzed by ArMs, this was done using a functional-group transformation classification. 
The review begins with a summary of the proteins and the anchoring strategies used to 
date for the creation of ArMs, followed by a historical perspective. Then follows a 
summary of the reactions catalyzed by ArMs and a concluding critical outlook. This 
analysis allows for comparison of similar reactions catalyzed by ArMs constructed using 
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different metallocofactor anchoring strategies, cofactors, protein scaffolds, and 
mutagenesis strategies. These data will be used to construct a searchable website on 
ArMs that will be updated regularly by the authors. 
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1. Introduction  
Artificial metalloenzymes (ArMs) result from the incorporation of a catalytically 
competent metallocofactor into a protein scaffold. Initial attempts to construct ArMs were 
reported by Wilson and Whitesides as well as Kaiser and coworkers in the late 1970s.1-2 
Despite several fascinating aspects of these hybrid catalysts, Whitesides concluded his 
article by stating "the catalytic system (...) is not a practical asymmetric catalyst."2 
Unfortunately, following this pronouncement, relatively little progress was made toward 
ArM development until the new millennium. Setting aside the question of whether 
practicality should dictate the course of scientific inquiry, it is certainly the case that ArM 
construction in those early days was limited by the tools available for both 
organometallic synthesis and protein engineering. Significant progress in these areas 
contributed to the revival in ArM research that continues to this day.  
The resurgence of interest in ArMs was also driven by increased appreciation of the 
potential benefits of combining attractive features of both homogeneous catalysis and 
enzymatic catalysis. For example, the ArM secondary coordination sphere could interact 
with metal catalysts, substrates, or intermediates to facilitate reactions or to discriminate 
similarly reactive sites on substrates. ArMs could also be generated from protein 
scaffolds with inherent functionality (e.g. catalytic activity, substrate binding, redox 
properties, etc.) that could be used to augment ArM function. Perhaps more intriguingly, 
ArMs could endow homogeneous catalysts with a genetic memory. Indeed, 
incorporating a homogeneous catalyst within a genetically-encoded scaffold (i.e. the 
genetic memory of the ArM) offers the opportunity to improve the ArM performance by 
mutagenesis. This enables to apply Darwinian evolution schemes for ArM optimization. 
Introduced in the early nineties by Frances Arnold and Pim Stemmer,3-4 directed 
evolution has had a revolutionary impact on biotechnology,5-7 leading to catalysts that 
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have supplanted well-established large-scale processes based on homogeneous 
catalysts.8 This technique relies on the efficient high-throughput screening of genetic 
diversity to identify and characterize functionally evolved mutants. Similar optimization of 
ArMs could ultimately lead to systems suitable for practical applications, and provide 
greater insight into the role of second coordination sphere interactions in organometallic 
catalysis.  
Four complementary strategies have been pursued to localize metallocofactors within a 
well defined second coordination sphere environment, provided by the host protein: i) 
covalent, ii) supramolecular, iii) dative and iv) metal substitution, Figure 1. 
i) Covalent anchoring, reminiscent of the well-established bioconjugation techniques,9 
involves a high-yielding and irreversible reaction between cofactors bearing a reactive 
functional group and an amino acid side-chain on the protein scaffold. Common 
reactions used for ArM formation include: a) nucleophilic attack by cysteine or another 
uniquely activated residue on an electrophilic moiety (maleimide, -halocarbonyl, etc.) 
on the cofactor, b) disulfide bond formation between cysteine and a cofactor substituted 
with an electrophilic sulfur moiety, and c) Huisgen [3+2]-cycloaddition between an 
unnatural amino acid bearing a terminal alkyne or azide with an azide- or alkyne-
substituted cofactor.10 
ii) Supramolecular anchoring exploits the high affinity that proteins may display for a 
limited set of non-covalent inhibitors, natural cofactors, or substrates. Covalent 
modification of these with the cofactor may, in some cases, maintain a high affinity, thus 
ensuring quantitative localization of the cofactor within the host protein. 
iii) Dative anchoring relies on the coordination of a nucleophilic amino acid residue (His, 
Cys, Glu, Asp, Ser etc.) to a coordinately unsaturated metal center. This type of 
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anchoring and activation of the metal often complements either covalent or 
supramolecular strategies. 
iv) Metal substitution builds upon the unique reactivity of non-native metals combined 
with the exquisitely tailored active site of natural metalloenzymes. Upon substituting the 
metal, new-to-nature reactivities can be introduced in the ArM's repertoire.11 This 
strategy builds upon the very elegant enzyme repurposing approach introduced by 
Frances Arnold in 2013.12-14 Because enzyme repurposing does not involve metal 
substitution (and all of the challenges associated with it), it is not covered here but is 
instead presented by Fasan and coworkers elsewhere in this issue of Chemical Reviews. 
 
Figure 1. Four anchoring strategies allow to firmly localize an abiotic cofactor within a 
protein scaffold: a) covalent, b) supramolecular, c) dative, and d) metal substitution. The 
following colour codes apply: protein and natural cofactor (green), supramolecular 
anchor (red), variable spacer and ligand (blue) and abiotic metal (black).  
 
Since its renaissance in the early 2000s, the field of artificial metalloenzymes has been 
extensively reviewed and highlighted.15-95 With catalytic applications in mind, the present 
review summarizes the progress in ArM according to the reaction they catalyze.  
The authors' initial intention was to classify the reactions according to the enzyme class 
system (EC) from the International Union of Biochemistry and Molecular Biology: 
oxidoreductase, transferase, hydrolase, lyase, isomerase and ligase. It rapidly became 
evident that the EC system is not best suited to ArM as the reactions these catalyze are 
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often non-natural: in what EC would one assign to an artificial metathase or Suzukiase? 
We thus followed a more classical functional-group transformation classification. 
In view of the focus on catalysis, artificial metalloproteins with no catalytic function are 
not covered comprehensively.34-35 The same applies to the fascinating fields of DNA- 
and RNAzymes as well as metallopeptides with less than one hundred amino acids (an 
arbitrary length set for inclusion in this review). These DNA/RNAzymes and 
metallopeptides have been reviewed recently by key players in the field.70, 96-98 
This review begins with a summary of the proteins and the anchoring strategies used to 
date for the creation of ArMs (chapter 2), followed by a historical perspective (chapter 3). 
Then follows a summary of the reactions catalyzed by ArMs (reduction chemistry, C–C 
bond-formation, oxygen insertion and hydration: chapters 4-7). This review ends with a 
critical outlook (chapter 8). 
The authors have invested significant effort to cover all artificial metalloenzymes 
published to date, albeit with the restrictions outlined above. Despite the care for the 
detail and the search tools available, there is no doubt that we have missed some 
articles. We strive to apply a fair ethics of citation and thus wish to apologize for any 
unintentional omission.99 In addition, this review served as a basis to set up a fully-
searchable website on ArM that will be updated regularly by the authors.100 
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2. Protein Scaffolds 
The table presented below summarizes all the protein scaffolds that have been used to date to create artificial metalloenzymes as well 
as relevant data including i) the anchoring strategy, ii) whether mutants have been tested, iii) the reaction that the resulting ArM 
catalyzes etc. Protein scaffolds that have been subjected to mutagenesis to optimize the performance of the ArMs are displayed 
throughout the article where most relevant. 
Table 1 Summary of protein scaffolds reported to date for the creation of artificial metalloenzymes. 
Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
1 3D peptide 2A3D 
Designed single 
chain three-
helix bundle 
Monomer 8 D 5.8 
De novo-designed 
protein 
n.d + H2O 
2 -chymotrypsin 1YPH 
Trypsin-like 
serine protease 
Homo dimer 25 D, C 8.7 Endopeptidase +/++ WT DO, M 
3 ß-lactamase 2FU7 
Metallo-
hydrolase/oxido
reductase 
Monomer 29 D 6.2 
Hydrolysis of ß-
lactams 
+/++ + CO, H20 
4 ß-lactoglobulin 3NPO Lipocalins Monomer 18 S, C 4.8 Transport ++ WT TH, SO 
5 
6-Phospho-
gluconolactonase 
(6-PGLac) 
4TM8 
NagB/RpiA/CoA 
transferase-like 
Monomer 27 D 4.7 Hydrolase ++ + PE 
6 
Adipocyte lipid 
binding protein 
(ALBP) 
1A18 Lipocalins Homo dimer 15 C 8.6 
lipid binding 
protein 
+/++ + HYD, TA 
7 
Alcohol 
dehydrogenase 
(ADH) 
5ENV GroES-like 
Homo 
tetramer 
141 D 5.4 Oxidoreductase +/++ WT DO 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
8 Antibody 03-1 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE 
9 Antibody 12E11G n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE 
10 Antibody 13G10 4AMK 
Immunoglobulin 
like ß sandwich 
Hetero dimer 46 S 8.1 Immune response n.d WT PE 
11 Antibody 14H7 4AT6 
Immunoglobulin 
like ß sandwich 
Hetero dimer 45 S 6.5 Immune response n.d WT PE 
12 Antibody 1G8 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT H 
13 Antibody 28F11 n.d 
Immunoglobulin 
like ß sandwich 
Hetero dimer 45 S n.d Immune response n.d WT PEP 
14 Antibody 2B4 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE 
15 Antibody 33F12 1AXT 
Immunoglobulin 
like ß sandwich 
Hetero dimer 47.5 C 8.5 Immune response +/++ WT ALD 
16 Antibody 38C2m n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d C n.d Immune response +/++ WT ALD, HYD 
17 Antibody 3A3 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE, SO, PN 
18 Antibody 7A3 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE, SO, EO 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
19 Antibody 7G12  n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT PE 
20 Antibody 84A3 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response n.d WT HYD 
21 Antibody SN37.4 n.d 
Immunoglobulin 
like ß sandwich 
n.d n.d S n.d Immune response +/++ WT SO 
22 Avidin (Av) 1VYO Streptavidin-like 
Homo 
tetramer 
60 S 10.4 Biotin-binding +++ WT H, M 
23 
Binding domain of 
Rabenosyn (Rab4) 
1YZM Long -hairpin Monomer* 6 D 5.6 
Membrane 
trafficking 
regulatory protein 
n.d + H2O 
24 
Carbonic 
anhydrase II 
Bovine (CA) 
1V9E 
Carbonic 
anhydrase 
Monomer 29 MS 6.4 CO2 hydration + + EO, H,PE 
25 
Carbonic 
Anhydrase II 
Human (hCAII) 
1CA2 
Carbonic 
anhydrase 
Monomer 29 D, MS 6.9 CO2 hydration ++ +++ 
TH, H, HF, 
EO, M,PE 
26 
Carboxypeptidase 
A 
1M4L 
Phosphorylase/
hydrolase-like 
Monomer 34.4 D 6.3 Protease +++ WT H2O, HYD, O 
27 
Catabolite activator 
protein from E. coli 
2CGP 
DNA/RNA-
binding 3-
helical bundle 
Homo dimer 47 D, Z 8.4 
DNA binding, 
regulation of 
catabolite  
+/++ + PE 
28 
C-terminal domain 
of Calmodulin 
2KZ2 EF Hand-like Monomer 17 D 4.1 
Messenger, Ca2+ 
binding protein 
+/++ + H2O 
29 Cutinase 1CEX /ß hydrolase Monomer 21 C 7.8 Cutin hydrolase + WT H, M 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
30 Cytochrome  b562 1QPU 
Four-helical up-
and-down 
bundle 
Monomer 11 MS 7.9 Electron transport ++ + H2 
31 Cytochrome c552 1DT1 Cyt c8 family Monomer 9 MS 9.6 Nitrite reduction +++ M61A H2 
32 Cytochrome cb562 2BC5 
Four 
-helix bundle 
Monomerh 12 D, S 5.0 Oxidoreductase +/++ +++ H2O 
33 
Cytochrome P450 
(CYP119) 
1IO7 
Cytochrome 
P450 
Monomer 43 S, D 6.1 Oxidoreductase ++/+++ +++ CH 
34 
Cytochrome P450-
BM3 
2IJ2 
Cytochrome 
P450 
Monomer 118 S 5.2 Oxidoreductase + + CP 
35 Due Ferro 1 1EC5 
Designed four-
helix bundle 
protein 
Homo dimer 12 D 4.8 
De novo-designed 
protein 
+/++ + PE 
36 Ferredoxin (Fd) 1A70 
 ß-Grasp 
(ubiquitin-like) 
Monomer 13 C, D 9.6 Electron transport ++ WT H2 
37 Ferritin (Fr) 1DAT Ferritin-like Homo 24-mer 480 D 5-5.7 Iron storage +/++ + PO, S 
38 FhuA CVFtev 1BY3 
Trans 
membrane      
ß-barrels 
Monomer 64 C n.d 
Ferric 
hydroxamate 
uptake 
+/++ + DA, M 
39 Flavodoxin (Fld) 1CZL Flavodoxin fold Monomer 19 MS 4.0 Electron transport ++ WT H2 
40 
Glyoxalase II 
(Human) 
1QH5 
Metallo-
hydrolase/oxido
reductase 
Homo dimer 58 D 6.9 
Hydroxyacyl-
glutathione 
hydrolase  
+/++ +++ H2O 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
41 (gp27-gp5)3 1K28 
Phage tail 
OB-fold 
Hetero 
hexamer 
>300 C 5.4 
Needle of 
bacteriophage T4 
++ WT SO 
42 [(gp5ßf)3]2 3A1M OB-fold 
Homo 
hexamer 
88 C 4.8 
Needle of 
bacteriophage T4 
++++ 
+ ER, CL, CR 
43 
Heme Oxygenase 
(HO) 
1IW0 
Heme 
oxygenase-like 
Monomer 24 S, D 5.5 
Heme 
oxygenation 
+/++ + H2, OR 
44 Hemoglobin 2DN1 Globin-like 
Hetero 
tetramer 
61.9 C 8.3 O2 transport ++ WT O 
45 
Hen egg white 
Lysozyme 
(HEWL) 
2VB1 Lysozyme-like Monomer 14 D 11.4 
Hydrolysis ß-(1-
4)- peptidoglycan 
+ +/+++ WT DO, THi 
46 
Horseradish 
Peroxidase (HRP) 
1W4W 
Heme-
dependent 
peroxidases 
Monomer 44 S 5.6 Peroxidase ++ WT PE, PO 
47 
Human retinoid-X-
receptor (hRXR) 
1RXR 
Glucocorticoid 
receptor-like 
Monomer 10 D 9.6 DNA binding +/++ +++ L 
48 HydA 3LX4 n.d Monomer 49 D 5.9 Hydrogenase + WT H2 
49 
Intestinal fatty acid 
binding protein 
(IFABP) 
1ICM Lipocalins Monomer 15 C 6.9 
lipid binding 
protein 
n.d + HYD, TA 
50 Laccase 1GYC Cupredoxin-like Monomer 53.6 MS 5.8 Oxidoreductase ++/+++ WT DO 
51 Lipase (C. rugosa) 1GZ7 
/ß hydrolase 
fold 
Monomer 67 D 4.6 Lipase +/++ WT DO 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
52 
Lipase B from C. 
antarctica (CALB) 
4K6G /ß hydrolases Monomer 33 C 5.8 
Hydrolysis of 
triglycerides 
+++ WT H, HK 
53 
Lipase from G. 
thermocatenulatus 
(GTL) 
2W22 Rossmann fold Monomer 43 C 6.4 Lipase +++ + DA 
54 LmrR 4ZZD n.d Homo dimer 13.5 C, S 6.6 
Transcriptional 
repressor 
n.d + DA, H2O, FC 
55 
Mouse adenosine 
deaminase 
1A4L TIM ß/-barrel Monomer 40 D 5.5 
Adenosine 
deamination 
++ +++ H2O 
56 
Myoglobin (Mb) 
(Horse heart) 
(Sperm whale) 
2V1K (HH) 
1MBI (SW) 
Globin-like Monomer 18 S, D, MS 
7.4 (HH) 
8.7 (SW) 
Oxygen transport +/++ +++ 
PE, SO, CH, 
H2, CP, DA, 
NO 
57 
Neocarzinostatin 
(Variant 3.24) 
2CBM 
Immunoglobulin
-like ß -
sandwich 
Monomer 14 S 4.2 Enediyne binding + WT SO, DA, TE 
58 NikA 4I9D 
Periplasmic 
binding protein-
like II 
Monomer 56 S 10.0 Nickel transport + WT SO 
59 Nitrobindin (Nb) 3EMM Lipocalins Monomer 19 C 8.7 NO transport +/++ + 
H2, DA, PO, 
EO, CH, M 
60 Papain (PAP) 1PPP 
Cysteine 
proteinases 
Monomer 23 C 8.8 Protease +/++ WT 
TH, DA, H, 
EO,O 
61 
Photoactive Yellow 
Protein (PYP) 
 
2PHY Profilin-like Monomer 14 C 4.8 Photoreceptor + WT H, AAm 
62 
Photosystem  I 
(PSI) 
1JBO Globin-like Monomer 215 U 5.3 
Photochemical 
energy conversion 
+ WT H2 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
63 Phytase 1IHP 
Phosphoglycera
te mutase-like 
Monomer 48.2 C, D 4.9 Phosphatase +/++ + SO, CP 
64 
Prolyl 
oligopeptidase 
(POP) 
1QFSn 
7-bladed beta-
propeller  
Monomer 80 C 5.5 
Prolyl 
oligopeptidase 
+++ +++ CP 
65 Proteinase-K 5AVK Subtilisin-like Monomer 28.9 D 8.9 Protease +/++ WT DO 
66 Ribonuclease S 2RNS RNase A-like Monomer 14 D 8.6 RNA cleavage ++ + TH 
67 Rubredoxin (Rd) 6RXN 
Rubredoxin-like 
Zinc-ribbon fold 
Monomer 5.5 MS 4.6 Electron transport ++ WT H2 
68 
Serum Albumin 
Bovine (BSA) 
4F5S 
Serum albumin-
like 
Monomer 66.5 D, S 4.7 
Plasma carrier, 
oncotic pressure 
regulator 
+/++ WT 
DO, DA, H, 
PO, SO 
69 
Serum albumin 
Chicken-egg (CSA) 
1UHG 
Serum albumin-
like 
Monomer 43 S 4.5 
Plasma carrier, 
oncotic pressure 
regulator 
+ WT DA, SO 
70 
Serum albumin 
Porcine (PSA) 
n.d 
Serum albumin-
like 
Monomer 67 S 5.8 
Plasma carrier, 
oncotic pressure 
regulator 
+ WT DA, SO 
71 
Serum albumin 
Rabbit (RSA) 
3V09 
Serum albumin-
like 
Monomer 66 S 5.7 
Plasma carrier, 
oncotic pressure 
regulator 
+ WT DA, SO 
72 
Serum Albumin 
Human (HSA) 
3JRY 
Serum albumin-
like 
Monomer 65 S 4.7 
Plasma carrier, 
oncotic pressure 
regulator 
+/++ WT SO, DA, HF 
73 
Serum albumin 
Sheep (SSA) 
4LUF 
Serum albumin-
like 
Monomer 66 S 5.6 
Plasma carrier, 
oncotic pressure 
regulator 
+ WT DA, SO 
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Entry Name PDB-code Protein Folda 
Oligomeric 
stateb 
Mw 
[kDa] 
Anchoring 
Modec 
PId Native Function Stabilitye 
Mutants 
testedf 
Reactionsg 
74 
Small heat shock 
protein (M. 
jannaschii) 
1SHS 
HSP-20 like 
chaperones 
Homo 24-mer 16.5 C 5.0 Thermotolerance +++ + M 
75 
Staphylococcus 
nuclease 
2SNS OB-fold Monomer 16.8 C 9.6 
DNA and RNA 
hydrolysis 
+/++ WT HYD (native) 
76 
Sterol Carrier 
Protein (SCP) 
1IKT SCP-like Monomer 12.5 C 9.5 Sterol carrier n.d + DA 
77 Streptavidin (Sav) 2BC3 Streptavidin-like 
Homo 
tetramer 
64 S, S+D, U 6.4 Biotin-binding ++++ +++ 
H, TH, M, S, 
AA, CH, AO, 
SO, DO, MA 
78 
Thermosome  
(THS) 
1A6D 
GroEL equat.+ 
The "swivelling" 
ß/ß/ domains 
 
 
Hetero 16-mer 117 C 
5.9 () 
5.1 (ß) 
domains 
Chaperonin +++ + PO 
79 tHisF 1THF 
TIM ß/- barrel 
 
Homo dimer 28 C, D 5.2 
imidazole glycerol 
phosphate 
synthase 
+++ + 
EO, CP, DA, 
Si-I 
80 TRI peptide 
3PBJ 
(structure 
analogue) 
Three-helix 
bundles 
Homo trimer 10 D 6.8 
De novo-designed 
protein 
n.d + H2O, NR 
81 Trypsin 1S81 
Trypsin-like 
serine 
proteases 
Monomer 23.5 D 8.3 Protease +++ +  PEP 
82 Xylanase A (Xln) 1E0X TIM ß/-barrel Monomer 51 S 6.2 
Glycoside 
hydrolysis 
+ WT PE, SO, EO 
83 
Zif268 zinc-finger 
protein 
1ZAA 
ß-ß- zinc 
fingers 
Trimer 33 D, Z 10.1 
DNA binding, 
mammalian 
transcription factor 
n.d +++ DNA binding 
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a based on Structural Classification of Proteins (SCOP). http://scop.mrc-lmb.cam.ac.uk 
b based on PDBe classification. 
c S = supramolecular, D = dative, C = covalent, MS = metal substitution, Z = non-natural aminoacid, U = undefined 
d Theoretical PI calculated with ProtParam based on the amino acid sequence of the natural/de novo-designed protein. 
e ++++ very high stability against chaotropic agents, +++ Tm >80°C,  ++ Tm > 60°C , + Tm > 40°C, n.d no data available. 
f  +++ > 50 mutants tested, ++ > 10 mutants tested, WT: only wild-type tested 
g AA = allylic alkylase, AAm = allylic aminase, ALD = aldolase, AO = alcohol oxidase, CH = C–H activase, CL = clickase, CO = catecohol oxidase, CP = 
cyclopropanase, CR = CO2 reductase, DA = Diels-Alderase, DO = dihydroxylase, EO = epoxidase, ER = epoxide Ring Opening, FC = Friedel-Crafts alkylase, H 
= hydrogenase,  H2 = dihydrogenase, HF = hydroformylase, HK = heckase, HYD = hydrolase, H2O = hydratase, L = ligase, M = metathase, MA = Michael 
addase, NR = nitrite reductase, NO = NO reductase, NU = nuclease, O = Oxidase, OR = oxygen reductase, PO = polymerase, PE = peroxidase, PEP = 
peptidase, PN = phenol nitratase, S = Suzukiase, Si-I = Si-H insertion, SO = sulfoxidase, TA = transaminase, TE = transesterase, TH = transfer hydrogenase. 
 
h Tezcan et al. used a Zn(II)-mediated tetramer of cytochrome cb562 (with a mass of ~ 50kDa). 
I  Ueno et al. used as tetragonal and orthorhombic crystal. 
l   Kuhlman et al. used the dimer of the Rab4 binding domain of Rabenosyn (with a mass of ~12 kDa). 
m Commercially available. 
n  POP from Pyrococcus furiosus (PDB : 5T88), submitted.  
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3. Historical Contributions 
The aim of this section is to cover work on artificial metalloenzymes dating from the 
earliest studies on hybrid metal-protein catalysts to those completed around the year 
2000. As noted in the introduction, around this date, modern tools of molecular biology 
began making a significant impact on ArM research. Presumably as a result of this, the 
five-year average number of publications on ArM research each year increased 
substantially in the early 2000's (Chart 1). These early studies are presented in 
chronological order to highlight how different advances were made using different 
scaffolds and ArM formation strategies at the time of the original reports. 
 
Chart 1. Number of publications and the five-year moving average of this number 
plotted versus publication year for publications cited in this review.  
 
The first example of transition metal-catalyzed asymmetric synthesis, reported in 1956, 
also constitutes the first realization of a protein-modified transition metal catalyst.101-102 S. 
Akabori et al. adsorbed palladium chloride on silk fibroin fibres and reduced the resulting 
material with hydrogen, likely resulting in the formation of Pd-nanoparticles embeded 
within an enantiopure protein environment.103 The protein-immobilized palladium 
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catalyzed asymmetric hydrogenation of dehydroaminoacid derivatives 1−3 to provide 
products 4 and 5 with significant enantiomeric excess (Scheme 1). The reduction of -
benzildioxime, however, led to variable results, suggesting that the catalyst was poorly 
defined. Despite reproducibility issues,101-102 this initial study has sparked research in 
biopolymer-immobilized Pd, sometimes termed bio-palladium.104 Pd-nanoparticles have 
recently also attracted attention for in vivo applications.105-106 
Scheme 1. Asymmetric hydrogenation of dehydroaminoacid derivatives with silk-fiber 
modified palladium reported in 1956. 
  
Metal substitution has been used for the study of natural metalloenzymes since the late 
1960s.107-108 Metal-exchange studies often aimed at introducing spectroscopically 
observable metals as a means to elucidate structural details but did not focus on 
catalysis.109-110 J. E. Coleman, however, observed that the CO2 hydration activity of 
carbonic anhydrase remains roughly half when Zn(II) is exchanged for Co(II), whereas 
the esterase activity increased after metal exchange for carbonic anhydrase B.108 In the 
same year (1967), P. Cuatrecasas et al. reported the replacement of Ca(II) for Sr(II) in a 
staphylococcal nuclease. Whereas the Ca(II)-dependent enzyme catalyzed both DNA 
and RNA cleavage, the Sr(II) exchanged nuclease cleaved DNA exclusively.107 
Although not catalytic, the potential of metal-ion exchange to impact enzyme function 
was convincingly demonstrated in the activation of the zymogen trypsinogen by trypsin 
in 1970.111 Trypsinogen contains two latent metal binding sites, the lower affinity of 
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which is located at the cleaved N-terminus.112 Ca(II)-ions bound to this site led to a 
lowering of the Km for the trypsin-trypsinogen interaction. Bound Nd(III) leads to a much 
more pronounced lowering of the Km compared to Ca(II), even at a 100 fold lower 
concentration of metal ions.  
The first example where alternative catalytic function was introduced through metal-
exchange in a metalloprotein was reported by K. Yamamura and E. T. Kaiser in 1976.1 
Carboxypeptidase A was converted to an oxidase by substitution of Zn(II) for Cu(II) 
(Scheme 2). Limiting kcat and Km values of kcat = 6 min-1 and Km = 0.24 mM where 
determined for the oxidation of ascorbic acid 6 to dehydroascorbic acid 7. 
Scheme 2. Oxidation of ascorbic acid by carboxypeptidase A (CPA) after substitution of 
Zn(II) for Cu(II).  
 
 
In 1978, Wilson and Whitesides were the first to anchor an abiotic cofactor inside a 
protein cavity.2 Exploiting the remarkable affinity of biotin for avidin, the biotinylated 
Rh(I)-diphosphine moiety 9 was employed for the hydrogenation of -acetamidoacrylic 
acid 8 in the presence of avidin (Scheme 3). The system showed significant, albeit 
moderate, stereoinduction in aqueous phosphate buffer and, importantly, a definite 
increase in activity when compared to the protein-free cofactor. Avidin is a 
homotetrameric protein that can bind up to 4 equivalents of biotin. One equivalent of the 
biotinylated catalyst precursor vs. biotin binding sites led to a higher enantiomeric 
excess than 0.5 equivalents indicating that the cofactors interact with each other when 
localized in adjacent binding sites.  
Scheme 3. Asymmetric hydrogenation of a dehydroamino acid derivative by a 
biotinylated Rh(I)-complex upon binding to avidin.  
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Catalytic enantioselective oxidation of sulfides by various oxidants in the presence of 
bovine serum albumin (BSA) was investigated by Sugimoto and Kokubo et al. in the late 
70's.113-115 In one publication, the effect of stoichiometric metal additives, namely Cu(II), 
MoO42-, or WO42-, in combination with t-BuOOH was reported, though the results were 
less promising than other systems tested in terms of yield and selectivity.113 In 1983, T. 
Kokubo et al. investigated the asymmetric OsO4-catalyzed dihydroxylation of alkenes 
with BSA as a scaffold with remarkable success (Scheme 4).116 An ee of 68 at a TON of 
40 in the dihydroxylation of -methylstyrene 10 with t-BuOOH as oxidant was reported. 
Scheme 4. Asymmetric dihydroxylation of -methylstyrene with OsO4/t-BuOOH in the 
presence of bovine serum albumin (BSA). 
 
 
Cytochromes P450 have long attracted the attention of chemists. The ability of these 
enzymes to catalyze regio- and stereo-selective oxidative processes using molecular 
oxygen and reducing equivalents from NAD(P)H has so far been impossible to mimic 
reliably with synthetic models. The sophisticated redox machinery required to transfer 
22 
electrons from reduced nicotinamide cofactors to the heme center and generate an 
active iron-oxo species has contributed to the interest in these systems,117 but it also 
hampers the application of P450 variants in synthetic processes.118 Hemoglobin, another 
heme-containg metalloprotein, has been shown to catalyze P450-type oxidations when 
supported by an NADPH-cytochrome P450 reductase containing FAD and FMN 
cofactors.119 Kokubo, Sassa, and Kaiser reported in 1987 on a catalytically competent 7-
cyanoisoalloxazine-hemoglobin conjugate.120 The flavin-substituted hemoglobin hybrid, 
named flavohemoglobin, catalyzed the p-hydroxylation of aniline 11 in the absence of 
NADPH-cytochrome P450 reductase with a higher rate than the reconstituted system 
and with a Km value similar to that of the hemoglobin scaffold (Table 2, Scheme 5). The 
flavin derivative was attached to cysteine -93 through a glycine-aminoethanethiol-linker. 
The X-ray structure (1988) of flavohemoglobin revealed that: i) the flavin derivative is 
readily accessible to NADPH ii) the center of the isoalloxazine and the heme of the 
same subunit are 14 Å apart iii) the flavins of neighbouring subunits are in close contact, 
possibly enabling electron transfer between subunits.121 Natural flavohemoglobins exist, 
for example in E. coli.122 
Table 2. Comparison of catalytic paramters of flavohemoglobin with hemoglobin and reductase 
complemented hemoglobin.  
 
Entry Protein 
kcat
app 
(min-1) 
Km
app 
(mM) 
1 flavohemoglobin 0.169 5.3 
2 
hemoglobin 
+ P450-reductase 
0.127 5.3 
3 hemoglobina 0.022 5.6 
 
Scheme 5: Hydroxylation of aniline 11 catalyzed by flavohemoglobin, reductase-
complemented hemoglobin or the non-modified parental protein. 
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Although enzymes are frequently highly substrate-specific, this is by no means a general 
feature. The introduction of specificity to a natural metalloenzyme by complementation 
with a molecular recognition element was demonstrated by Corey and Schultz in 1987. 
Upon attachment of an oligonucleotide via a disulfide bridge, the Ca(II)-dependent 
staphylococcal nuclease cleaved single-stranded DNA in proximity to the attachment 
site. Only superstoichiometric conditions were reported.123 In a similar manner, various 
oligonucleotide binding proteins or protein domains were converted to oligonucleotide 
cleaving proteins via covalent modification with EDTA or phenanthroline complexes of 
Fe(II) or Cu(II), respectively.124-127 The combination of a reducing agent such as a thiol 
or ascorbic acid with molecular oxygen resulted in oxidative cleavage of the 
oligonucleotide backbone.128 The systems were typically employed in 
superstoichiometric amounts relative to the oligonucleotide. 
The ability to raise monoclonal antibodies against any hapten inspired ambitious 
research into the generation of antibody-based artificial metalloenzymes. It was 
envisioned that these could possess the ability to discriminate substrates and hence 
provide specificity toward cleavage motifs.129 Iverson and Lerner first reported in 1989 
on a specific antibody-based ArM hydrolase for peptide substrates.130 Monoclonal 
antibodies were raised against a peptide (trien)Co(III) complex 12 (trien = 
triethylenetetramine). Substitution of the hapten for other metal(trien) complexes led to 
active peptidases that could distinguish between structurally related substrates 13-18 
and cleaved a specific peptide bond in the small set of peptidic substrates investigated 
17-18; Scheme 6. The antibody ArM design was based on the prospective exchange of 
a coordinatively inert octahedral Co(III) complex used as the hapten against a kinetically 
more labile complex used for catalysis. Various metal(trien) complexes were tested 
employed, and a turnover number of 400 with a turnover frequency of 6  10-4 s-1 was 
reported.  
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Scheme 6. Metal-dependent antibodies for specific cleavage of peptidic substrates. a) 
Kinetically inert cobalt(III) complex employed as hapten; b) peptidic structures not 
accepted as substrates; c) cleavage of peptidic substrates with antibody 28F11 in the 
presence of Zn(II)trien. 
 
  
Following Kaiser's work demonstrating that hemoglobin could be converted into a 
reductase-independent hydroxylase, Sasaki and Kaiser decorated Fe(III) coproporphyrin 
with four identical fifteen-residue peptides.131 In the presence of acetylflavin and NADPH, 
the resulting 'helichrome' hydroxylated aniline with kcat and Km values of 0.02 min-1 and 
Km = 5.0 mM, respectively. The unmodified Fe(III) coproporphyrin showed only negligible 
hydroxylase activity under the same conditions. The study, published in 1989 constitutes, 
to the best of our knowledge, the first report of a de novo 'heme'-enzyme. 
Cochran and Schultz raised in 1990 monoclonal antibodies against N-
methylmesoporphyrin IX 19 as a hapten (Figure 2).132 N-methylporphyrins displays out-
of-plane distortion and can be considered as a transition state model for the metalation 
of the porphyrin, a reaction typically catalyzed by ferrochelatase in the conversion of 
protoporphyrin to heme. Three purified antibodies were specific for the hapten, and two 
of these catalyzed Zn(II)- and Cu(II)-porphyrin complex formation. Further studies 
revealed that the same antibody was effectively inhibited by iron(III) mesoporphyrin 20. 
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Intriguingly, the resulting construct catalyzed the oxidation of a range of typical 
chromogenic peroxidase substrates (using H2O2 as a stoichiometric oxidant) with 
significantly higher rates than iron(III) mesoporphyrin itself.133 Notably, ABTS and 
pyrogallol red were converted by the construct, but not by iron(III) mesoporphyrin. In a 
related study, Harada and coworkers reported several years later that antigen binding 
fragments in combination with meso-tetrakis(4-carboxyphenyl)porphyrin (TCPP) 
complexes of Mn(III) and Fe(III) catalyzed the oxidation of pyrogallol with H2O2 
exclusively while other substrates tested by Cochran and Schulz such as hydroquinone, 
resorcinol, catechol and ABTS with a higher redox potential were not converted.134  
In 1990, E. Keinan et al. raised antibodies against the water soluble Sn(IV) porphyrin 
complex meso-tetrakis(4-carboxyvinylphenyl)porphinato tin(IV)dihydroxide 
(Sn(TCP)(OH)2) 21, Figure 2.135 Antibody metallation with Mn(III)(TCP) cofactor 22 led 
to an ArM that catalyzed the epoxidation of styrene in the presence of iodosobenzene. 
The highest activity was observed under heterogeneous conditions in CH2Cl2, but no 
enantioinduction was detected. 
 Figure 2. Haptens and cofactor precursors for monoclonal antibody-based, metallo-
porphyrin-dependent artificial metalloenzymes. a) N-methylated porphyrin as a transition 
state mimic for ferrochelatase afforded an antibody for Zn(II) and Cu(II) mesoporphyrin 
formation; b) the same antibody formed an active oxidase upon loading with  
Fe(III)mesoporphyrin; c) water soluble Sn(TCP)(OH)2 used as a hapten to raise 
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monoclonal antibodies that were subsequentely combined with Mn(TCP)Cl to yield an 
artificial epoxidase.  
 
Despite the prevalence of non-covalent cofactor incorporation in early ArM efforts, work 
on covalent incorporation was also actively pursued. Germanas and Kaiser reported an 
artificial oxidase based on a covalently bound Cu(II)-bipyridine complex linked to the 
cysteine in the active site of papain. The construct catalyzed the air-oxidation of ascorbic 
acid and more lipophilic derivatives at 15 to 26 fold higher rates compared to the free 
cofactor.136 Although no catalysis was probed, in 1993, Gray, Imperiali, and coworkers 
demonstrated photoinduced electron transfer between a covalently linked Ru-center and 
heme in a cytochrome c mutant. The heme-bearing mutant beared a Ru(bipy)2-fragment 
coordinated to a bipyridylalanine-bearing peptide constructed by semisynthesis.137 
In 1993, Lerner, Janda, and coworkers disclosed a strategy to generate an antibody-
based ArM hydrolase using a hapten that contained a methylpyridinium unit 23, rather 
than a metal moiety (Scheme 7).138  Based on the activation of picolinic acid esters by 
Lewis acids coordinated to the pyridine nitrogen atom, it was envisioned that the 
methylpyridinium-substituted hapten would select for antibodies that address to scaffold 
design criteria. First, the methyl group in the hapten would act as a placeholder for a 
metal ion. Second, the positive charge would elicit the expression of carboxylate 
residues to serve as additional ligands near the prospective metal binding site and 
thereby increase metal affinity. The ester moiety envisaged as a cleavage site, or more 
specifically, the expected tetrahedal intermediate, was simulated with a hydroxyl 
functional group. Upon metallation with Zn(II), the resulting antibody-based ArM showed 
a > 10,000-fold rate acceleration against background and a > 1,000-fold rate 
acceleration against Zn(II) in equivalent concentration. The affinity of the antibody for 
Zn(II) and the substrate complexed to Zn(II) was modest, whereas the affinity for the 
substrate itself was substantially higher. 
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Scheme 7. Monoclonal antibodies catalyze the hydrolysis of a specific picolinic acid 
ester in the presence of Zn(II). a) N-methyl pyridinium employed as the hapten; b) 
substrates not accepted by the antibody; c) hydrolysis of the substrate by the antibody in 
the presence of Zn(II). 
 
 
Imperiali and Roy reported in 1994 on an artificial transaminase generated by 
reassembly of the subtilisin-cleaved bovine ribonuclease A (RNase A) with a synthetic 
peptide fragment carrying a pyridoxal derivative, Figure 3. One reassembled construct 
displayed eighteen-fold rate acceleration for the conversion of L-alanine to pyruvate 
under single turnover conditions compared to the pyridoxal-derivative carrying the 
peptide fragment alone. Accelerating effects of metal ions observed with pyridoxal 
models had been studied previously and consequently their addition was probed in this 
complex system.139 Cu(II)-ions had either beneficial or detrimental effects on the rate 
depending on the peptide fragment employed.140 In a subsequent study, multiple 
turnovers could be realized in the conversion of pyruvate to alanine through the addition 
of L-phenylalanine accompanied by a moderate enantioselectivity.141 
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Figure 3. An artificial transaminase based on RNase A. RNase A is cleaved by subtilisin 
into fragments termed S-protein140 and S-peptide (magenta). Reassembly of S-protein 
with suitable synthetic S-peptides affords functional supramolecular constructs. a) The 
side chain of 8-Phe targeted for cofactor introduction is displayed in stick mode (PDB ID 
3DH5); b) unnatural amino acid used to introduce the pyridoxal mimic into the synthetic 
S-peptide; c) S-peptide bearing the pyridoxal mimic as a side chain resulting from 
deprotection and oxidation; d) postulated interaction of Cu(II)-ions with the Schiff-base 
formed by condensation of side chain functionality with L-alanine. 
 
Craik and coworkers engineered a metal binding site into trypsin in order to change its 
substrate specificity.142 A double mutation to introduce histidines in the S2' pocket 
(N143H-E151H) allowed selective cleavage of the substrate AGPYAXSS, containing 
tyrosine at P1. Cleavage occured exclusively upon addition of either Zn(II) or Ni(II) and if 
the peptide contained a histidine at P2' (X = H; Figure 4). WT-trypsin was also able to 
cleave this substrate in the presence of Zn(II) at 10-fold lower rate, although cleavage 
after tyrosine is highly disfavored in the absence of zinc. This unexpected result was 
rationalized by complexation of the substrate with the participation of glutamate 151. 
Indeed, exchange of glutamate for glutamine led to an inactive mutant towards 
AGPYAHSS.  
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Figure 4. Modifying the substrate profile of trypsin through an engineered metal binding 
site for substrate coordination. Adapted with permission from ref.142. Copyright 1995 
American Chemical Society. 
 
Starting in 1997, Davies and Distefano reported covalent scaffold modifications to 
anchor transition metal complexes inside fatty acid binding proteins. Iodoacetamido-
1,10-phenanthroline was reacted with a unique cysteine residue inside the cavity (V = 
600 Å3) of adipocyte lipid binding protein (ALBP) resulting, after complexation with Cu(II), 
in ALBP-Phen-Cu(II) (PDB ID 1A18) for the stereoselective hydrolysis of racemic esters 
such as 25 and 26 although only modest activity was observed (Scheme 8).143-144 In a 
subsequent study, the position of the phenanthroline inside the protein cavity was varied 
by site directed mutagenesis. The resulting selectivities and activities were moderately 
but significantly affected (Figure 5).145 
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Figure 5. Cartoon representation of ALBP protein (PDB: 1A18) studied by Distefano.143-
145 Highlighted 1,10-phenanthroline (coloured in green C, blue N and red O) linked to 
Cys117. Side chains of aminoacids mutated to cysteine in susequent constructs with 
alternative phenanthroline positions are highlighted as yellow sticks. 
 
Scheme 8. Kinetic resolution of racemic amino acid esters catalyzed by a Cu(II)-
phenanthroline complex anchored covalently to a cysteine residue in the cavity of ALBP.  
 
 
Another set of constructs resulted from immobilisation of a pyridoxamine-derived 
cofactor by cysteine linkage via disulfide bond formation in ALBP and the closely related 
intestinal fatty acid binding protein (IFABP).146 A 1998 study scrutinized the effect of 
Cu(II), Ni(II), and Zn(II) on the catalytic performance resulting in rate acceleration but 
also erosion of enantioselectivity for the transamination of keto-carboxylic acids with 
phenylalanine as a sacrificial donor.147 
Inspired by the phytase inhibition by transition metal oxoanions and the structures of 
vanadium chloroperoxidases, Sheldon and coworkers doped phytase from Aspergillus 
ficuum with vanadate.148 The resulting ArM oxidized thioanisole 27 in the presence of 
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H2O2 at considerably increased rates relative to free vanadate and provided an ee of up 
to 66% (S)-28, Scheme 9. Unexpectedly, phytase even in the absence of vanadate also 
catalyzed the reaction, albeit at reduced rates and enantioselectivity.149-150  Subsequent 
studies examined a range of protein hosts doped with various transition metal oxoanions, 
including MoO42-, ReO4-, and WO42-. Although significant enantiomeric excess and rate 
acceleration was observed in the oxidation of thioanisole, none of the systems tested 
could improve on the original phytase-vanadate system.  
Scheme 9. Sulfoxidation of thioanisole with H2O2 catalyzed by vanadate-doped phytase. 
 
 
Finn, Lerner, and Barbas, III, published in 1998 a study on the effect of metal ions on 
rate and enantioselectivity of antibody catalyzed aldol reactions.151 The antibodies 
(33F12 and 38C2) were originally raised against a hapten able to form a covalent 
intermediate with a reactive lysine residue in the antibody active site via reactive 
immunization.152-153 A wide range of metal ions was examined, but substantial effects 
were only observed for Pd(II) salts: rate enhancements of 2.3-2.6 fold with variable 
enantioselectivity. The authors concluded that a direct binding of Pd in the active site 
seemed unlikely given the moderate effect and favoured instead an allosteric interaction. 
Following Whiteside's - at the time two-decade old - lead, Chan and coworkers 
published in 1999 a study in which a more rigid and, importantly, enantiopure pyrphos 
ligand was biotinylated and the corresponding Rh(I)-complex 29 incorporated into 
avidin.154 The authors studied the effect of hydrogen pressure, temperature and 
stereochemistry of the pyrphos moiety on the catalysis outcome in the hydrogenation of 
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itaconic acid 30, Scheme 10. Although stereoselectivity was improved in the presence of 
avidin and could even be inverted compared to the protein free cofactor, only moderate 
enantioselectivities were reported. 
Scheme 10. Asymmetric hydrogenation of itaconic acid catalyzed by an enantiopure 
biotinylated Rh-diphosphine complex in the presence of avidin.  
 
 
Nimri and Keinan reported in the same year on antibodies raised against a modified 
hapten compared to Keinan's previous design from 1990 (Figure 2 c).155 Apart from a 
variation of the porphyrin scaffold (TCPP instead of TCP), the axial hydoxo-ligands of 
the tin center were exchanged for bulky -naphthoxy-groups with the intention of eliciting 
a substrate binding site in the antibody scaffold. Antibody metallation with TCPP-Ru(II)-
CO led to an active and enantioselective ArM sulfoxidase in the presence of 
iodosobenzene. A kcat of 24 min-1, a KM of 10 mM, and an ee of 43% were obtained for 
the oxidation of thioanisole 27. A significantly higher kcat-value (174 min-1) was 
determined for the electron-rich substrate 4-methoxythioanisole, albeit at the expense of 
a diminished enantioselectivity (27% ee).  
Marchetti and coworkers studied the biphasic rhodium-catalyzed hydroformylation of 
alkenes in the presence of a range of protein scaffolds. The initial study was published in 
2000 and followed by a more detailed investigation in 2002.156-157 The most successful 
system reported was generated by combining human serum albumin with 
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[Rh(acac)(CO)2]. A TON of 741,000 was observed at a TOF of 30,000 h-1. At higher 
catalyst loadings (S : C = 10,400 : 1) good recyclability was demonstrated. 1,1-
diarylethenes were not viable ArM substrates despite their reactivity toward the common 
TPPTS-Rh(I) system (TPPTS = triphenylphosphine-3,3',3''-trisulfonic acid trisodium salt). 
A branched : linear-ratio of 90 : 10 was observed for styrene, whereas only a qualitative 
comment on stereoinduction (i.e. very low, but observable) was made. Stereoselectivity 
in biphasic hydroformylation reactions is generally considered to be challenging.158  
In 2002, Nicholas, Janda and coworkers published an application of a monoclonal 
antibody for the generation of an artificial metalloenzyme.159 Whereas previously 
antibodies were raised against metal complexes or ligands for the generation of ArMs, 
the authors relied on an antibody raised for a metal-free aldolase. Addition of a 
copper(II)-bis-imidazole complex afforded a catalytic metalloantibody for the hydrolysis 
of picolinic ester 24 (kcat = 2.3 min-1, Km = 2.2 mM).152-153  
The advent of increasingly convenient site directed mutagenesis in the late 70's opened 
new opportunities to optimize natural enzymes enzymes for biocatalysis.160-161 The 
possibilities for biocatalyst development were further expanded by the development of 
directed evolution methods involving iterative rounds of random mutagenesis or gene 
shuffling followed by screening or selection.162 A wide range of site-directed and random 
mutagenesis strategies are now commonly used to rapidly optimize biocatalyst activity, 
while limiting the screening effort.163-164  
Despite these advances, the considerable effort required to express, purify, modify, and 
evaluate protein scaffolds for ArM catalysis posed and continues to pose a considerable 
obstacle to ArMs optimization via mutagenesis. In 2002, Reetz proposed in conceptual 
articles the application of directed evolution protocols to hybrid catalyst development for 
non-biological reactions such as hydroformylation, olefin hydrogenation, metathesis, and 
34 
allylic substitution.165-166 In contrast, Ward and coworkers initially focused on a chemo-
genetic strategy to reduce the number of ArM components (protein scaffolds and 
cofactors) and simplify ArM optimization. This strategy involves the combination of a 
small set of protein mutants with a small set of cofactor variants to generate ArM 
diversity.31  
Many exciting studies on systems related to ArMs but outside the scope of this review as 
outlined in the introduction were reported during the timeframe discussed in this section. 
These include active site redesign of natural metalloenzymes to elucidate structure-
function relationships,110 and early efforts on de-novo designed coiled-coil and helical 
bundle metallopeptides that would later be used for ArM catalysis.167-169 Considering the 
widened opportunities for rational design guided by structural information and molecular 
modelling, standardized and new molecular biology protocols and kits, the renewed 
interest in water compatible transition metal catalysts and, a few years later, affordable 
gene synthesis, the ground was set for further research endeavors in the field of artificial 
metalloenzymes.  
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4. Reduction Chemistry 
4.1 Hydrogenation 
The discovery of homogeneous, transition metal phosphine complexes capable of 
promoting the addition of molecular hydrogen to carbon-carbon double bonds ultimately 
precipitated the entire field of asymmetric transition metal catalysis.101, 170 Factors 
contributing to the importance of this reaction for organic synthesis include its i) perfect 
atom economy, ii) high reaction rates, iii) high tunability via ligand design, and iv) ability 
to generate valuable, chiral products. Asymmetric hydrogenation has also been 
extensively explored as a benchmark reaction for artificial metalloenzymes.  
As previously noted, Whitesides' seminal example of asymmetric hydrogenation using a 
biotinylated Rh(I)-bisphosphine complex embedded within avidin constituted not only the 
first example of ArM-catalyzed hydrogenation, but also the first example of asymmetric 
catalysis using an ArM and the first example of ArM formation via non-covalent cofactor 
anchoring. This work was first revisited by Chan and coworkers in 1999 (Scheme 10).2, 
154 M. T. Reetz later demonstrated that Cu-, Pd-, and Rh-complexes of maleimide-
substituted dipyridine compounds (Figure 6) could readily alkylate the active site 
cysteine of papain, a cysteine protease. Only preliminary catalytic activity was reported 
for these ArMs, which were reported to catalyze hydrogenation with low 
enantioselectivity.165-166 
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Figure 6: Dipyridine complexes by Reetz.165 
 
Initial efforts in the Ward group on building an artificial hydrogenase aimed at improving 
the original Whitesides’ system. Instead of avidin (pI = 10.4), streptavidin (pI = 6.2) with 
an anticipated improved affinity for cationic complexes such as [Rh(COD)(34)]+ was 
used. Position S112171 was targeted for mutagenesis and the resulting 20 isoforms 
combined with 22 biotinylated ligands with variable spacer units and two different 
bisphosphine chelating groups 33, 35 precomplexed with [Rh(COD)2]BF4 for individual 
experiments.44, 172-177 A mix of two dehydroamino acid derivatives as substrates was 
hydrogenated simultaneously to yield amino acid derivatives 31, 32. Results (Scheme 
11 and Table 3) can be summarized as follows:  
i) Generally, the “chemical” Rh-complex library contributed more to diversity 
than the “genetic” Sav-mutant library.  
ii) The more flexible bisphosphine 33 scaffold afforded more active and selective 
ArMs than the rigid six-membered chelate formed with 35. 
iii) The two substrates displayed similar reactivity and selectivity profiles. This 
suggested a broad substrate scope of the artificial transfer hydrogenase, 
reminiscent of homogeneous catalysts. 
iv) Mutation at position S112X enabled an inversion of enantioselectivity (Table 3, 
entries 13 and 14) which could be optimized by choosing suitable ligand, 
mutant (X = H, K, R; Table 3, entries 2-4) and linker combinations. 
Scheme 11: Biotinylated rhodium diphosphine complexes anchored within Sav catalyze 
the asymmetric hydrogenation of dehydroamino acid derivatives. To optimize the 
reaction, a library of biotinylated rhodium complexes with varying spacers and ligand 
head groups a) was combined with a Sav site-saturation mutagenesis library of position 
S112. Both conversion and enantioselectivity for each protein-ligand combination are 
summarized in a fingerprint display b). Enantiopure amino acid spacer with flexible head 
group 33 c). Adapted with permission from ref.176 Copyright Wiley VCH 2005. 
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Table 3. Selected results for chemogenetic optimization of the artificial hydrogenase 
based on the biotin-(strept)avidin technology.  
 
Entry Ligand Protein 
31 
ee (%) 
31 
Conv. (%) 
32 
ee (%) 
32 
Conv. (%) 
1 34 WT Sav 94 (R) quant. 93 (R) 84 
2 40 S112H 58 (S) quant. 81 (S) 88 
3 40 S112K 63 (S) quant. 88 (S) 89 
4 40 S112R 63 (S) quant. 86 (S) 71 
5 38 S112W 59 (S) 96 33 (S) 8 
6 39 S112Q 87 (S) quant. 92 (S) 77 
7 42 WT Avi 87 (S) quant. 89 (S) quant. 
8 42 WT Sav 86 (S) quant. 91 (S) quant. 
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9 
10 
11 
12 
13 
14 
42 
42 
42 
42 
43 
43 
WT Savb 
WT Savc 
WT Savd 
S112W 
S112H 
S112M 
87 (S) 
83 (S) 
76 (S) 
95 (S) 
87 (S) 
73 (R) 
quant. 
90 
76 
quant. 
quant. 
quant. 
86 (S) 
87 (S) 
89 (S) 
95 (S) 
78 (S) 
87 (R) 
94 
85 
36 
quant. 
65 
quant. 
a quant.: quantitative conversion; b Reaction carried out in 45% DMSO; c Biphasic with EtOAc; d Protein immobilization on biotin-
sepharose.  
 
In early studies, van Koten and Klein-Gebbink demonstrated that lipase inhibitors, such 
as nitrophenol phosphonate esters, can be used to selectively anchor metallopincers 
within Cutinase (44).178-180 Cutinase from Fusarium solani pisi is a 21 kDa lipase 
containing a Ser120-Asp175-His188 catalytic triad that hydrolyses fatty acids. Phosphonate 
esters function as transition-state analogues for this reaction and react irreversibly with 
Ser120. A pincer–metal complex linked to a phosphonate moiety (45 or 46) may thus be 
suitable for covalent anchoring to cutinase. (Scheme 12). M. T. Reetz and coworkers 
discussed related studies with an esterase in 2002, but the resulting construct suffered 
from low hydrolytic stability. They suggested to improve hydrolytic stabilty by exchanging 
a nitrophenoxy-group at phosphorus for an ethoxy group, a strategy later realized by van 
Koten and Klein-Gebink.165 
Scheme 12. Covalent anchoring of pincer–metal complexes via nucleophilic substitution 
of an activated phosphonate ester Ser 120 in the active site of cutinase 44. The 
anchoring is conveniently monitored by the release of para-nitrophenolate. 
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van Koten and Klein-Gebbink subsequently extended their approach with Pd- and Pt-
pincer complexes to Rh-based systems for the creation of artificial hydrogenases.181 
Building on the work of Kühn et al. concerning the hydrogenation of acetophenone in 
aqueous media with rhodium N-heterocyclic carbenes (NHCs),182 Klein-Gebbink 
covalently linked the lipase inhibitor 47 within Cutinase 44 and CalB (33.5 kDa, lipase 
from Candida antarctica), Scheme 13.183  
Scheme 13. Covalent anchoring of a Rh(NHC) in serine-hydrolases for the creation of 
artificial hydrogenases. 
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The resulting hybrids 47·Cutinase and 47·CalB (obtained using Cutinase and CalB 
respectively), were tested in the hydrogenation of acetophenone 48, and methyl 2-
acetamidoacrylate 49 (Scheme 14). Acetophenone was reduced in 90% yield (18 TON) 
with the free Rh-NHC catalyst (Table 4, entry 1), while the Rh-ArMs showed a reduced 
catalytic activity, yielding 1-phenylethanol 50 in 27% and 0% yield for Rh-cutinase 
47·Cutinase and 47·CalB, respectively (Table 4, entries 2 and 3). For the hydrogenation 
of the olefinic substrate, both artificial hydrogenases afforded complete conversion to 
methyl-acetylalaninate 51, (Table 4, entries 5 and 6), highlighting the preferred reduction 
of olefins over ketones.184 Accordingly, 47·CalB was fully chemoselective for the 
hydrogenation of olefin 49 (Table 4, entries 3 and 6), highlighting the benefit of the deep 
binding pocket provided by the active site in CalB to discriminate between both 
substrates. Similar results were observed for 47·Cutinase at shorter reaction times 
(Table 4, entries 7-10). Unfortunately, no enantioselectivity was observed for any of the 
systems reported. These examples highlight the potential of second coordination sphere 
interactions provided by a host protein to discriminate between similarly reactive 
substrates. 
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Table 4. Selected results for the catalytic hydrogenation of acetophenone 48 and methyl 
2-acetamidoacrylate 49 with 47·Cutinase and 47·CalB. 
 
Entry Protein Sub. T (h) 
Ratio 
[Rh]/[Prot] 
ee 
(%) 
Conv. 
(%) 
TON 
1 – 48 20 - rac. 90 18 
2 cutinase 48 20 1 rac. 27 5.4 
3 CalB 48 20 1 rac. 0 0 
4 – 49 20 - rac. >99 20 
5 cutinase 49 20 1 rac. >99 20 
6 CalB 49 20 1 rac. >99 20 
7 – 48+49 20 - rac. 71, 93a 14, 19b 
8 cutinase 48+49 20 1 rac. 15, 78a 3, 16b 
9 – 48+49 0.66 - rac. 15, 70a 3, 14b 
10 cutinase 48+49 0.66 1 rac. 0, 63a 0, 13b 
a Conversion  for 1-phenylethanol 50 and methyl acetylalaninate 51, respectively. b TON for 1-phenylethanol 50 and methyl 
acetylalaninate 51, respectively. 
 
Scheme 14. Hydrogenation reaction catalalyzed by Cutinase and CalB. 
 
 
Papain was used by de Vries and coworkers as a scaffold for covalent attachment of a 
monodentate phosphite ligand (Scheme 15) that was subsequently metallated by 
[Rh(COD)]+ to generate an hydrogenase, but only very modest enantioselectivity was 
observed for the reduction of methyl-2-acetamidoacrylate.185  
Scheme 15. Immobilization of a bulky phosphite ligand by thioether formation with the 
reactive site cysteine of papain and subsequent complexation to Rh(I).  
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Kamer demonstrated that a non-catalytic cysteine residue in apo-photoactive yellow 
protein (PYP) could be selectively acylated with a carboxylic imidazolide-substituted 
bisphosphine. This phosphine could also be metallated with [Rh(cod)(MeCN)2]BF4 52 
and subsequently reacted with PYP to generate an artificial hydrogenase, which 
catalyzed the reduction of dimethyl itaconate (53) with full conversion but low ee 
(Scheme 16). 186 
Scheme 16. Hydrogenation of itaconic acid methyl ester catalyzed by 52. 
 
 
Harada and coworkers elicited a monoclonal antibody 1G8 against an achiral rhodium 
complex 54, Scheme 17.187 In the hydrogenation of the 2-acetamidoacrylic acid 8, the 
antibody 1G8 in combination with the hapten 54 afforded the reduction product with > 
98% ee (S) and a TON of 854. In contrast, racemic product was obtained with either 54 
or 54·BSA (BSA = bovine serum albumin) accompanied by lower TONs, Table 5. 
Table 5. Selected results for the hydrogenation of 8 catalyzed by an antibody loaded 
with hapten 54.  
 
Entry Proteina 
ee 
(%) 
TON 
 
1 No protein 0 409 
2 Antibody 1G8 > 98 (S) 854 
3 BSA 0 446 
 
Scheme 17. Combination of hapten 54 with the antibody results in a highly selective and 
active hydrogenation catalyst.  
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A number of researchers have explored the formation of ArMs by substituting the 
catalytic Zn ion located in a His3 binding site of carbonic anhydrase with different metals. 
For example, Kazlauskas created a cis-stilbene hydrogenase by metallation of apo-
hCAII with [Rh(cod)2]BF4.188 In addition to Rh incorporation in the CA active site, Rh also 
bound to the surface of the scaffold (Rh : hCAII = 6.5 by ICP-MS), leading to cis/trans 
isomerization (hydrogenation : isomerization = 6.3), Scheme 18. Site-directed 
mutagenesis was used to remove 9 histidine residues on the surface of hCAII that were 
believed to be involved in non-specific Rh-binding. The resulting ArM, 9*His-hCAII-[Rh], 
was found to have a reduced Rh : hCAII ratio of 1.8, yielded an increased 
hydrogenation : isomerization ratio of 20.6, and displayed improved specificity for cis-
stilbene, Table 6.  
Table 6. Hydrogenation and cis/trans isomerization of cis-stilbene catalyzed by 9*hCAII-
[Rh].  
 
Entry Catalyst Rh / hCAII Ratio. 55 / 56 
1 [Rh(cod)2]BF4 - 6.3 
2 hCAII-[Rh] 6.5 3.5 
3 9*His-hCAII-[Rh] 1.8 20.6 
 
Scheme 18. Hydrogenation of stilbene catalyzed by Rh-substituted hCAII.  
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Eppinger designed cofactors comprised of not only a catalytically active metal complex 
and a reactive group (epoxide) to covalently link the cofactor to protein scaffolds, but 
also a non-covalent amino acid recognition motif to steer the cofactor’s orientation within 
the scaffold.189 Half-sandwich ruthenium and rhodium cofactors were constructed and 
linked to cysteine proteases from the papain family to generate ArM hydrogenases. 
Ketone hydrogenation could be achieved with up to 64% ee for p-chloroacetophenone 
as substrate (Table 7 and Scheme 19). 
Table 7. Hydrogenation of aromatic ketones catalyzed by protein affinity labels.  
 
Entry Catalyst Substrate H2 (bar) t (h) Yield (%) ee (%) 
1 57 60 25 65 4 4 (R) 
2 57·Papain 60 75 96 89 24 (R) 
3 58·Papain 60 35 65 41 20 (R) 
4 59·Papain 60 96 75 44 20 (R) 
5 57·Papain 61 75 96 12 64 (R) 
 
Scheme 19. Hydrogenation of ketones catalyzed by Rh/Ru-substituted Papain. 
 
 
Knölker-type [4-(cyclopentadienone)Fe(CO)3] complexes catalyze the hydrogenation of 
polarized C-X double bonds (X = O, N).190 Renaud, Ward and coworkers investigated 
the potential of biotinylated Knölker-type complexes (Figure 7) to catalyze the 
enantioselective hydrogenation of aromatic ketones and imines inside Sav.191 A library 
of seven catalysts was synthesized with a biotin anchor tethered to the 
cyclopentadienone moiety via various linkers. Hydrogenation of ,,-trifluoro-
acetophenone afforded the corresponding secondary alcohol with 20 TON but only 9 % 
ee. The best enantioselectivity (34 % ee (R)-product) was obtained in the conversion of 
p-methoxy-acetophenone albeit with only a single turnover.  
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Figure 7. Biotinylated Knölker-type complexes.  
 
4.2 Hydrogen Generation: Towards Artificial Hydrogenases 
Today, scientists face the challenge of finding a sustainable source of energy to support 
tomorrow's societal needs. In this context, the valorization of solar energy is regarded by 
many as the "Holy Grail". However, efficient ways to convert solar energy into electricity 
or to a fuel, for storage and transportation, remains challenging. The development of 
artificial photosynthesis would allow conversion of sunlight into a fuel. Hydrogen (H2) is 
one of the most explored potential fuel candidates.60 Interestingly, its production from 
light and water has been observed in a living organism, and biocatalytic hydrogen 
production is catalyzed by hydrogenases. These are classified according to the nature of 
their active site, namely [FeFe]-, [NiFe]-, and [Fe]-hydrogenases. They catalyze the 
generation of H2 from protons and electrons provided by the electron transport chain of 
photosynthesis under near thermodynamic equilibrium conditions (i.e. no overpotential 
required) with high catalytic rates (TOF up to 20’000 s-1).68 Interestingly, hydrogenases 
operate both in the forward and reverse reaction and approach the efficiency of platinum.  
The technological applications of natural hydrogenases are impaired by i) their 
biosynthesis, which requires a complex maturation machinery, ii) their air sensitivity, and 
iii) their high molecular weight, which limits the number of active sites that can be 
immobilized on an electrode.58  
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The former limitation has been recently addressed by Fontecave and coworkers with the 
[FeFe]-hydrogenase HydA. The formation of its di-iron catalytic site (H-cluster) requires 
a complete maturation machinery, involving at least HydE, HydG and HydF. HydE and 
HydG provide the exogeneous ligands (CO, CN-, aza-propanedithiol), and HydF is the 
host protein in which the di-iron complex is ultimately assembled. In the last step, the 
nearly-mature di-iron complex is transferred to apo-HydA. Fontecave and coworkers 
demonstrated that a hydrogenase could be maturated in vitro, without the need of the 
entire maturation machinery. By loading an inactive artificial di-iron cofactor into apo-
HydF, they could transfer the synthetic complex into the apo form of the hydrogenase 
HydA, reconstituting a fully active HydA (Scheme 20, path a).192 This work 
unambiguously settled the controversy concerning the nature of the central atom of the 
bridging dithiolate ligand: catalytic activity was detected only in the presence of a 
nitrogen atom at this position (X in Scheme 20). Building on these results, Happe and 
Fontecave demonstrated that the use of HydF could even be avoided, that is, a direct 
loading of a synthetic complex into apo-HydA is possible (Scheme 20, path b).193 
Building upon this strategy, Hu and coworkers reported the direct reconstitution of an 
[Fe]-hydrogenase by loading its apo-form with a synthetic complex (Scheme 20, path 
c).194  
Scheme 20. Reconstitution of apo-hydrogenases with synthetic cofactors affords 
functional hydrogenases.  
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Besides shedding light on a long controversy concerning the key features of the cofactor, 
this methodology demonstrated that it is indeed possible to generate an active 
hydrogenase without the need of its complex maturation machinery. These results are of 
particular interest as: i) they allow the expression of the hydrogenase in a heterologous 
organism and ii) they open the possibility of introducing a fully synthetic cofactor within 
an apo-hydrogenase. The former feature should allow large screening campaigns of 
hydrogenases (e.g. homologous, directed evolution), to identify variants with higher 
activity and/or oxygen-resistance. The later was recently explored by Hu and Lubitz. 
They demonstrated that subtle variations of the cofactor lead, in most cases, to inactive 
hydrogenases, thus allowing to establish structure-activity relationships for the 
cofactor.195  
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The strategy described relies on a highly evolved scaffold, optimized for hydrogen 
production from its constituents (i.e. presence of proton- and electron-channels leading 
to and from the active site). The drawbacks of this strategy lie in the complexity and the 
size of the scaffold. For technological applications, one would favor a scaffold reduced to 
its minimum size and with a structure that is stable over a wide range of conditions. With 
large scale applications in mind, some groups explored the possibility of assembling 
synthetic complexes within various protein scaffolds to produce hydrogen. Only a limited 
number of catalysts and protein scaffolds have been used so far. Alternatively, the 
metal-substitution strategy to repurpose natural metalloenzymes for hydrogenase 
activity has also been used. In this section, we summarize the reported studies fitting 
into either category, with a particular emphasis on the catalytic activity of the resulting 
artificial hydrogenases. Several recent papers have also reviewed other aspects of 
artificial hydrogenases.57, 59, 61, 66, 68, 196  
Hayashi et al. inserted synthetic complexes that mimic the active site of [FeFe]-
hydrogenases into various host proteins. They datively anchored a di-iron complex into 
the active site of apo-cytochrome c.197 This protein naturally contains a Fe-
protoporphyrin(IX) cofactor that is covalently attached to the protein via thioether linkage 
at a Cys-X2-Cys motif. After removal of the heme, the Cys-X2-Cys motif of the apo-
cytochrome c could bind catalytically-inactive [Fe2(CO)9] 62 (Scheme 21) to afford an 
active artificial hydrogenase containing a [(µ-S)2Fe2(CO)6]-moiety. When irradiated in the 
presence of the photosensitizer (PS hereafter) [Ru(bpy)3]2+ and ascorbate as sacrificial 
electron donor, in Tris·HCl at pH 4.7, the ArM produced hydrogen (82 TON in 2h), with a 
maximum observed TOF of 0.035 s-1 (Table 8, entry 1). Notably, the electron transport 
from the PS to the active site is proposed to be the limiting factor in the reaction. 
Although the structure of this artificial hydrogenase is poorly defined, the protein 
environment provides robustness to the catalytic activity. When compared to 62 bound 
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to a synthetic heptapeptide containing the Cys-X2-Cys motif and a His residue to mimic 
the active site of cytochrome c, the entire protein scaffold performed better (i.e. ~4 fold 
higher TOF and ~8 fold higher TON), demonstrating a protective role of the protein 
environment.  
Next, Hayashi et al. selected a more rigid scaffold to engineer an artificial hydrogenase. 
The di-iron cofactor [(µ-S)2Fe2(CO)6]-moiety was anchored via a maleimide linker to the 
cysteine of apo-nitrobindin Q96C (Figure 8).198 As suggested by the docked structure, 
the synthetic complex 63, (Scheme 21) is embedded in the cavity formed by the β-barrel 
of nitrobindin, surrounded by a well-defined protein environment. Upon irradiation, the 
63·nitrobin generated hydrogen with a maximum TOF of 0.038 s-1 and up to 130 TON 
after 6 h of irradiation (120 after 2 h) (Table 8, entry 2). Under similar conditions, the free 
cofactor 63 performed c.a. 3 fold faster. This phenomenon is most likely due to a 
decreased accessibility of the complex inside the protein, decreasing the rate of electron 
transfer from the PS. Despite this decrease in rate, it is clear that the protein provides a 
stabilizing environment to 63 since its deactivation is slower than in solution. Compared 
to 62·cytochrome c, the activity of 63·nitrobin was less sensitive to the pH: raising the 
pH to 7.8 decreased the activity of the former by 93 % versus 72 % for the latter (Table 8, 
entry 3). In addition, due to the well-defined environment around the active site, 
improving catalytic activity by rationally mutating residues around at the β-barrel cavity 
can be envisioned.  
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Figure 8. Nitrobindin (PDB code 3EMM) was employed to create ArMs for 
hydrogenation,198 ring-closing metathesis,199 phenylacetylene polymerization200 and 
benzylic oxidation.201 To afford ArMs, nitrobindin was produced in absence of the heme 
cofactor. Residues highlighted in yellow were mutated to cysteine residues to covalently 
attach a catalyst. Improved substrate accommodation was achieved by replacing bulky 
residues flanking the active site cavity (magenta) with smaller hydrophobic residues. 
 
Scheme 21. Dative and covalent anchoring of [Fe2(CO)6] afford [FeFe]-hydrogenase 
mimics, upon irradiation in the presence of [Ru(bpy)3]2+ as photosensitizer.  
 
 
Another example of an artificial hydrogenase containing a biomimetic-center was 
recently reported by the group of Shafaat. This work is reminiscent of the pioneering 
work from the groups of Moura and LeGall.202-203 In this example, the aim was not to 
mimic the active site of the [FeFe]-hydrogenases, but those of [FeNi]-hydrogenases. For 
these systems, the nickel, coordinated by four cysteinate residues, is the redox-active 
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metal operating during the proton reduction. The first coordination sphere is reminiscent 
of rubredoxin. An iron to nickel substitution in the active site of rubredoxin yields an 
enzyme, termed NiRd, able to produce dihydrogen, Scheme 22, a). When irradiated in 
presence of [Ru(bpy)3]2+ and ascorbate, in phosphate buffer at pH 6.5, NiRd generated 
hydrogen at a rate of 0.0083 s-1 and afforded approximately 70 TON over 8 h (Table 8, 
entry 4). Using Ti(III)-citrate as a light-independent electron source, NiRd yielded up to 
300 TON in 8 h, at 22 °C at pH 9.4 (Table 8, entry 5), suggesting that, with a strong 
reductant, NiRd can generate hydrogen at pH > 7. Importantly, most of the catalyst can 
be recycled, indicating that the inactivation is not due to protein degradation. However, 
this system requires a high overpotential (540 mV at pH 3-5). It is proposed that 
mutagenesis of residues close to the Ni-center may help to improve the catalytic 
properties of this artificial hydrogenase. 
Scheme 22. Metal substitution in natural metalloenzymes yield artificial hydrogenases. 
The iron of rubredoxin can be replaced with nickel a). The iron in a heme protein can be 
substituted by cobalt either by demetallation followed by incubation with excess of 
[Co(Ac)2] b), or by removing the heme from the enzyme and inserting a [CoPP(IX)] 
complex c).  
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Following in Hayashi's footsteps, other groups have designed artificial hydrogenases 
based on heme-proteins. This family of proteins has been used extensively for their 
ability to bind heme moiety substituted by other metals as well as other planar 
complexes containing non-porphyrin ligands.204 In addition, the potential of Co-
porphyrins and cobaloximes for hydrogen production in aqueous solutions has been 
known since the 80’s.205-206 The latter usually require a smaller overpotential than the 
former, and both exhibit promising oxygen-tolerance properties. 
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Bren and coworker demonstrated that substituting iron by cobalt in enzymes containing 
iron-protoporphyrin(IX) affords efficient artificial hydrogenases. The iron of the heme-
protein cytochrome c552 from Hydrogenobacter thermophilus (Ht c-552) was substituted 
with cobalt, taking advantage of the thioethers linking the protoporphryrin(IX) ligand and 
the cysteines of the protein that anchor the porphyrin even under forcing conditions 
(Scheme 22 b).61 In this scaffold, the histidine residue acting as axial ligand was 
conserved.  However, the distal methionine was mutated to alanine (M61A) to keep a 
free coordination site for the proton reduction. Though no data was presented for 
photocatalysis, the electrocatalysis experiments showed remarkable stability for proton 
reduction: 11,000 TON after 6 h and up to 27,000 TON in 24 h at pH 7.0 (Table 8, entry 
6). The major drawback of this system lies in the high overpotential that is required (i.e. 
830 mV). On the other hand, comparing the performance of Co·Ht c-552 and CoMP11-
Ac, an eleven aminoacid proteolytic fragment of the horse cytochrome c containing a 
cobalt-substituted heme, highlights the beneficial effect of a full protein environment (for 
a related structure, see Fe-microperoxidase-8 217).207 CoMP11-Ac exhibits interesting 
proton reduction activity coupled with a remarkable oxygen tolerance. Although cobalt 
possesses an identical first coordination sphere, it is exposed to the solvent in CoMP11-
Ac but buried in the protein in Co·Ht c-552. The surrounding protein environment results 
in a longer catalyst lifetime (~24 h against ~4h), allowing to reach a ~10 fold higher 
TONs for the former. The presence of a defined protein environment however did not 
lead to a decrease of the overpotential required (830 vs 850 mV).  
Ghirlanda and coworkers used a cobalt-substituted myoglobin termed 64·Mb (i.e. dative 
anchoring via a His and no cysteine thioether linkages, Scheme 22 c).208 Upon 
irradiation at pH 7.0 in the presence of ascorbate and a photosensitizer, 64·Mb 
catalyzes the production of hydrogen in up to 518 TON in 12 h (Table 8, entry 7). This 
corresponds to a 4.3 fold increase of TON compared to the free cofactor 64, highlighting 
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the effect of the host protein. With this system, the maximum TON was observed at pH 
7.0. Upon lowering the pH, the cofactor is released from 64·Mb, and raising the pH 
decreases the proton concentration. In addition to the axial H93 ligation to the Co, 
second coordination sphere residues H64 and H97 form hydrogen bonds with the 
carboxylates of the cofactor 64. Mutating these residues positively affects the catalytic 
activity. The corresponding TONs are 234 (64·Mb), 331 (64·Mb H64A) and 512 (64·Mb 
H64A-H97A) at pH 6.5. This increase may arise from a flexibilization of the protein 
structure in the proximity of the catalyst, facilitating interactions of the protein-bound 
cofactor with the photosensitizer (i.e. facilitating the electron transfer). (Figure 15 for Mb 
active site). 
More recently, Ghirlanda and coworkers applied a similar strategy to anchor 64 within 
cytochrome b562.209 In this system, the metal of the heme is anchored via H102 and M7 
(Figure 9). Mutation of the methionine-7 to an alanine (M7A) results in a 2.5 fold 
increase in photocatalytic activity (305 vs 125 TON), as it liberates one coordination site 
for catalysis. Continuous removal of hydrogen increased 64·b562 M7A TON to 1450 
(Table 8, entry 8). Even in the presence of air, 64·b562 M7A afforded up to 400 TON. 
Upon catalyst stalling, addition of fresh photosensitizer ([Ru(bpy)3]2+) partially restored 
catalytic activity, while addition of fresh 64·b562 M7A did not.  
Next, 64·b562 M7D and 64·b562 M7E mutations were investigated. The authors 
speculated that the presence of a carboxylic acid in the vicinity of the catalytic center 
could enhance hydrogen production, similar to protonated amines.210-211 Although better 
than the WT, the activity of these carboxylate-bearing mutants did not surpass that of 
the M7A mutant, suggesting that these residues do not behave as proton relays.  
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Figure 9 Mutation of the coordinating methionine of a cobalt-substituted Cytochrome 
b562 (PDB code 1QPU) affords an artificial hydrogenase.209 
 
Artero and coworkers explored a similar strategy using cobalt complexes. Cobaloximes 
65 and 66 (Scheme 23) were inserted into the apo-form of the sperm whale 
myoglobin.204 The cobaloximes were shown to occupy the heme-site, where cobalt was 
coordinated by H93 and a water molecule. Modeling with 66 suggested that the 
coordinated water molecule could form a hydrogen bond with the distal histidine (H64). 
EPR parameters obtained for 65·Mb suggest that the cobalt is exposed to a hydrophobic 
environment. This environment may account for the difference in redox potential (of the 
Co(I)/Co(II) couple) between 65·Mb and 65·imidazole. This observation suggests that 
the second coordination sphere from the protein indeed influences the redox-properties 
of a protein-bound synthetic complex. Both 65·Mb and 66·Mb catalyzed dihydrogen 
production under neutral aqueous solution with a low overpotential (~200 mV). 66·Mb 
performed better than 65·Mb, and at pH 7.0, 66·Mb converted up to 65 % of the electron 
donor [Eu(EGTA)]2+ to H2, corresponding to 3.2 TON, within 5 min. For comparison free 
cofactor 66 was deactivated after 2.5 TON, indicating that Mb provided modest catalyst 
protection.  
Photochemical hydrogen production by cobaloxime·Mb ArMs was also performed  using 
deazaflavin (DAF hereafter) and tris buffer as electron donor. At pH 7.0, 66·Mb 
performed up to 5 TON in 15 min (Table 8, entry 9). In this case however, the free 
cofactor 66 outperformed the artificial hydrogenase, TON 8.3. Other heme-binding 
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proteins were also investigated as scaffolds to generate ArM hydrogenases using either 
65 or 66. These included: rat heme oxygenase 1 (HO1 hereafter) and Corynebacterium 
diphteriae heme oxygenase (HmuO hereafter).212 The resulting artificial hydrogenases 
66·HO1 and 66·HmuO were more active than 66·Mb both under thermal- and 
photochemical conditions. 66·HO1 converted up to 82 % of the electron donor 
[Eu(EGTA)]2+ into H2 within 5 min, corresponding to 6.2 TON (Table 8, entry 10). Both 
TON and TOF were higher than that of 66 free in solution. However, these did not 
outperform the free catalyst 66 under photocatalytic conditions:  at 10 µM concentration, 
66 afforded 20 TON in 15 min, versus 6.3 and 15.3 for 66·HO1 and 66·HmuO 
respectively (Table 8, entries 11 and 12). Despite the low overpotential required and the 
shielding effect provided by the protein, these artificial hydrogenases suffered from a 
poor affinity for the host.  
Scheme 23. Cobaloximes and nickel phosphines are synthetic complexes with high 
hydrogen production catalytic activity. Cobaloximes can be anchored via a histidine or a 
methionine residue of the apo-heme protein.  
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The artificial hydrogenases of Artero and coworkers proved to be better catalysts than 
the free cobaloximes at pH 7.0 in the case of thermal catalysis (using [Eu(EGTA)]2+ as 
electron donor), while in photocatalysis, the free catalysts performed better. This could 
arise from the shielding effect of the protein, obstructing interaction between the PS and 
the anchored catalyst. In addition, the deactivation of the catalyst occurred rapidly. The 
authors hypothesize that Co(III)–H intermediate may reduce the oxime ligand. A faster 
electron transfer to the catalyst could shorten the lifetime of this intermediate thereby 
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preventing ligand degradation. One way to achieve this would be to maintain the PS and 
the catalyst in close vicinity, thus favouring fast electron transfer. 
This issue has been elegantly addressed by Utschig and coworkers. In a first attempt, 
Utschig, Tiede and coworkers made use of the direct interaction between the synthetic 
complexes 67 and 68 with photosystem I (PSI hereafter).213-214 This natural component 
of the photosynthetic electron transport chain possesses both a light-harvesting center 
and a series of electron relays, scaffolded within a large protein assembly. They 
demonstrated that 67 and 68 interact with PSI in a non-covalent manner. In contrast to 
other artificial hydrogenases described herein, the interaction between PSI and the two 
complexes were not unambiguously defined: the authors hypothesize that interaction 
may occur at the hydrophobic patches of PSI (and possibly at a histidine residue in the 
case of 67). Following incubation of 67 with PSI, affording 67·PSI, ascorbate (as 
sacrificial electron source) and cytochrome c6 as electron transport (to reduce the 
oxidized PSI) were added, and dihydrogen evolution could be detected upon irradiation. 
Relative to the cobalt content, this system performed 2080 TON in 1.5 h, with a 
maximum TOF of 1.13 s-1, at pH 6.3 (Table 8, entry 13). Under similar conditions, 
68·PSI performed 1870 TON in 3 h (Table 8, entry 14). For both 67 and 68, analysis of 
the catalytic mixture upon completion of the reaction revealed that approximately 90 % 
of the metal was lost. The poorly defined and weak interactions between PSI and those 
catalysts combined with possible catalyst degradation pathways may lead to leaching 
during catalysis. To overcome this limitation, the authors combined 68 with apo-
flavodoxin (Fld), a protein known to interact via electrostatic interactions with the FB 
cluster of PSI. The authors hypothesized that 68 could be inserted is the FMN pocket of 
apo-flavodoxin. The metal content of the assembly was quantified, confirming this 
hypothesis. Irradiation of PSI in the presence of 30 equivalents of 68·flavodoxin led to 
the rapid production of dihydrogen relative to PSI, improving the photon to hydrogen 
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conversion. However, when converted to catalyst concentration (ie. 30 eq. vs. PSI), only 
94 TON were obtained after 4 h (Table 8, entry 15). Despite its efficiency and elegant 
design, this biomimetic artificial hydrogenase is challenging to handle because of the 
membrane-bound nature of the proteins.  
To reduce the complexity of the above system, Utschig and coworkers recently reported 
a simpler design, in which both the synthetic PS and the catalyst are anchored on a 
ferredoxin protein, acting as scaffold naturally containing an electron relay.215-216 This 
latter feature, as well as the defined and stable structure of the scaffold, differentiates 
their work with previous report from Hayashi and coworkers, in which a PS and a 
catalyst were attached on a peptide.217 Ferredoxin is a small electron carrier protein 
containing a [2Fe−2S]-cluster. The cofactors 65 or 67 were datively anchored at H90 
and the [Ru(bpy)3]2+-photosensitizer linked to C18 of ferredoxin. Only 40 % - 50% of the 
artificial hydrogenase included the covalently-bound PS, to afford 
65·ferredoxin·[Ru(bpy)3] and 67·ferredoxin·[Ru(bpy)3] respectively. Both ArMs produced 
dihydrogen under irradiation and in the presence of ascorbate at pH 6.3. In 6 h, 
65·ferredoxin·[Ru(bpy)3] and 67·ferredoxin·[Ru(bpy)3] yielded 210 and 650 TON 
respectively relative to the PS, with a maximum 0.047 s-1 TOF observed for the latter 
(Table 8, entries 16 and 17). Upon removal of the [2Fe−2S]-cluster from 
65·ferredoxin·[Ru(bpy)3], complete loss of photocatalytic activity resulted. Spectroscopic 
analysis suggested that electron transfer from Ru(II)* to cobalt does not occur. The 
authors elegantly demonstrated that this could be traced back to the loss of the 
[2Fe−2S]-electron relay, substituting it by its redox inactive [2Ga−2S]-congener. The 
quaternary structure of 65·ferredoxin was maintained but no photocatalytic dihydrogen 
evolution could be observed, suggesting that the extended distance between the 
cofactor and the PS prevents electron transfer in the absence of the electron relay 
station. The [2Fe−2S]-cluster is separated from the Ru PS and the cobalt cofactor by 
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approximately 15 Å and 12.5 Å, respectively. Anchoring the PS and the cofactor to a 
rigid scaffold not only keeps them in close vicinity, but also maintains a suitable distance 
between them, thus avoiding fast charge recombination after the electron transfer. This 
increase of the lifetime of the charge-separated state, in which Co(I) is a key 
intermediate, empowers the proton reduction. For 65·ferredoxin·[Ru(bpy)3], the lifetime 
of this state was determined to be ~6 ms. 
Finally, based on the observation that apo-flavodoxin can bind synthetic complexes, it 
was loaded with 65 and covalently modified by a [Ru(bpy)3]2+-moiety ~10 Å away from 
the FMN-binding site. This PS-catalyst distance is considerably shorter than within the 
ferredoxin host resulting in a faster direct electron transfer (~3000 times, based on 
distance alone), as well as a faster charge recombination. In contrast to the ferredoxin 
construct, only 85 TON were achieved by 65·flavodoxin·[Ru(bpy)3] in 6 h (Table 8, entry 
18). This corresponds to 40 % of the activity of 65·ferredoxin·[Ru(bpy)3], highlighting the 
superiority of assemblies in which the PS and the catalyst are far enough to slow down 
back-donation (within milliseconds), but in which an electron relay favours the first 
electron transfer event (within microseconds). Accordingly, the difference in activity of 
65·ferredoxin·[Ru(bpy)3] and 65·flavodoxin·[Ru(bpy)3] correlates well with the lifetime of 
the charge-separated state containing Co(I): for 65·flavodoxin·[Ru(bpy)3] and 
65·ferredoxin·[Ru(bpy)3] the lifetimes are ~800 µs  and ~6 ms respectively. 
Table 8. Selected results for dihydrogen production by artificial hydrogenases.  
 
Entry Cof. Proteina PSb 
Elec. 
donor 
[Cof] 
(µM) 
Ratio 
[PS] 
[Cof] 
t 
(h) 
pH 
T 
(°C) 
TOF 
(s-1) 
TON Ref 
1 65 cyt c [Ru(bpy)3]
2+ asc.c 14 10 2 4.7 25 0.035 82 197 
2 66 NB [Ru(bpy)3]
2+ asc.c 7.8 18 6 4.7 25 0.038 130 198 
3 66 NB [Ru(bpy)3]
2+ asc.c 7.8 18 6 7.8 25 nd 36.4 198 
4 Ni Rd [Ru(bpy)3]
2+ asc.c 2 500 8.3 6.5 4 0.008 70l 203 
5 Ni Rd - [Ti(citrate)]d 2.5 - 8 9.4 22 nd 300 203 
6 Co c-552 - -e 0.1 - 24 7.0 r.t. nd 27000 61 
7 64 Mb [Ru(bpy)3]
2+ asc.c 2.5 400 12 7.0 r.t. 0.025 518 208 
8 64 b-562 [Ru(bpy)3]
2+ asc.c 4 250 25 7.0 r.t. 0.025h 1450g 209 
9 66 Mb DAF Tris 30 0.5 0.25 7.0 r.t. 0.015i 5 204 
10 63 HO1 - 
[Eu(EGTA)]2- 
f 
40 - 0.08 7.0 r.t. 0.067j 6.2 212 
11 66 HO1 DAF Tris 10 0.5 0.25 7.0 r.t. 0.015k 6.3 212 
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12 66 HmuO DAF Tris 10 0.5 0.25 7.0 r.t. 0.058k 15.3 212 
13 67 PSI PSI asc.c,g 0.152 0.4 1.5 6.3 r.t. 1.13 2080 m 213 
14 68 PSI PSI asc.c,g 0.060 1 3 6.3 r.t. 0.73 1870 m 214 
15 68 Fld PSI asc.c,g 2 0.033 4 6.3 r.t. 0.042 94 m 214 
16 65 Fd c-[Ru(bpy)3]
2+ v asc.c 2 0.36 6 6.3 r.t. 0.014 210 n 216 
17 67 Fd c-[Ru(bpy)3]
2+ v asc.c 2 0.42 6 6.3 r.t. 0.047 650 n 215 
18 65 Fld c-[Ru(bpy)3]
2+ v asc.c 1.7 1 6 6.3 r.t. 0.008 85 n 215 
Entries highlighted in gray correspond to non-photocatalytic experiments. a apo-cytochrome c (cyt c); apo-nitrobindin (NB); 
rubredoxin (Rd); apo-Ht cytrochrome c552 M61A (c-552); myoglobin (Mb); apo-cytochrome b562 M7A (b-562) ; apo-rat heme 
oxygenase 1 (HO1); apo-Corynebacterium diphteriae heme oxygenase (HmuO); photosystem I (PSI) ; apo-flavodoxin (Fld) ; 
ferredoxin (Fd). b deazaflavin (DAF); [Ru(bpy)3]
2+ free in solution ([Ru(bpy)3]
2+) or covalently attached to the protein scaffold (c-
[Ru(bpy)3]
2+). c ascorbate 100mM (asc.); d [Ti(III)citrate], 39 mM ([Ti(citrate)]). e Electocatalysis. f 600 µM. g Cyt c6 (4-20 µM) was 
added as an electron carrier. h Derived from Fig. 5 of ref [209]. i Minimal value, estimated from Fig. 11 of ref [204]. j Minimal value, 
estimated their Fig. 7 of ref [212]. k Minimal value, estimated from Fig. S7 of ref [212]. l The 40 TON observed in the absence of catalyst 
were substracted from the 110 TON for NiRd, depicted in Fig.3.203  m Re-calculated relative to the metal cofactor. n Calculated relative 
to the PS, considering the metal cofactors embedded in a scaffold not containing a PS have no catalytic activity, based on the fact 
that solution of PS and cat at 1 µM did not yield the photocatalytic production of H2. 
 
In summary, the artificial hydrogenases reported to date show that anchoring a 
catalytically competent proton-reduction catalyst within a protein scaffold can impart 
compatibility with aqueous media at neutral pH and increase both TOF and TON. In 
some cases however, the artificial hydrogenases are less efficient than the cofactor 
alone. This is especially valid for photocatalytic systems whereby the PS/catalyst 
interactions are hampered, eventually leading to slow catalytic rates or catalyst 
degradation. The recent studies from Utschig and coworkers offer promising avenues to 
overcome this issue.  
Some advantageous aspects of artificial hydrogenases remain to be systematically 
explored. For example, very few reports on random mutagenesis or directed evolution 
schemes have been published, although such avenues are often suggested in the 
outlook of these publications. Only a handful of modifications in the direct environment of 
the metal have been tested either by mutating residues or by testing different scaffolds 
from a same family (e.g. heme-binding proteins). None of these examples led to a 
dramatic improvement of catalytic activity however. In contrast, directed evolution could 
be used to tune the protein environment, rather than the PS or the catalyst.218 Finally, in 
a biomimetic spirit, artificial hydrogenases could be improved by engineering facilitated 
pathway for proton/electron delivery/removal at the metal center, and gas release 
pathways, reminiscent of the channels and electron relays present in natural 
hydrogenases.  
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4.3 Transfer Hydrogenation 
Background. Catalytic asymmetric transfer hydrogenation (ATH) provides a powerful 
means for reducing unsaturated substrates including ketones, imines, nitro compounds, 
nitriles, oximes, ,-unsaturated carbonyl compounds, heterocycles, alkenes, and 
alkynes.219-227 It requires neither hazardous hydrogen gas nor pressure vessels. Instead, 
a number of cheap, non-toxic, and easy to handle reductants, including formic acid, 
formate salts or isopropanol, have been used as hydrogen donors. Recent advances 
and trends in ATH using homogeneous, heterogeneous, organo- and transition-metal 
catalysts were recently reviewed.228 
A major breakthrough in ATH was reported by Noyori and coworkers in 1995: 
enantiopure TsDPEN-Ru(II)-based complexes (TsDPEN = N-(p-toluenesulfonyl)-1,2-
diphenylethylenediamine) were found to be outstanding homogeneous catalysts for the 
asymmetric reduction of a variety of substrates.229-231 Building upon this finding, some of 
the most effective catalysts reported to date are d6-pianostool complexes of rhodium, 
iridium and ruthenium. As amply demonstrated by Xiao and coworkers, closely related 
homogenous catalysts are efficient for the asymmetric reduction of prochiral ketones 
and cyclic imines in water.232-234 This is obviously an important feature in the context of 
ArMs. 
In nature, NAD(P)H-dependent enzymes including ketoreductases, imine reductases 
(IRED), and ene reductases can be used for the asymmetric reduction of C=O, C=N and 
activated C=C bonds respectively. While both keto-235 and ene-reductases236 are well 
known and widely used on industrial scale,163 IREDs were only recently discovered by 
Nagasawa in 2011.237 These have been further exploited by, among others, the Turner 
and Hauer groups.238,239  
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In this section, we summarize the progress in artificial transfer hydrogenases (ATHases) 
for the asymmetric reduction of prochiral ketones, enones, imines as well as NAD(P)+ 
and its analogs. For several groups, ATHase has provided a fertile playground to 
benchmark various challenging concepts including: catalyst immobilization, directed 
evolution, enzyme cascades, allosteric regulation etc. These are presented at the end of 
this section. 
Transfer Hydrogenation of ketones. To assemble an artificial metalloenzyme for the 
asymmetric transfer hydrogenation of prochiral ketones, the Ward group set out to adapt 
Noyori's homogeneous d6-pianostool complexes bearing a Ts-DPEN-ligand.230 Several 
Ir(III), Rh(III) and Ru(II) d6-pianostool complexes were prepared by complexation of a 
achiral biotinylated N-arylsulfonamide-1,2-ethylenediamine ligands (69, q = ortho, meta, 
para) to either [5-Cp*IrCl(H2O)2]+, [5-Cp*IrCl(H2O)2]+, or [(6-arene)RuCl(H2O)2]+. The 
resulting pianostool complexes [(n-arene)M(69)Cl]+ were combined with an Sav site-
saturation mutagenesis library Sav S112X as well as selected single- and double point 
mutants (Scheme 24).18, 240 The aminoacid positions subjected to mutagenesis were 
selected based on their estimated proximity to the catalytic metal. Ward and coworkers 
first screened all cofactors [(n-arene)M(69)Cl]+ with a subset of Sav isoforms and only 
the best biotinylated catalysts were then screened with the entire set of proteins. The 
best catalystprotein combinations were evaluated toward various substrates. Selected 
results are summarized in Table 9.  
Noteworthy features for the ATHases included (Scheme 24 and Table 9):  
i) Complexes bearing a para-substituted spacer (70) outperform those with 
ortho- and meta-spacers. 
ii) Exchange of the capping arene ligand from benzene to p-cymene led to 
stereoinversion; this is most pronounced with mutants Sav S112K ((S)-
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selective) and Sav S112A ((R)-selective), respectively (Table 9, entries 6 vs. 
3). 
iii) Aryl alcohols 71-73 were obtained with good to very good ee (> 90%) whereas 
reduction of dialkyl ketones resulted in only modest ees.  
An X-crystal structure of the most (S)-selective artificial transfer hydrogenase 
(ATHase hereafter) [6-(benzene)Ru(70)Cl]Sav S112K was determined (PDB 2QCB, 
Figure 10).241 The following features are apparent: 
i) The Ru-center is located in the biotin-binding vestibule in close proximity to 
residues S112KA, L124A, S112KB, K121B (subscripts A and B refer to Sav 
monomers).  
ii) A (S)-Ru-Cl absolute configuration was determined for [6-
(benzene)Ru(70)Cl]Sav S112K. This configuration is reminiscent of the 
homogeneous catalytic system as both ArM and homogeneous catalyst, (S)-
reduction products are formed preferentially in the presence of an (S)-Ru-Cl 
moiety. This suggests that both catalysts rely on a similar enantioselection 
mechanism.  
iii) The short RuA······RuB distance (4.44 Å) suggests that it is unlikely that two 
neighboring cofactors can fit within a biotin-binding vestibule (which contains 
two biotin binding sites): the maximum activity and selectivity is achieved in 
the presence of two cofactors occupying one Sav tetramer. 
iv) The overall Sav structure in the complex-bound Sav vs. apo-Sav is virtually 
identical (RMSD = 0.276 Å).  
From the crystal structure, it was concluded that site-saturation mutagenesis libraries 
in position K121 and L124 may allow to further fine-tune the catalytic performance of 
the ATHase. Thus, the following libraries K121X, L124X, S112A-K121X, S112K-
K121X, S112A-L124X and S112K-L124X were produced to afford eighty double 
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mutants and forty single mutants. This Sav library was combined with both (S)- and 
(R)-selective cofactors [6-(benzene)Ru(70)Cl] and [6-(p-cymene)Ru(70)Cl] 
respectively. The resulting ATHase were screened for the reduction of aryl-alkyl and 
dialkylketones, Scheme 24. To speed-up the screening effort, the Sav mutants were 
tested in catalysis in semi-purified form. With this procedure, ATHases could be 
obtained that produced up to 97 % ee (R) and 92 % (S) for aryl-alkylkalcohols 71, 72 
and 73 (Table 9, entries 15-18) and up to ee 90 % (R) for dialkylalcohols 74 and 75 
(Table 9, entries 19-21).  
Scheme 24: An artificial transfer hydrogenase based on biotinylated Noyori-type d6-
pianostool complexes anchored within Sav catalyzes the asymmetric reduction of 
ketones.  
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Table 9. Summary of the catalytic performance of ATHase for the reduction of prochiral 
ketones.a 
 
Entry Complex Protein Product ee. (%) Conv. (%) 
1 [6-(p-cymene)Ru(70)Cl] WT Sav 71 89 (R) 95 
2 [6-(benzene)Ru(70)Cl] WT Sav 71 29 (R) 38 
3 [6-(p-cymene)Ru(70)Cl] S112A 71 91 (R) 98 
4 [6-(benzene)Ru(70)Cl] S112A 71 41 (R) 74 
5 [6-(p-cymene)Ru(70)Cl] S112K 71 10 (S) 34 
6 [6-(benzene)Ru(70)Cl] S112K 71 63 (S) 24 
7 [6-(p-cymene)Ru(70)Cl] P64G 71 94 (R) 92 
8 [6-(benzene)Ru(70)Cl] P64G 71 44 (S) 44 
9 [6-(p-cymene)Ru(70)Cl] S112Y 72 97 (R) 79 
10 [6-(benzene)Ru(70)Cl] S112A 72 51 (S) 44 
11 [6-(benzene)Ru(70)Cl] S112R 73 70 (S) 95 
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12 [6-(p-cymene)Ru(70)Cl] S112F 73 76 (R) 95 
13 [6-(p-cymene)Ru(70)Cl] S112A 74 48 (R) 98 
14 [6-(p-cymene)Ru(70)Cl] S112A 75 69 (R) 97 
15 [6-(p-cymene)Ru(70)Cl] L124V 71 96 (R) 97 
16 [6-(p-cymene)Ru(70)Cl] L124V 72 87 (R) 20 
17 [6-(benzene)Ru(70)Cl] S112A-K121N 72 92 (S) 54 
18 [6-(benzene)Ru(70)Cl] S112A-K121N 73 92 (S) quant. 
19 [6-(p-cymene)Ru(70)Cl] S112A-K121T 74 88 (R) quant. 
20 [6-(p-cymene)Ru(70)Cl] S112A-K121W 74 84 (R) quant. 
21 [6-(benzene)Ru(70)Cl] S112A-K121T 75 90 (R) quant. 
a The catalytic runs were performed at 55 °C for 64 h using the mixed buffer HCO2Na (0.48 M) + B(OH)3 (0.41 M) + MOPS (0.16 M) 
at pHinitial = 6.25. Ru/substrate/formate ratio 1:100:4000 (i.e., 100 equiv. substrate vs. Ru).  
 
 
Figure 10: X-ray crystal structure of [6-(benzene)Ru(70)Cl]·Sav-S112K tetramer (PDB 
code 2QCB) reveals the ruthenium location in the biotin-binding vestibule. Optimization 
of the artificial transfer hydrogenase is achieved by mutagenesis of residues S112 and 
K121 and L124 located in proximity of the metal in the Sav monomer (blue)-monomer 
(yellow) interface. For simplicity the cofactor in Sav monomer B was removed.  
 
The asymmetric reduction of trifluoroacetophenone 60 was evaluated by Salmain and 
coworkers. Previously, they demonstrated that the active site of papain (PAP) could be 
used to anchor organometallic cofactors via a covalent linkage to the Cys25.242-243 They 
applied this strategy to anchor d6-pianostool complexes (Ru(II) and Rh(III)) via a 
maleimide moiety. Upon covalent anchoring of either 77 or 78 in PAP (Scheme 25), 
respectively 99 and 82 TON were obtained after 60 h. Low enantioselectivity was 
observed (15 % for (R)-76 at best),244 which was proposed to stem from the high 
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conformational flexibility of the cofactor within the protein-cavity. Attempts to address this 
challenge by shortening the linker led to test cofactors 79 and 80. The ArM 80·PAP 
performed best, with 48 TON in 24 h and up to 9 % ee in favor of (S)- 76. The free 80 
afforded 100 TON in 1.25 h.245  
Scheme 25. Covalent anchoring of 77-80 in PAP affords ArMs that catalyze the transfer 
hydrogenation of trifluoroacetophenone 60.  
 
 
Moving away from ArMs based on covalent anchoring, Salmain and coworkers designed 
ATHases based on the “Trojan horse” strategy relying on bovine β-lactoglobulin (β-LG 
hereafter). This β-barrel protein binds long fatty acids with submicromolar affinity, with 
the carboxylate group pointing towards the solvent. The authors coupled different fatty 
acids to the dipyridylamine of the [(η5-Cp*Rh(N(Py)2)Cl)-moiety, resulting in 81-83, 
Scheme 26.246-247 The resulting ArMs catalyzed the transfer hydrogenation of 
trifluoroacetophenone 60. The ATHase 81·β-LG, led to full substrate conversion (i.e. 25-
50 TONs), but only 7 % ee in favor of (R)- 76. 83·β-LG(A) was the most enantioselective 
ArM based on the lactoglobulin scaffold achieving 32 % ee for (R)- 76. 
Although the authors identified the EF loop of β-LG and L39 as a position to mutate, no 
attempt to genetically improve the catalytic performance of the artificial transfer 
hydrogenase was reported.248 
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Scheme 26. Supramolecular anchoring of 81-83 into β-LG affords ArMs that catalyze 
the transfer hydrogenation of trifluoroacetophenone.  
 
 
Protein Crystals. The asymmetric transfer hydrogenation of acetophenone derivatives 
was also investigated by Ueno and Kitagawa et al. in 2014.249 In this study, a pianostool 
catalyst precursor was soaked into a protein crystal to generate a heterogeneous ArM. A 
tetragonal crystal and an orthorhombic crystal of the hen egg white lysozyme (HEWL, 
hereafter) were used for ArM formation. After treatment of the crystals with 
glutaraldehyde to cross-link the monomers, the resulting protein crystals were soaked 
with a solution of [Ru(benzene)Cl2]2 86, Scheme 27. For the transfer hydrogenation of 
isobutyrophenone 84 using sodium formate as a hydride source, 86·HEWL (tetragonal) 
and 86·HEWL (orthorhombic) afforded the corresponding alcohol in 23 % ee (R)-85 and 
36 % ee (S)-85 respectively, Table 10. When using dissolved HEWL and 86, the ATHase 
conversion decreased to 7% (0.3 TON) compared to 38% (3.3 TON) and 46% (4.0 TON) 
conversions obtained using either  86·HEWL (tetragonal) and 86·HEWL (orthorhombic) 
respectively.  Based on Sadler's report,250 it seems reasonable to speculate that the Ru-
pianostool complex is coordinated to H15 of HEWL. These results suggest that the 
formation of catalytic compartments upon incorporation of Ru(II) complexes favour the 
ATH and affords different enantiomers depending on the crystal form used (tetragonal 
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vs. orthorhombic). 
Table 10. Selected results for transfer hydrogenation of isobutyrophenone 84 catalyzed 
by a ruthenium complex immobilized within and hen egg white lysozyme (HEWL) protein 
crystal.249 
 
Entry Cofactor Protein Sub. pH T (°C) [Ru] (mM) ee (%) TON 
1 86 HEWL_solution 84 7.5 35 2.6 24(R) 0.3 
2 86 HEWL_tetragonal 84 7.5 35 1.3 23(R) 3.3 
3 86 HEWL_orthorhombic 84 7.5 35 1.3 36(S) 4.0 
 
Scheme 27. Cross-Linked Egg Hen White Lysozyme crystals catalyze the ATH of 
isobutyrophenone in the presence of [Ru(benzene)Cl2]2.  
 
 
Transfer Hydrogenation of Imines. Besides the ATH of ketones, the Ward group 
developed ATHases for the reduction of cyclic imines. In an initial screening, the 
complex [5-(Cp*)Ir(70)Cl] outperformed complexes [6-(arene)Ru(70)Cl] (which were 
most active in the asymmetric transfer hydrogenation of ketones) and [5-
(Cp*)Rh(70)Cl].251 For the reduction of the salsolidine precursor 88, 57 % ee in favor of 
(R)-amine 87 was obtained with [5-(Cp*)Ir(70)Cl] · WT Sav. Genetic optimization of the 
ArM was achieved by screening the site-saturation mutagenesis libraries in position 
S112X and K121X as well as double mutants thereof. The following trends are apparent 
(Scheme 28): 
i) Artificial transfer hydrogenase [5-(Cp*)Ir(70)Cl]Sav  S112A yielded 91 % ee 
for (R)-87 with > 100 TON at pH 6.5, 5 °C in 24 h.  
ii) The opposite enantiomer (S)-87 was obtained with ee 78 % at 5 °C with [5-
(Cp*)Ir(70)Cl]Sav  S112K. 
iii) The double mutant [5-(Cp*)Ir(70)Cl]Sav S112A-K121A displayed a 7.6-fold 
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improved catalytic efficiency compared to WT Sav for substrate 89.252  
iv) Reducing the ArM concentration to 17 µM for the reduction of 88 resulted in 
TON > 4'000. 
Scheme 28: Artificial transfer hydrogenases for the reduction of cyclic imines result from 
incorporation of an iridium d6-pianostool complex within Sav isoforms.  
 
To compute the transition state for the reduction of isoquinoline 88 in the presence of 
either [5-(Cp*)Ir(70)Cl]Sav S112A/K, Ward, Maréchal and coworkers relied on a 
custom tailored QM/MM strategy.253 The computed results nicely corroborated the 
catalysis results:  
i) In the transition state for [5-(Cp*)Ir(70)Cl]  Sav  S112A, the imine cofactor is located 
in the biotin-binding site opposite to the position of the biotinylated cofactor (see below). 
ii) Residue K121B forms a cation-π with the electron-rich arene moiety of the substrate 
88. 
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iii) The computed difference in transition-state free energy (1.21 kcal · mol-1) is in line 
with the enantioselectivity observed at room temperature.  
Varying the Cofactor : Protein Ratio In order to investigate the influence of adjacent 
cofactors, Ward and Maréchal analyzed the ATHase structure, reaction rates and 
resulting enantioselectivites as a function of Ir : Sav ratios for both [5-(Cp*)Ir(70)Cl]  
Sav  S112A  and [5-(Cp*)Ir(70)Cl]  Sav  S112K.254 For [5-(Cp*)Ir(70)Cl]  Sav S112A, 
increasing the Ir-cofactor: Sav tetramer ratio from 1:1 to 4:1 caused an erosion in ee for 
the formation of (R)-amine 87 from 96 to 45 %  in the transfer hydrogenation of 88. This 
erosion was accompanied by a twentyfold decrease in catalytic efficiency (kcat/KM = 0.22 
min-1mM-1 to 0.011 min-1· mM-1). In contrast, the catalytic efficiency of the (S)-selective 
ATHase [5-(Cp*)Ir(70)Cl]  Sav  S112K decreased only 1.5-fold. The ee increased from 
70 % (S)- 87 to 78 %  (S)- 87 at  Sav tetramer saturation. Analysis of the X-ray structure 
of [5-(Cp*)Ir(70)Cl]  Sav  S112K revealed two equally populated metal cofactor 
positions, allowing to fit up to four cofactors without leading to significant steric clash. 
Importantly, the absolute configuration at the metal was found to be opposite that found 
for the [5-(Cp*)Ir(70)Cl]  Sav  S112A.  
As mentioned above, enantiopure 1,2-aminosulfonamides, such as TsDPEN combined 
with d6-pianostool moieties are privileged catalysts for asymmetric transfer 
hydrogenation.231 Building upon this, Gandolfi-Rimoldi and coworkers investigated the 
properties of Ru complexes chelated with chiral 1,3-aminosulfonamides for the ATH of 
prochiral ketone in water.255 Inspired by the work of Ward and coworkers based on 1,2-
aminosulfonamides,38 Rimoldi extended this work to biotinylated substituted 1,3-
aminosulfonamides for the reduction of prochiral imines. Both enantiopure and achiral 
bidentate ligands were evaluated, Figure 11.256 
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Figure 11.  Biotinylated 1,3 aminosulfonamides. All six diastereoisomers 90-95 as well 
as the achiral ligands 70a, 96, 97 were used for the preparation of d6 Ir piano-stool 
complexes. ArMs formed after supramolecular interaction with streptavidin were tested 
in the ATHase of salsolidine precursor 88. 
 
Biotinylated 1,3-aminosulfonamides 70a, 90-97 were used as ligands for the preparation 
of d6 Ir-pianostool complexes and tested for their ATHase properties for the reduction of 
the salsolidine precursor 88, Scheme 29. The free cofactor 90 (Table 11, entry 1) 
displayed high activity and very low enantioselectivity (6% ee (S)-87). Upon 
incorporation within WT Sav, the cofactors 90-95 led to nearly racemic 87 (up to 18 % 
(R)-87, Table 11, entries 2-7). Various Sav S112-mutants were tested and led to an 
improvement in enantioselectivity, Table 11.240-241, 251  
Table 11. Selected results for the asymmetric transfer hydrogenation of prochiral imine 
88 in MOPS buffer using sodium formate as a hydride source.  
 
Entry Protein Ligand Sub (mM) [Ir] (µM) eea(%) Conv(%) TON 
1 - 90 28 280 - 6 >99 100 
2 SavWT 90 28 280 5 58 58 
3 SavWT 91 28 280 18 83 83 
4 SavWT 92 28 280 5 99 99 
5 SavWT 93 35 350 8 76 76 
6 SavWT 94 28 280 rac. >99 100 
7 SavWT 95 35 350 rac. >99 100 
8 S112R 90 28 280 - 12 43 43 
9 S112C 91 28 280 65 60 60 
10 S112C 93 35 350 40 26 26 
11 S112Y 92 28 280 - 47 72 72 
12 S112M 94 28 280 9 95 95 
13 S112E 95 28 280 18 73 73 
14 S112C 70a 10 140 83 25 18 
15 S112C 96 10 140 52 15 11 
16 S112C 97 10 140 56 15 11 
apositive and negative ee values correspond to the (R)- and (S)-enantiomers respectively. 
 
Scheme 29. ATHase of imine 88 based on six-membered ring aminosulfonamide 
chelating ligands. 
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To rationalize these results, a docking study was carried out with S112C and S112Y 
mutants in combination with [5-Cp*Ir(91)Cl] and [5-Cp*Ir(92)Cl] catalysts respectively. 
As for previous studies by Maréchal and coworkers,254 the host protein dictates the 
absolute configuration at iridium, which in turn determines the preferred approach of one 
prochiral face of the substrate 88. Ward and Maréchal coined this chiral relay 
mechanism "induced lock-and-key" as the host protein favours one metal absolute 
configuration upon incorporation within Sav. With the diastereopure cofactor in place, the 
approach of the prochiral substrate is dictated by the Sav host. 
A Dual Anchoring Strategy for ATHAse Based on the Biotin-Streptavidin 
Technology. Although incorporation of ArMs in Sav is best achieved via a biotin anchor, 
additional dative interactions between the metal cofactor and engineered amino acid 
side chains can be envisaged. This strategy may contribute to firmly localize the metal 
within the shallow biotin-binding vestibule. To evaluate the potential of this strategy, 
Ward designed a biotinylated Cp* ligand, thus ensuring localization of a d6-pianostool 
moiety but leaving the remaining three coordination sites available for coordination to 
amino acid residues and for catalysis. Accordingly, Ward and coworkers used cofactor 
[(98)MCl2(H2O)] (M = Rh(III), Ir(III)) inspired by structure-based modeling.257 The 
presence of the ethyl spacer projects the metal in proximity to both Sav S112 and Sav 
K121 positions. The authors hypothesized that the imidazole side chains of mutations 
S112H and K121H may coordinate the metal thereby influencing the ArMs activity and 
selectivity. As a model reaction, the asymmetric transfer hydrogenation of imine 88 was 
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selected. The reaction's stereoselectivity was very similar for complexes [(98)IrCl2(H2O)] 
and [(98)RhCl2(H2O)] in the presence and absence of WT Sav (rac-87 and 6 % (S)-87, 
respectively). When [(98)RhCl2(H2O)] · Sav S112H was tested, (S)-87 was produced 
with 55 % ee and > 100 TON at 55 °C and pH 5, Scheme 30 a). As suggested by 
docking, [(98)RhCl2(H2O)]·Sav K121H leads to stereoinversion; (R)-87 is obtained with 
79 % ee and > 100 TON under identical conditions. Decreasing the temperature leads to 
erosion in ee and TON. X-ray crystal structures were solved for both 
[(98)RhCl2(H2O)]Sav  S112H and [(98)RhCl2(H2O)]Sav  K121H (Scheme 30 b) and c).  
Scheme 30: A dual-anchoring strategy allows to localize and activate the biotinylated 
cofactor [(98)MCl2(H2O)] within Sav. a) The imine reductase is activated by introduction 
of a coordinating His-residue either at position Sav S112 or Sav K121; band c) as 
highlighted by a crystal structure. Adapted with permission from ref.38 Copyright 2016 
American Chemical Society.  
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Transfer Hydrogenation of Imines, Bidentate Ligand Screening. Iridium pianostool 
complexes bearing a biotinylated arene cap allow for the screening of a bidentate ligand 
library within the Sav scaffold. This easily accessible chemical diversity component may 
lead to a rapid identification of ATHases with improved activity and selectivity. To test this 
hypothesis, Ward and coworkers preincubated complexes [(98)M2Cl2)]2 (M = Rh, Ir) in 
the presence of eight bidentate ligands (diamines, amino acids and amino amides) at 
room temperature followed by addition of WT Sav.258 The reaction was initiated by 
addition of the substrate 1-phenyl-3,4-dihydroisoquinoline and 1.5 M sodium formate in a 
MOPS-buffered solution (pH 7.8). All Rh-based ATHases displayed very limited activity 
and yielded virtually racemic product. The bidentate ligand glycineamide in conjunction 
with [(98)IrCl2(H2O)]  WT Sav was most active (372 TON) and most selective albeit 
yielding the corresponding imine in 43 % (S)-ee. Encouraged by the promising result 
obtained with glycineamide, the amide derivatives of all 20 natural amino acids were 
screened in the presence [(98)IrCl2(H2O)]WT Sav. The amides of L-proline (67 % ee), L-
valine (63 % ee), L-leucine (63 % ee), L-arginine (61 % ee), L-isoleucine (65 % ee) and 
L-threonine (63 % ee) displayed improved selectivity for (S)-product. Further genetic 
fine-tuning with a focused Sav mutant library did not further  contribute to improve the ee 
significantly.258 
Transfer Hydrogenation of Imines, ATHase Immobilized on Silica Nanoparticles. 
Silica nanoparticles are used in biocatalysis to immobilize enzymes, to protect these 
against denaturation and to improve the reaction rates. Ward and coworkers tethered 
the ATHase [5-(Cp*)Ir(70)Cl]Sav S112A, Sav S112K and Sav S112A-K121A via imine 
formation to an aldehyde group at the surface of a silica nanoparticle (SNP). The 
protein-functionalized SNP surface was further treated with a protective silica layer.259 
The immobilized ATHase [5-(Cp*)Ir(70)Cl]Sav S112A had a 4-fold increased TON vs. 
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the free enzyme (TON: 4294 vs. 1154) in the asymmetric transfer hydrogenation of cyclic 
imine 88. Upon lowering the catalyst loading to 0.0013 mol% 16990 TON were achieved. 
The selectivity of complex [5-(Cp*)Ir(70)Cl]Sav S112A for (R)-87 increased from 79 % 
ee to 90 % ee upon immobilization. The opposite effect was observed with (S)-selective 
mutant S112K where the ee decreased from 66 % ee to 56 % ee upon immobilization. 
The most active mutant tested was S112A-K121A which afforded up to 46'747 TON (in 
24 hours) at a catalyst loading of 0.0075 mol%.  
Neutralizing Cellular Glutathione for ATHases. Natural evolution of function relies on 
mutagenesis and selection. In contrast to homogenous catalysts, ArMs bear the 
potential to be genetically optimized by mutagenesis. Directed evolution relies on the 
efficient high-throughput screening of genetic diversity to identify and characterize 
functionally evolved mutants. Parallel in vivo expression of Sav in E. coli (e.g. in 96-well 
plates) followed by cofactor addition would allow directed evolution of the corresponding 
ArMs. A challenge in the development of HTS methods for ArMs optimization is the 
presence of glutathione (GSH) in millimolar concentrations in aerobic E. coli cells.260 The 
soft acid character of the precious metals in ArMs favors their coordination to GSH. One 
way to decrease the cellular GSH content is to treat cell lysates with GSH scavengers 
such as electrophiles or oxidants. Ward and coworkers evaluated the potency of various 
GSH scavengers to recover artificial transfer hydrogenase activity in cellular media.261 
From all the GSH scavengers tested, diamide 99, phenylvinylsulfone 100 and 2-
bromoacetophenone 101 led to the best recovery of activity. Up to 90 % initial activity 
and similar ee were obtained with [5-(Cp*)Ir(70)Cl]Sav  S112A for substrate 88 after 
incubation with 99. With 10 mM 99 and only 2 h preincubation time, > 50 % of the pure 
protein's activity and very similar ee's were obtained. When cell lysates were used, very 
good results could be obtained with [5-(Cp*)Ir(70)Cl]Sav  S112K (64 % pure protein 
activity, - 68 % ee) whereas the corresponding ArM with mutant Sav S112A yielded 
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reduced ee and TON.  
Scheme 31. Biotinylated Ir-pianostool complexes anchored within Sav are inactivated by 
physiological concentrations (~1 mM) of glutathione. Electrophiles and oxidizing agents 
react with glutathione and restore ATHase activity. Adapted with permission from ref.38 
Copyright 2016 American Chemical Society.  
 
 
 
Transfer Hydrogenation of Imines, High-Throughput Screening. Ward and 
coworkers extended the glutathione scavenger strategy to implement a high-throughput 
genetic screening of artificial transfer hydrogenases.262 To parallelize Sav mutant 
expression, a 24-well deep well plate format was introduced. In six milliliter medium, 
sufficient Sav (~>0.5 mg) can be produced to run 1-2 catalytic reactions. Accordingly, 
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twenty-eight amino acids within a 15 Å distance to the metal were selected for 
mutagenesis. Instead of introducing all 20 amino acids at each position, the effort was 
reduced to 12 amino acids: A, V, L, D, E, Q, K, H, M, Y, S, P as representatives of the 
different types of amino acids (acidic, basic, polar, hydrophobic). The autoinduction 
medium Zyp-5052 was used to express all Sav isoforms, Scheme 32. After 24 h 
expression, cell free extracts of the mutants were prepared and biotin-4-fluorescein 
titration was applied to determine the number of free biotin-binding sites per well. To 
generate an artificial transfer hydrogenase, Sav was coupled to a biotinylated three-
legged iridium pianostool complex [Cp*Ir(70)Cl], after the treatment of the cell-free 
extracts with 99. To produce an artificial metathase the cell free extracts containing Sav 
were combined to a biotinylated second-generation Grubbs-Hoveyda catalyst following 
immobilization of Sav on Sepharose-iminobiotin beads.  
The two procedures summarized above allow to screening of 335 Sav mutants within 20 
days (including mutagenesis, expression and activity screening).  
Scheme 32. a) Streamlined Sav library production, isolation and screening for ATHase 
activity in cell-free extracts relying on diamide treatment; b) metathesis activity in cell 
free extracts using a reversible imminobiotin-sepharose immobilization. Adapted with 
permission from ref.262 Copyright MacMillan 2016.  
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The streamlined protocol allows the preparation of cell lysates and corresponding CFEs 
containing the overexpressed Sav isoforms. The simple preincubation of either cell 
lysates or CFEs with 5 mM diamide 99 (for ATH) or the immobilization of Sav from CFEs 
on the iminobiotin-Sepharose beads (for olefin metathesis) allows to restore most of the 
catalytic activity. 
 
Transfer Hydrogenation of Imines, Cascade with Amine Oxidase. In the Ward group, 
initial efforts towards the creation of cascade reactions aimed at combining an artificial 
transfer hydrogenase with a natural amine oxidase. ATHase [5-(Cp*)Ir(70)Cl] · Sav 
S112T is moderately (R)-selective (59 % ee) for imine 89.263 The ATHase was combined 
with monoamineoxidase MAO-N which has very high selectivity for the oxidation of (S)-
amine 102, Scheme 33. Unfortunately, shortly after the reaction had started, the ATHase 
was inhibited by the hydrogen peroxide produced by the MAO upon oxidation of the 
amine substrate. Addition of catalase restored activity and allowed the dynamic kinetic 
resolution to afford (R)-102 in > 99 % ee. The same strategy was applied for the one pot 
dynamic kinetic resolution of pyrrolidines 103 and 105 which were obtained in essentially 
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enantiopure (R)-form thanks to the exquisite (S)-selectivity of MAO-N. Similarly, tertiary 
imine 104 was reduced to the corresponding (R)-amine 105 with >99 % ee and 65 TON. 
Cyclic imine 104 is in equilibrium with the ring-open keto form 106 at pH 7.5. 
Interestingly, the nature of the Sav mutant determines which substrate is preferentially 
reduced: [5-(Cp*)Ir(70)Cl]·Sav S112A-K121T produces preferentially the imine 104 (76 : 
11). In contrast, [5-(Cp*)Ir(70)Cl]·Sav S112G favors the reduction of the keto form of 
104, yielding the corresponding alcohol 107 (3 : 79). 
Transfer Hydrogenation of Enone and Nicotinamide Regeneration. Many enzyme-
driven reactions utilize NAD(P)H as cofactor which increases the production costs of 
biocatalytic transformations. Several enzymatic NAD(P)H regeneration systems are 
known. Additionally, NAD(P)H regeneration systems based on organometallic catalysts 
were developed. However only few of them actually work in cascade reactions in the 
presence of NAD(P)H-dependent enzymes. Ward and coworkers applied the ATHase 
[5-(Cp*)Ir(70)Cl] · WT Sav to recycle NADH in a cascade with NADH-dependent 
hydroxybiphenyl monooxygenase (HbpA, Scheme 34).263 In this reaction, 
hydroxybiphenyl 108 was converted to the corresponding catechol 109 with TON > 99 in 
the presence of O2 as oxidant. No catalase was required since the reaction's byproduct 
is water. 
Scheme 33. Enzyme cascades combining an ATHase and an amine oxidase afford 
enantiopure amines. This can be applied for the synthesis of isoquinolines, a-b) and 
pyrrolidines, nicotine, c) and pipecolic acid d). Addition of either horseradish peroxidase 
or catalase prevents the oxidation of the iridium cofactor by hydrogen peroxide resulting 
from MAO activity. 
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Scheme 34. ATHases can be used to recycle NADH using formate as reductant. The 
NADH-recycling ATHase can be applied in a cascade with HbpA monooxygenase to 
produce dihydroxy biphenyl. 
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The NADH regeneration employing ArMs and sodium formate as hydride source 
(Scheme 35) was also investigated by Salmain and coworkers. The Papain scaffold was 
used to host the precious metal d6-pianostool complexes using a covalent anchoring 
strategy via a maleimide moiety.242-243 They evaluated the catalytic transfer 
hydrogenation performance for the reduction of NAD+ 111 into NADH 110. The authors 
showed that the artificial transfer hydrogenase 77·PAP has comparable catalytic activity 
to the free cofactor 77 and to the benchmark complex [(η5-Cp*)Rh(bpy)H2O]2+.264 
Disappointingly, no attempt was reported by the coauthors to couple this NADH 
regeneration ArM with natural NADH-consuming enzymes. 
Scheme 35. Covalent anchoring of 77 in PAP yields an ArM that catalyzes the reduction 
of NAD+ to NADH using formate as hydride source.  
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Transfer Hydrogenation of Enones, Regeneration of NADH Mimics. Mimics of 
NAD(P)H are attractive in biocatalysis as the natural NAD(P)H cofactors are costly. Non-
enzymatic regeneration systems based on organometallic catalysts are only moderately 
active when applied in cascades as they are typically inhibited by enzymes. Based on a 
previous finding that ATHase [5-(Cp*)Ir(70)Cl]·Sav S112A regenerates NADH using 
sodium formate as hydride source, Ward and coworkers set out to investigate whether 
NADH mimics could be regenerated. The ATHases were applied in a cascade with ene-
reductase TsOYE of the old yellow enzyme family which was previously shown to accept 
NADH mimics as reducing equivalents.265 Various ATHase isoforms with point mutations 
at positions Sav S112, K121 and L124 were tested towards the reduction of five NAD+ 
mimics (mNAD+ hereafter). The model substrate N-ethyl-2-methylmaleimide 113 was 
converted by TsOYE to the corresponding enantiopure unsaturated imide 114, Scheme 
36. Only the ketone-bearing mNAD+ 112 afforded high turnover numbers (100 – 1000 
TON) and enantioselectivity (~90 % ee for (R)-product). Sav-mutant S112K showed the 
highest conversion (~100 %). The protein prevents the inactivation of the organometallic 
cofactor by TsOYE. The (R)-selectivity of the cascade could be increased to 98 % ee 
when the Ir-catalyst concentration was reduced to 5 µM and the substrate was added 
slowly. This strategy helps to minimize the reduction of the substrate by the ATHase, 
which leads to an erosion of ee. The maximum TON achieved was > 1980.  Other 
substrates tested included ketoisophorone 115 and 2-methylcyclohexenone 116 which 
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were converted into the corresponding products with up to 86 % ee ((R)-product) and 
94 % ee ((R)-product), respectively, and TONs ranging between 550 and 1655.  
Scheme 36. An ATHase for the recycling of NADH-mimics in the presence of an ene 
reductase. a) Structure of NAD+ and mNAD+; b-c) the ATHase can be applied in an 
enzyme cascade in the presence of ene-reductase TsOYE to afford highly 
enantioenriched ,-saturated ketones from the corresponding enones.  
 
 
 
Ward and coworkers demonstrated that ATHase [5-(Cp*)Ir(70)Cl]Sav can be applied in 
the diasteroselective transfer hydrogenation of NAD+ with sodium formate.266 In 
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phosphate buffer (pH 7.5) and in the absence of Sav, the reduction of NAD+ by DCO2Na 
proceeded with a diastereomeric excess de = 38 %. For [5-(Cp*)Ir(70)Cl]Sav S112A 
and [5-(Cp*)Ir(70)Cl]Sav S112K, the de increased to 87 % and 90 % respectively. In 
stark contrast to the reduction of either ketones or imines, both ATHases yielded the 
same enantiomer as determined by 1H-NMR. 
Transfer Hydrogenation of Imines, NADH-dependent ATHase. Living organisms rely 
widely on NAD(P)H as redox cofactor to modulate redox reactions. The artificial transfer 
hydrogenases developed in the Ward group utilize formate as hydride source. To 
integrate an ATHase into an in vivo cascade, it would be desirable to use NAD(P)H as 
hydride source. To address this challenge, Ward and coworkers screened a number of 
bis-imino Ir-Cp* complexes for the reduction of 1-methyl-dehydroisoquinoline 89 using 
NADH as hydride source.267  The most active ligand identified was 4,7-dihydroxy-1,10-
phenantroline (117). Complex [(98)Ir(117)Cl]+ afforded ~200 TON in 20 h. Next, to 
recycle the spent NADPH, glucose dehydrogenase (GDH) was added to the cascade for 
the reduction of imine 89. By screening various Sav isoforms, [(98)Ir(117)Cl]·Sav K112R 
yielded the highest conversion in 14 hours (up to 961 TON). Unfortunately, amine 102 
was produced in low ee (13 % (R)-102), Scheme 37. To upgrade the ee via a dynamic 
kinetic resolution, monoamine oxidase (MAO-N) and catalase were added to the 
ATHase-GDH cascade. The four-enzyme cascade yielded amine (R)-102 with >99 % ee 
and >99 TON, Scheme 37.  
Scheme 37: A biotinylated [(98)Ir(117)Cl]+ cofactor anchored within Sav can rely on 
NADPH as reducing agent for the asymmetric transfer hydrogenation of imines.267 This 
ATHase was integrated in a four-enzyme cascade to produce enantioenriched 102, 
relying on glucose as hydride source (blue frame) and MAO-N to upgrade the 
enantioselectivity of the ATHase (red frame). Adapted with permission from ref.267  
Copyright 2016 American Chemical Society. 
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Transfer Hydrogenation of Imines, Allosteric regulation. In living organisms, 
enzymatic activity is typically (cross)-regulated via weak molecular interactions. 
Molecular or physical (e.g. optical, magnetic, temperature etc.) tools with the ability to 
control artificial metalloenzyme's activity would be highly desirable to regulate enzyme 
cascade in vivo. Ward and coworkers developed a latent artificial transfer hydrogenase 
that is activated by a protease, Scheme 38.268 As cofactor, a biotinylated Ir-Cp* complex 
[(98)IrCl2(H2O)] was selected. As demonstrated previously, activation by an additional 
ligand is required to ensure ATHase activity. Inspired by the work of Hilvert and 
coworkers269  they screened and identified a Ser-Gly-Phe tripeptide (SGF) that leads to 
significant enhancement of the catalytic activity upon coordination to [(98)IrCl2(H2O)].269 
Fused to the C-terminus of Sav and flanked by a protease-recognition sequence, the 
tripeptide becomes available to activate the cofactor upon digestion of the C-terminus by 
protease Factor Xa. While [(98)IrCl2(H2O)]·WT Sav was only moderately active for the 
reduction of pentafluoroacetophenone 118 (29 TON), addition of SGF led to a fiftyfold 
increase in activity (1431 TON). Next, the SGF peptide was fused to the C-terminus of 
Sav preceeded by the Factor Xa protease cleavage site. Incubation of the ATHase with 
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Factor Xa prior to addition of formate and the ketone 118 led to significantly improved 
TONs (compare 23 for the undigested to 1778 TON, Scheme 38). Such irreversible 
activation is widespread amongst enzymes and is commonly referred to zymogens. 
Scheme 38: An artificial transfer hydrogenase is upregulated by a protease. A zymogen 
is formed upon incorporation of [(98)IrCl2(H2O)] into Sav K121A bearing an SGF 
tripeptide at its C-terminus. Incubation of the zymogen with the protease Factor Xa 
releases the SGF ligand to afford [(98)Ir(SGF)Cl]·Sav K121A which displays significant 
ATHase activity b).268 Adapted with permission from ref.268  Copyright Wiley VCH 2016. 
 
 
 
Transfer Hydrogenation of Imines using Ribonuclease S as host protein. 
Ribonuclease A digestion by subtilisin affords a clove-shaped S-protein as well as an -
helical S-peptide. The S-protein and the S-peptide bind to each other with nanomolar 
affinity to form a functional RNase S enzyme. Sträter, Ward and coworkers set out to 
engineer RNase S into an artificial metalloenzyme.270 S-peptide variants with metal 
binding capacity including non-natural amino acids were produced by solid-phase 
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synthesis. Incubation of metallated S-peptides with S-protein may allow to engineer 
RNase S isoforms displaying new-to-nature activities. Tuning of reaction activity and 
selectivity may be possible via second coordination sphere interactions stemming mainly 
from the S-protein. This concept was tested with the asymmetric transfer hydrogenation 
of the cyclic imine 88. The authors speculated that two histidine residues provided by the 
host protein may activate the cofactor. The RNase S crystal structure allowed to identify 
two residues (K7 and Q11) in the proximity of the -helical S-peptide. Thus RNase S 
K7H-R10Q-Q11H isoform was synthesized and incubated with [5-(Cp*)IrCl2]2, [5-
(Cp*)RhCl2]2 or [6-(p-cymene)RuCl2]2 prior to complexation with the S-protein. The 
iridium RNase S K7H-R10Q-Q11H complex was most active affording 28 TON. The 
corresponding WT RNase S however yielded 70 TON under the same conditions, 
suggesting that the metal does not bind to the two-histidines introduced in the S-peptide. 
The enantioselectivity was very low (4-8% ee (S)-87) for both S-peptide triple mutant 
and WT. When the WT S-peptide Ir complex was used in the absence of S-protein, the 
ee increased minimally to 22 % (S)-87 at the cost of a lower activity (10 TON), 
suggesting a modest protein acceleration. The best ee obtained with the RNase S 
system was 39 % (S)-amine 87 obtained with RNase S mutant H12A in which the only 
histidine within the WT S-peptide was replaced by an alanine.  
Transfer Hydrogenation of Imines, hCAII as host protein. Most artificial 
metalloenzymes developed in the Ward group are based on the (strept)avidin-biotin 
technology to anchor a transition metal complex within a protein environment. Human 
carbonic anhydrase II (hCAII) is another attractive scaffold for ArM design. It is a 
monomeric protein which binds with sub-nanomolar affinity numerous 
arylaminosulfonamide derivatives.271 In an initial effort to build an ArM from hCAII, Ward 
and coworkers tethered pianostool complex [6-(C6Me6)Ru(bispyridine)Cl]+ to a benzene 
sulfonamide anchor.272 The Ru-cofactor did not afford any transfer hydrogenation activity 
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but bound to hCAII with nanomolar affinity. A second arylsulfonamide cofactor was 
based on iridium complexes [5-(Cp*)Ir(pico)Cl] (119-120).273 In the asymmetric transfer 
hydrogenation of cyclic imine 88 inside WT hCAII, this ArM afforded 9 TON and up to 70 
ee for (S)-salsolidine 87, Scheme 39. A crystal structure of complex [5-(Cp*)Ir(pico)Cl] 
119WT hCAII was solved which served as a model for a computational enzyme 
redesign. In a collaboration with the Baker group, Ward and coworkers relied on the 
Rosetta design algorithm to identify mutants that may stabilize the Ir-cofactor within 
hCAII.274 The hypothesis was that cofactor stabilization and localization might increase 
the relative concentration of the active catalytic species vs. unproductive conformations 
of the ATHase. Rosetta predicted four hCAII constructs containing up to 8 mutations (d1 
– d4) that were predicted to display increased affinity. Binding assays of the mutated 
hCAII revealed that indeed the designs had on average a ~50-fold increased affinity vs. 
WT hCAII (Kd = ~0.33-0.46 nM vs. 21 nM). Gratifyingly, the imine reduction activity was 
also positively affected: up to 98 TON with 74 % ee (S)-87 with the hCA II d1 construct. 
The best enantioselectivity was obtained with the design hCAII d4 and afforded 92 % ee 
(S)-87 and 78 TON. Substituting a single methyl- by a propyl group on the Cp* cap in the 
hybrid [5-(Cppropyl)Ir(pico)Cl] 120  hCAII d4  further increased the ee to 96 % (S)-87 
and 59 TON at 4°C, Scheme 39. 
Scheme 39, Rosetta-optimization of an ATHase based on human carbonic anhydrase II. 
a) Reaction conditions; b) structure of the pianostool complex and computationally-
designed mutants predicted to increase the affinity of [5-Cp*Ir(pico)Cl] for hCA II and c) 
X-ray crystal structure of the WT ATHase crystal structure (PDB 3zp9) used as template 
for computational mutagenesis with the Rosetta design algorithm (complex stabilizing 
residues displayed in purple). Adapted from ref.274 Copyright 2015 American Chemical 
Society.  
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Transfer Hydrogenation of Enones. Noyori-type pianostool complexes have been 
widely applied in the asymmetric reduction of enones.275 To test whether ATHase [5-
(Cp*)Ir(70)Cl]·WT Sav chemoselectively reduces enones to the corresponding ketones, 
Ward and coworkers designed the profluorescent enone 121. Upon Michael addition of a 
hydride, a spontaneous E1cB elimination leads to the release of fluorescent 
umbelliferone, Scheme 40 a).276 As little as 1 µM of [5-(Cp*)Ir(70)Cl]·WT Sav sufficed to 
observe the appearance of the fluorescent product. Screening purified Sav mutants in 
positions S112X and K121X led to the identification of [5-(Cp*)Ir(70)Cl] · Sav K121F 
with a twenty fold improved activity vs. WT.  
With in vivo-applications in mind, Ward and coworkers encapsulated the best ATHase 
[5-(Cp*)Ir(70)Cl]·Sav K121F within a polymersome. The polymersome consisted of 
block-co-polymers poly(2-methyloxazoline)--poly(dimethylsiloxane)--poly(2-
methyloxazoline) (PMOXA-PDMS-PMOXA) developed by Meier and coworkers Scheme 
40 b).277 Upon incorporation inside the capsule, the ATHase activity was reduced 
however. Activity could be improved upon incorporation of the bacterial outer membrane 
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protein ompF into the polymersome which assists small molecule trafficking across the 
membrane.  
Scheme 40. An artificial transfer hydrogenase consisting of Sav and [(5-Cp*)Ir(70)Cl] 
reduces enones. a) The reduced ketone spontaneously undergoes an E1cB elimination 
to release umbelliferone, thus allowing high-throughput genetic optimization of ATHase 
activity; b) the best ATHase-K121F is active inside a polymersome equipped with 
bacterial pore protein ompF. Adapted with permission from ref.38 Copyright 2016 
American Chemical Society.  
 
 
4.4 Hydroformylation 
Hydroformylation of olefins is widely used to synthesize aldehydes in both commodity 
and fine chemicals due to its perfect atom economy and the availability of olefins and 
syngas.278 Both linear and branched aldehydes can be accessed, in the latter case 
leading to a stereogenic center α to the aldehyde, presenting the opportunity for catalyst 
control over both regio- and enantioselectivity.279 As noted in section 3, early studies by 
Marchetti established that ArMs generated via metallation of HSA with Rh(acac)(CO)2 
catalyze styrene hydroformylation with a branched-to-linear ratio of ~90:10.157 Building 
on extensive work showing that the active site Zn of carbonic anhydrase could be 
substituted with different metals,280 Kazlauskas replaced the active site Zn of hCAII with 
93 
[Rh(acac)(CO)2] to generate a hydroformylase.281 The branched aldehyde product of 
styrene hydroformylation was favored by the free cofactor and ArMs generated using 
WT hCAII, Scheme 41. Analysis of this ArM using ICP-MS indicated that it possessed a 
Rh/scaffold ratio of 5.4, which was believed to result from non-specific Rh-binding sites 
on the scaffold surface. Targeted mutagenesis and chemical modification of surface 
histidine residues was therefore carried out, and ArMs generated from the resulting 
hCAII variants had Rh/scaffold ratios of 1.2 and 1.4. The hydroformylation of styrene 
catalyzed by the modified ArMs reversed its regioselectivity to favor the linear product 
(linear/branched ratio up to 8.4, Scheme 41). 
Scheme 41. Hydroformylation of styrene catalyzed by a Rh-substituted hCAII.  
 
More recently, Hartwig reported detailed characterization of rhodium- and iridium-
substituted hCAII ArMs.282 Metallation of apo hCAII was monitored using a colorimetric 
assay, which indicated that metallation was significantly impacted by the ligands on the 
metal precursors used but suggested that surface histidine residues had only a minor 
impact. [Rh(nbd)2]BF4 and [Rh(acac)(CO)2] (nbd = norbornadiene and acac = 
acetylacetonate) afforded 71% and > 90% metallation, and the Rh/scaffold ratio was 
approximately 1:1 even with surface histidines present. A elegant series of HSQC NMR 
experiments, which had been previously used to study the catalytic mechanism of 
hCAII,283 indicated that Rh was only coordinated by two of the three His residues in the 
active site. Multiple ligand substitution reactions of hCAII-[Rh(nbd)2] were also examined.  
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4.5 Small Molecule Reductases 
Natural enzymes performing reduction of small molecules are located in the super-group 
of the oxidoreductases (Enzyme Commission number: E.C. 1) and act on nitrite, nitric 
oxide, nitrous oxide, elemental nitrogen, sulfite, elemental sulfur as well as dioxygen, 
chlorate and perchlorate. Enzymes involved in these transformations are amongst 
others flavodiiron proteins284, heme proteins285-286 and enzymes depending on copper287, 
molybdenum288-290 and vanadium.291 Beside the large variety of natural small molecule 
reductases, researchers have engineered artificial metalloenzymes for the reduction of 
nitrite, nitric oxide, dioxygen and carbon dioxide.  
Inspired by the structural homology of heme copper oxidases (HCOs) and nitric oxide 
reductases (NORs), Lu designed and engineered a copper binding site in sperm whale 
myoglobin (Mb) by introducing two histidine residues (L29H, F43H) into the distal heme 
pocket. Metal binding in the resulting scaffold (CuBMb) was supported by UV-Vis and 
EPR, and increased O2 affinity was observed when Ag(I) (as a Cu(I) mimic) bound.292 
NO reduction (Equation 1) was catalyzed by CuBMb-Cu(I), with a turnover number close 
to a native enzyme (~ 2 mol NO · mol CuBMb-1 · min-1).293 Lu later designed a 
heme/non-heme FeB binding site in Mb by incorporating the L29H-F43H-V68E 
mutations.294 The binding of Fe(II) in the new artificial enzyme (FeBMb) was supported 
by the crystal structure of Fe(II)-FeBMb, in which the non-heme iron was coordinated 
with three histidines, one O atom of glutamate and one water molecule. Thirty percent 
conversion was observed for NO reduction catalyzed by Fe(II)-FeBMb. The catalytic 
activity was further enhanced (~ 100% increase) by introducing a second glutamate into 
the second coordination sphere of FeB binding site (I107E), which was believed to 
facilitate proton delivery via a hydrogen binding network. The same group reported an 
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alternate binding pocket (FeBMb(-His)) for Cu, Fe and Zn ions, consisting of two 
histidines and one glutamate (L29E-F43H-H64). Both FeBMb(-His)-Cu and FeBMb(-His)-
Fe catalyzed the reduction of NO, while the former ArM had better activities (32% vs 6% 
conversion after 20 h).295  
  
In 2006, Watanabe and coworkers studied the electron transfer between an artificial 
metalloenzyme and a natural enzyme. For this purpose, they incorporated a Fe-
salophen (122 or 123) into heme oxygenase (HO). This enzyme converts heme to 
biliverdin using electrons provided by NADPH/cytochrome P450 reductase (CPR, 
Scheme 42).296 The crystal structure of 123·HO highlighted the presence of a hydrogen 
bond between the propionic acid carboxyl group and R177 of HO. Accordingly, the 
electron transfer rate from CPRred to 123·HO is 3.5-fold faster than that of 122·HO, 
although the redox potential of 123·HO is lower than that of 122·HO (Table 12).  
Table 12. Catalytic NADPH and O2 consumption by HOs reconstituted with Fe-salophen 
complexes.a  
 
Entry Cofactor Protein [Cof] (µM) 
-d[NADPH]/dt 
(µM / min) 
-d[O2]/dt 
(µM / min) 
-d[NADPH]/d[O2] Ref 
1 122 No Protein 2 24 4.8 0.20 296 
2 123 No Protein 2 31 12 0.39 296 
3 122 HO 2 21 21 1.0 296 
4 123 HO 2 5.5 5.1 0.93 296 
a Reactions conditions: see Scheme 42.  
 
Scheme 42. Dioxygen reduction catalyzed by HO reconstituted with Fe-salophen 
coupled with cytochrome P450 reductase (CPR). 
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An artificial CO2 reductase, based on two covalently-anchored metal complexes within 
[(gp5βf)3]2 (sections 5.8 and 7.4), was designed by Ueno et al. in 2011.297 A maleimide-
Re(bpy)(CO)3Cl complex 124 and a succinimide-Ru(bpy)3 complex 125 were conjugated 
to a cysteine and a lysine residue respectively (Scheme 43 and Figure 12). In the 
presence of 1-benzyl-1,4-nicotinamide as a sacrificial reductant, the electron-transfer 
from the photo-reduced Ru-moiety to the Re-moiety for the reduction of CO2 to CO was 
investigated. The reaction efficiency depends on the distance between the Ru-moiety 
and Re-moiety: the turnover frequency of 124-125·[(gp5βf)3]2 was 3.3 times higher than 
a mixture consisting of 124·[(gp5βf)3]2 and Ru(bpy)3-COOH 126 (Table 13).  
Table 13. Selected results for the photocatalytic reduction of CO2 by Ru and Re 
complexes covalently anchored to [(gp5βf)3]2.a  
 
Entry Cof1 Cof2 Protein 
[Cof1] 
(µM) 
[Cof2] 
(µM) 
[1-benzyl-1,4-
nicotinamide] (mM) 
TOF 
(s–1) 
Ref 
1 124 125 [(gp5βf)3]2 (K41C) 70 20 100 2.8 
297 
2 124 125 [(gp5βf)3]2 (N57C) 72 20 100 1.2 
297 
3 124 125 [(gp5βf)3]2 (D69C) 80 20 100 1.5 
297 
4 
124 126 [(gp5βf)3]2 
(K41C) 
70 20 100 0.8 297 
a Reactions were carried out in a solution of 1 : 1 DMF/MOPS (40 mM, pH 7.0) at 25°C. 
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Scheme 43. Photocatalytic reduction of CO2 catalyzed by Ru and Re complexes 
anchored to [(gp5βf)3]2 with 1-benzyl-1,4-dihydronicotinamide as the stoichiometric 
reductant. 
 
 
 
 
Figure 12. The bionanotube [(gp5f)3]2 (PDB code 3A1M) was covalently functionalized 
at selected positions (magenta) with a Sc(bpy) complex to afford a clickase298, an 
epoxide ring forming metalloenzyme299 and a CO2 reductase.297 
 
One year later, Pecoraro et al. engineered an artificial nitrite reductase based on a 
previously designed α-helical coiled-coil motif (section 7.1).300 The construct (TRIL23H)3 
is able to bind Cu(I) and Cu(II) with picomolar and nano/micromolar affinities 
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respectively. Binding occurs via coordination to three histidine residues (mutation L23H). 
The nature of the active site, a structural analogue of copper nitrite reductase, was 
characterized by spectroscopy. The designed artificial metalloenzyme 
Cu(I/II)(TRIL23H)3+/2+ catalyzes the reduction of nitrite to nitric oxide with ascorbate as 
electron donor, Equation 2. Kinetic investigations revealed similar rates for the oxidation 
of ascorbate by Cu(II)(TRIL23H)32+ and for the oxidation of Cu(I)(TRIL23H)3+ by nitrite 
(kascorbate = 4.6 · 10-4 s-1 and kCu = 5.2 · 10-4 s-1 at pH 5.8). This suggests that the electron 
transfer from Cu(I)(TRIL23H)3+ to nitrite with simultaneous formation of 
Cu(II)(TRIL23H)32+ is the rate-limiting step of the catalytic cycle. Under optimized 
conditions, the artificial nitrite reductase exceeded 5 turnovers and formed 
predominantly NO as product (i.e. almost no formation of N2O).  
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5. C–C Bond Formation 
5.1 Allylic Alkylation  
Allylic alkylation is a C–C bond forming reaction catalyzed by a range of transition metal 
complexes, though Pd-phosphine complexes are most commonly used for synthetic 
applications.301 These catalysts activate heteroatom-substituted allyl compounds to 
attack by a soft nucleophiles via a metal-allyl intermediates. Though no natural enzyme 
has been reported to catalyze this reaction, terpene synthases rely on allyl cation 
intermediates that react in a similar fashion with an intramolecular carbon nucleophile to 
create a C-C bond.302 Researchers have demonstrated that Ru-catalyzed allylic 
substitution proceeds even inside of cells, making this reaction particularly attractive for 
in vivo applications.303-305 Encapsulating the transition metal within a protein scaffold 
could help to protect the metal in a biological environment, induce substrate specificity, 
and enable selective cell or even organelle targeting.  
Toward this end, Ward and coworkers generated a panel of ArMs by incorporating 
biotinylated Pd-bisphosphine complexes into different Sav variants and investigated their 
activity toward asymmetric allylic alkylation of 1,3-diphenylallylacetate using malonate as 
a nucleophile.306 In total, fourteen Pd complexes were screened against 20 Sav isoforms 
bearing mutations at S112X and two additional positions (Scheme 44 and Table 14). 
Didodecyldimethlyammonium bromide (DMB) was added to suppress 1,3-
diphenylallylacetate hydrolysis (Scheme 44). With this modification, ArMs containing 
ligands 37 (which yielded rac-product), 41 (mostly (R)-selective), and 42 (mostly (S)-
selective) were identified. Replacement of DMB by DMSO was possible in case of ligand 
41 and led to increased enantioselectivity and conversion (i.e. 95 % ee, TON 45, Table 
14, entry 3). The (S)-selectivity was increased to 82 % ee upon combining S112G and 
V47G mutations.  
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Scheme 44. A biotinylated bisphosphine palladium complex anchored within streptavidin 
affords an artificial allylic alkylase.  
 
 
 
Table 14. Selected results of the catalytic performance of the allylic alkylase based on 
the biotin-streptavidin technology.  
 
Entry Liganda Protein ee (%) Conv. (%) 
1 41 S112A 90 (R) 95 
2 41 S112Ab 93 (R) 20 
3 41 S112Ac 95 (R) 90 
4 41 S112Q 31 (S) 96 
5 42 S112Y 80 (R) 87 
6 42 S112G 54 (S) 96 
7 42 S112G-V47G 82 (S) 92 
a See Scheme 11 for the structure of the ligands.  bNo DMB added. cNo DMB added, reaction carried out in 45% DMSO.  
 
5.2 Suzuki Cross-Coupling  
Carbon-carbon cross-coupling reactions offer a highly versatile means to assemble 
functional molecules. The palladium-catalyzed Suzuki-Miyaura cross-coupling reaction 
of aromatic halides and aryl boronic acids to afford biaryls is particularly notable in this 
regard.307 The importance of biaryls to the agrochemical, pharmaceutical, and polymer 
industries, coupled with the bioorthogonality of the Suzuki-Miyaura cross-coupling in 
general have led to extensive development of catalysts for this reaction. Researchers 
have also started to apply this and closely-related reactions for chemical biology 
applications,308-311 although these efforts are limited by the high catalyst loadings 
required, presumably due to catalyst inactivation under biologically relvant conditions308. 
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Anchoring Pd-catalysts within a protein scaffold could potentially i) protect the Pd-
catalyst from inactivation in a biological reaction medium and ii) control the 
stereochemistry of the cross-coupling reaction.  
To date, three studies have been reported on ArM Suzukiases. The first of these, 
reported by Ueno, Watanabe, and coworkers, was generated by loading [Pd(allyl)Cl]2 
127 into apo-ferritin (Scheme 45).312 Ferritin is an iron storage protein consisting of 24 
self-assembled four helix-bundle subunits. The crystal structure of 127·apo-ferrtin 
reveals two dinuclear Pd complexes located at the so-called accumulation center and 
threefold channel, respectively (Figure 13). Localization of the Pd centers is ensured via 
coordination to cysteine, histidine, and glutamic acid residues. The resulting ArMs 
catalyzed the Suzuki–Miyaura cross-coupling between 4-iodoaniline 128 and 
phenylboronic acid 129 with up to TOF = 3500/hour (Scheme 45 and Table 15, entry 1).  
Figure 13. Ferritin (PDB code 1DAT) was engineered to carry out Suzuki-Miyaura cross- 
coupling312 and phenylacetylene polymerization reactions.313 Crystal structure analysis 
of Pd- and Rh-bound ferritin indicated metal binding to amino acid side chains in the 
“threefold channel” (magenta) and the “accumulation center” (red). Only a cross-section 
of ferritin is displayed for clarity.  
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Several mutations were introduced around the Pd binding site in 127·apo-ferrtin to 
decipher the role of the coordination geometry on the catalytic activity (Figure 13).314 
Among the mutants, the ferritin E45C-R52H variant gave the highest TOF = 4300/hour 
(Table 15, entry 7). 
Table 15. Suzuki-Miyaura coupling reaction catalyzed by a Pd(allyl) · ferritin ArM.  
 
Entry Cofactor Protein 
NaOH  
(mM) 
T  
(°C) 
[Pd] / [Fr] 
determined by ICP 
TOF per Pd(allyl) · Fr  
(h–1) 
Ref 
1 127 Fr (WT) 4.5 50 103 3500 312 
2 127 Fr (H49A) 4.5 50 99 3400 312 
3 127 Fr (C48A-H49A) 4.5 50 54 1900 312 
4 127 Fr (H114A) 4.5 50 78 900 312 
5 127 Fr (C126A) 4.5 50 37 830 312 
6 127 Fr (E45C-C48A) 4.5 50 98 4200 314 
7 127 Fr (E45C-R52H) 4.5 50 154 4300 314 
8 127 Fr (E45C-H49A/R52H) 4.5 50 154 4200 314 
 
Scheme 45. Suzuki-Miyaura coupling reaction catalyzed by a [Pd(allyl)Cl]2-loaded 
ferritin.  
 
 
 
Based on the promising results obtained with the asymmetric allylic alkylases outlined 
above, Ward and coworkers screened a number of biotinylated NHC- and 
monophosphine ligands in the presence of [Pd(3-cinnamyl)Cl]2 for Suzuki cross-
coupling to afford enantioenriched binaphtyls (Scheme 46).315 Anchored within WT Sav, 
the monophosphine complexes [Pd(3-cinnamyl)Cl(Biot-Et-P(t-Bu)2)] 131 and [Pd(3-
cinnamyl)Cl(Biot-Pr-P(t-Bu)2)] 132 yielded binaphtyl 135 with 78 and 73 TON, 
respectively. The NHC-complex [Pd(3-cinnamyl)Cl(Biot-L)] 130 was less active (45 
TON) and afforded rac-135. For the tert-butyl phosphine complexes, the ethyl and propyl 
spacers yielded opposite product enantiomers in 58 % ee ((R)-135) and 10 % ee ((S)-
135), respectively. Screening a panel of ArMs generated by combining different Sav 
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variants with [Pd(3-cinnamyl)Cl(Biot-Et-P(t-Bu)2)] 131 led to the identification of Sav 
S112Y-K121E, which produced (R)-135 with 90 % ee and 50 TON at 4 °C. Mutant 
K121A yielded the (S)-135 with 47 % ee and 32 TON.  
Scheme 46. An artificial Suzukiase for the synthesis of enantioenriched binaphtyls 
based on the biotin-streptavidin technology. Insert: X-ray crystal structure of [Pd(3-
cinnamyl)Cl(Biot-Et-P(t-Bu)2)] 131·Sav S112Y K121E. Adapted from ref.315 - Published 
by The Royal Society of Chemistry. 
 
  
 
5.3 Heck Reaction 
The Heck reaction is an extremely powerful means of forging C-C bonds between widely 
available aryl halides and olefins. Moreover, substituted olefins can give rise to regio- 
and enantiomeric products, which necessitates the development of catalysts that can 
impart selectivity to these transformations. Filice and Palomo therefore took on the 
challenge of developing an ArM Heckase.316 Covalent modification of a variety of lipases, 
including CAL-B, was achieved using phosphonate-substituted Pd-pincer complex 136 
(Figure 14 a) in analogy to the previous work of Gebbink and van Koten (Scheme 12).181, 
183 Optimization of reaction conditions and immmobilization methods led to the finding 
that 136·CAL-B immobilized on aldehyde-activated Sephabeads (136·CAL-B-CHO-SP) 
catalyzed a model Heck reaction with high efficiency (Figure 14 b). This system was 
compatible with remarkably high temperatures (70-120 C) and organic solvent 
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concentrations (75-100% DMF). Further optimization of the SP surface using different 
alkyl amine capping agents (methyl, octyl, etc.) led to the development of 136·SP-CAL-
B-C8, which had higher activity toward the model Heck reaction than 136·CAL-B-CHO-
SP. Even more remarkably, this catalyst provided high enantioselectivity (96.6 % ee) in 
the Heck coupling of 2,3-dihydrofuran 137 with phenyl iodide at 120 C in 75% DMF, 
though no conversion was observed at 70 C or with phenyl bromide (Figure 14 c). 
Beyond highlighting the potential for ArMs to catalyze selective Heck reactions, this 
study provides compelling support for further exploration of immobilized ArMs.  
 
Figure 14. Structure of phosphonate-substituted Pd-pincer complex used to generate 
ArM Heckase a). Model Heck reaction used to optimize immobilized ArM Heckases b). 
ArM-catalyzed asymmetric Heck reaction between 2,3-dihydrofuran and iodobenzene 
c).316 
 
5.4 C–H Activation 
Carbon-carbon bond formation via carbon-hydrogen (C-H) bond functionalization 
remains a highly attractive yet equally challenging transformation in organic synthesis.317 
By eliminating the need for prefunctionalized starting materials, these reactions can 
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enable new disconnection strategies, reduce synthetic manipulations, and decrease 
waste. All of these benefits, however, require a catalyst to activate a single C-H bond in 
the presence of many other, often similarly reactive, C-H bonds, and functionalize the 
resulting metallated position with the desired regio- and enatioselectivity. The impressive 
levels of selectivity exhibited by a number of natural enzymes that catalyze C-H bond 
functionalization clearly demonstrates the potential for protein scaffolds to control these 
transformations.318 A number of researchers have therefore explored the possibility of 
using ArMs to control the selectivity of synthetic C-H functionalization catalysts.  
Rovis and Ward, for example, hypothesized that incorporating a biotinylated Rh-complex 
[(98)RhCl2(H2O)] into Sav could provide a chiral environment for enantioselective 
hydroarylation reactions319-320 catalyzed by [5-(Cp*)RhCl2]2.321 One such reaction, 
involving hydroarylation of methyl acrylate with pivaloyl-protected benzhydroxamic acid 
138 and subsequent cyclization (i.e. benzanulation), provides regioisomeric 
isoquinolones 139 and 140 (Scheme 47 a)). While this reaction proceeded poorly using 
the free cofactor in water, addition of acetate buffer increased TON from 5 to 80 and 
provided 139 and 140 in a 4:1 ratio. This was hypothesized to result from acetate 
participation in a rate limiting concerted metallation-deprotonation step (CMD) of the 
overall C-H functionalization process (Scheme 47 b). Incorporating [(98)RhCl2(H2O)] into 
WT Sav decreased TON to 40, but the regioisomeric ratio (rr) and ee values increased 
to 9:1 and 50% (favoring R-139), respectively. Sav variants bearing a carboxylate 
residue in the proximity of the Rh cofactor (i.e. S112D/E or K121D/E) were then 
examined to determine if these could replace acetate and allow to carry out the desired 
reaction at neutral pH. Indeed, Sav K121D provided an ArM that catalyzed 
benzanulation of 138 with improved TON and rr (up to 89 and 15:1, respectively), but the 
ee remained virtually identical to WT Sav. Promising single point mutations were then 
combined to generate Sav variants N118K-K121E and S112Y-K121E, which, upon 
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metallation, provided (R)-139 with 50 TON, 64% ee, 15:1 rr and 47 TON, 82% ee, and 
19:1 rr, respectively.  
The role of glutamate K121E as general base in the rate limiting ortho-Caryl-H 
deprotonation step was investigated. A kinetic isotope effect (KIE) of 4.8 was observed 
for substrate 138 with [(98)RhCl2(H2O)]Sav S112Y-K121E. The KIE of the 
corresponding WT Sav ArM was only 2.8. To highlight the rate accelerating effect of the 
Sav, the protein/cofactor ratio was varied and the enantioselectivity was determined 
using substrate 138. Strikingly, the artificial benzannulase [(98)RhCl2(H2O)]Sav S112Y-
K121E retained a high ee even in the presence of a large excess of cofactor; a rate 
acceleration of ~100-fold was determined.  
Scheme 47. An artificial benzannulase for the synthesis of enantioenriched 
dihydroisoquinolones based on the biotin-streptavidin technology. Reaction conditions 
and substrate scope and postulated transition state of the CMD step are displayed in a) 
and b), respectively. Adapted with permission from ref.38 Copyright ACS Publications 
2016. 
 
 
 
Metal porphyrin complexes catalyze a range of C-H insertion reactions via generation of 
highly reactive metal-oxo, -peroxy, -carbene, and -nitrene intermediates upon reaction 
with suitable precursors for these species.322 While oxo insertion reactions catalyzed by 
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heme-dependent oxygenases and peroxygenases have been extensively studied,323 
reactions of these enzymes with carbene and nitrene precursors has only recently been 
explored in detail.324 As discussed in the review by Fasan and coworkers elsewhere in 
this issue, this has been exploited to enable carbene insertion into olefins 
(cyclopropanation)12 and nitrene insertion into C-H bonds using cytochromes P450, 
myoglobin, and other heme enzymes.325-326 To obtain systems with further expanded 
function, a number of researchers have incorporated unnatural porphyrins and other 
heme-like cofactors into heme proteins and enzymes to generate ArMs.55 These efforts 
take advantage of well-formed active sites that evolved to accommodate a planar 
(heme) cofactors and small molecule substrates. While this approach has also been 
extensively explored for oxo-insertion reactions (section 6.1), significantly less has been 
done for carbene and nitrene insertion reactions. 
Despite the ability of heme enzymes to catalyze carbene insertions into olefins, 
analogous insertions into C-H bonds using these enzymes have not been reported. 
Hartwig, Clark and coworkers therefore investigated the activity of ArMs generated by 
metallating eight different apo-myoglobin variants containing a different mutation at the 
axial ligand position (H93X) in the presence of protoporphyrin IX (PPIX) cofactors 
containing different noble metals. Of these, an ArM generated from (PPIX)Ir(Me) 
catalyzed both cyclopropanation (vide infra) and intramolecular carbene insertion using 
diazo carbene precursors.327 In the later case, reaction of diazoester 141 to form the 
corresponding chiral dihydrobenzofuran, which has not been reported for natural heme 
enzymes, was examined. Stepwise targeted mutagenesis of the myoglobin active site 
led to ArMs with good enantioselectivity reactions of multiple substrates (86% ee for C-H 
insertion, Figure 15). Variants were identified that catalyzed intramolecular carbene 
insertion in one particular substrate to provide either product enantiomer with up to 84% 
and 50% ee (Scheme 48 a).  
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Figure 15. Cartoon representation of Myoglobin's active site with its natural cofactor 
(PDB: 1MBI). Highlighted in magenta and yellow are the axial (H93) and distal (H64) 
histidines, respectively. Highlighted in orange are additional amino acids modified to 
evolve the ArMs as C-H activase, cyclopropanase327 and dihydrogenase.208 Highlighted 
in beige are amino acids mutated to modify the affinity or the orientation of the artificial 
cofactors for the evolution of sulfoxidase328 329-330 and peroxidase.331-333 Heme displayed 
in green (C), red (O) and blue (N). 
 
The same group also reported that a thermostable cytochrome P450 from Sulfolobus 
solfataricus (CYP119) could be reconstituted with (PPIX)Ir(Me) to generate a 
thermostable ArM (Tm = 69 °C).334 Intramolecular carbene insertion using diazoester 141 
was again selected as a model reaction (Scheme 48 b). A catalytic efficiency (kcat/KM) of 
0.071 min-1∙mM-1 was observed for the single mutant C317G, which was improved by 
introducing hydrophobic and uncharged residues into the ArM active site (Figure 16). 
The quadruple mutant (L69V-T213G-V254L-C317G) showed a more than 4000-fold 
higher catalytic efficiency (kcat/KM = 269 min-1 ∙ mM-1) than the initial wild type construct, 
accompanied by an initial turnover frequency of 43 min-1 and a high enantioselectivity 
(94% ee).  
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Figure 16. Cytochrome P450 Cyp119 (PDB code 1IO8) catalyzes carbene insertion into 
C-H bonds.334 Residues in proximity to the heme cofactor that were subjected to 
mutagenesis are highlighted in magenta and yellow.  
 
ArMs optimized for this model reaction also catalyzed the intramolecular carbene 
insertion into a variety of activated primary, secondary and sterically hindered C-H 
bonds with high turnover numbers and enantioselectivities, Scheme 48 b). 
Intramolecular carbene insertion into an unactivated primary C-H bond, (Scheme 48 c) 
and intermolecular reaction between phthalan 143 and ethyl diazoacetate 142 to provide 
144 was also observed (Scheme 48 d). The latter is particularly challenging since diazo 
coupling 145 or formal insertion of the carbene into the O-H bond of water to form 
alcohol 146 can occur. Diazoester 141 was transformed into the corresponding 
dihydrobenzofuran on a preparative scale (1.0 g substrate, 55% isolated yield, 93% ee), 
whereby the ArM exceeded 3200 turnovers. On a smaller scale (10 mg substrate) a 
TON > 35,000 was achieved. Supported on sepharose beads, the ArMs could be 
recycled at least 4 times without erosion of enantioselectivity and retaining 64% of its 
initial activity. 
Scheme 48. C-H insertion reactions catalyzed by heme-substituted ArMs. 
Intramolecular insertion into activated C-H bonds catalyzed by a) myoglobin variants and 
b) P450-CYP119 variants; c) intramolecular insertion into unactivated C-H bonds by a 
P450-CYP119 variant; d) intermolecular insertion into activated C-H bonds by a P450-
CYP119 variant. TON: turnover number, e.r.: enantiomeric ratio, d.r.: diastereomeric 
ratio (trans : cis), * with 0.0025 mol% catalyst. 
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The work by Hartwig clearly represents a major step towards the use of ArMs as a 
widely applicable synthetic tool. Indeed, in view of the large number of heme-binding 
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proteins and the diversity of reactions catalyzed by metalloporphyrins, the potential of 
such metal-subsituted hemoproteins is huge. 
Although the protocol reported by the authors requires: i) E. coli culture under Fe-
depleted conditions, ii) affinity purification of the protein, iii) addition of the precious-
metal containing heme cofactor (in default vs. a rough estimate concentration of the apo-
hemoprotein) and iv) catalysis under inert atmosphere, all of these technical challenges 
are readily amenable to automation. 
 
5.5 Olefin Metathesis 
Transition metal catalyzed olefin metathesis has become a highly versatile tool for C–C 
bond formation.335 The development of Z- and E-selective cross metathesis catalysts 
has enabled construction of a wide range of molecules containing a double bond. 
Moreover, the bioorthogonality of many olefin metathesis reactions has led to their use 
in chemical biology,336-338 particularly for selective functionalization of biopolymers.339-340 
More recently, olefin metathesis has been considered as a means to expand the 
chemical toolkit of biochemistry given that it is thus far unknown to living organisms. A 
number of ArM metathases have been developed toward this end.  
The first two ArM metathases were introduced in 2011 by Ward et al. and Hilvert et al. in 
the same issue of Chem. Commun.341-342 The former employed (strept)avidin as a host 
for biotinylated cofactors based on a Grubbs-Hoveyda 2nd generation catalyst (GH-type 
catalyst). In fact, all the artificial metathase published to date use this type of cofactor. 
This is most probably due to its stability toward air and water. Two such cofactors 148 
and 149 with different linkers were synthesized and anchored within either avidin or 
streptavidin via a supramolecular interactions. Diallyl tosylamide 147 served as a model 
substrate for ring closing metathesis (Scheme 49).  
Scheme 49. Artificial metathase based on the biotin-(strept)avidin technology.  
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Different reaction conditions were explored, and the best yields were obtained at low pH 
with high concentrations of MgCl2 (Table 16). Similarly, Matsuo et al. investigated the 
effect of added chloride ions in aqueous metathesis and found that catalyst stability is 
significantly enhanced by the addition of KCl.343 They proposed that the replacement of 
the chloride ligands by hydroxy ions may lead to decomposition of the catalyst. This 
could explain why the addition of chloride salts and lowering of the pH has a beneficial 
effect. In a subsequent article, Ward and coworkers tested a large number of 
biotinylated catalysts where the biotin anchor was placed not at the backbone but on 
one of the mesityl units of the NHC ligand.344 This strategy improved the activity of the 
Sav-based metathase for a poor RCM substrate that affords fluorescent umbelliferone 
169 upon metathesis. 
Table 16. Summary of the results obtained for the artificial metathase system based on 
the biotin-(strept)avidin technology for substrate 147.  
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Entry Catalyst Protein pHa 
MgCl2 
[M] 
Yield 
(%) 
TON 
1 148 - 7 - 74 15 
2 148 Sav 7 - <1 0 
3 149 Sav 7 - 8 2 
4 149 Sav 7 0.5 33 7 
5 149 Sav 4 - 41 8 
6 149 Sav 4 0.5 71 14 
7 148 Avi 7 - 17 3 
8 149 Avi 7 - 6 1 
9 149 Avi 7 0.5 54 11 
10 148 Avi 4 - 79 16 
11 148 Avi 4 0.5 95 19 
12 148 - 4 0.5 95 19 
a pH 7: no buffer; pH 4: acetate (0.1 M) 
 
The construct of Hilvert et al., on the other hand, was generated via covalent 
modification of a small heat-shock protein from Methanocaldococcus jannaschii 
(MjHSP).342 This protein assembles into a spherical substructure with large pores, which 
allow for the diffusion of small molecules. Similar to streptavidin, the protein displays a 
remarkable stability towards high temperatures and low pH. GH-type catalyst 150 
substituted with a -bromoacetyl group was reacted with the thiol of a surface cysteine 
in the G41C mutant of MjHSP to yield the artificial metathase 151 (Scheme 50).  
Scheme 50. Covalent anchoring strategy to produce a metathase by Hilvert et al.342 
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The same trend observed for the metathase of Ward et al. was also apparent for this 
system: the lower the pH, the better the performance of the metathase. A total turnover 
number of 25 could be achieved for ArM 151 at pH 2, but the free catalyst 150 gave 
slightly better results (Table 17, compare entries 1-3 with entries 4-6). 
Table 17. Selected results for the metathase with substrate 147 based on the heat-
shock protein MjHSP by Hilvert et al.342  
 
Entry Catalyst pHa Catalyst loading (mol %) TON 
1 150 7.0 2 2 
2 150 3.9 2 16 
3 150 2.0 2 33 
4 151 7.0 4 3 
5 151 3.9 4 12 
6 151 2.0 4 25 
 a pH 7.0: 50 mM phosphate; pH 3.9: 50 mM MES; pH 2.0: 10 mM HCl. 
A covalent anchoring strategy was also used by Matsuo et al. to generate an ArM 
metathase.345 GH cofactor 152, which contains an L-phenylalanine moiety bearing an -
chloroketone, was used to both covalently anchor the cofactor to -chymotrypsin and 
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selectively interact with the S1 site of -chymotrypsin via hydrophobic contacts. 
Nucleophilic attack of the imidazole of H57 on the chloroketone resulted in a covalent 
link between the cofactor and -chymotrypsin to provide 153. Interestingly, the authors 
showed that the enantiomer of 152 with inverted stereochemistry did not react with the 
protein. This provided convincing evidence that the functionalization indeed occured 
inside the active site of -chymotrypsin which is known to only recognizes L-
phenylalanine. The authors tested three different substrates for metathesis and reported 
good turnover numbers when using the glycosylated diene 154. In contrast, they 
observed only low TONs for the cationic substrate 155 and the lipophylic diallyl tosylate 
147 (Table 18, entries 1-6 and Scheme 51).  
Scheme 51. Conversion of -Chymotrypsin into a metathase via covalent anchoring.  
 
 
 
Table 18. Selected results for RCM using the metathase based on -chymotrypsin.  
 
Entry Catalyst Sub. TON (after 2 h) 
1a 153 154 20 
2a,b 152 154 14 
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3c 153 155 N.D. 
4c,d 152 155 < 2 
5b,e 153 147 4 
6b,e 152 147 12 
[KCl] = 100 mM; a [154] = 8 mM; [cat] = 50 µM; b contains 10 % DMSO (v/v); c [155] = 8 
mM, [cat] = 0.2 mM;  d contains 10 % MeOH (v/v); e [147] = 1 mM, [cat] = 25 µM. 
 
Yet another anchoring strategy was used by Gebbink et al.346 to link a GH-type catalyst 
substituted with a phosphonated alkyl chain to cutinase. The cofactor underwent 
irreversible transesterification with S120 in the cutinase active site to form an ArM 
(Figure 17). The authors first explored a catalyst with a short alkyl chain 156, but this 
had no metathesis activity. When the chain length was increased (157), the resulting 
ArM catalyzed both ring closing metathesis of diallyl tosylamide 147 and cross-
metathesis of allylbenzene 158. To our knowledge this was the first example of cross-
metathesis using an ArM (Table 19).  
 
 
Figure 17. Artificial metathase using cutinase as a host.  
 
Table 19. Selected results for an artificial metathase with a cutinase host.  
 
Entry Catalyst Sub. Buffer TON 
1 156 147 tris-HCl pH 8.5 - 
2 156 147 HCl 0.01M - 
3 156 147 acetate pH 5 <1 
4 Grubbs-Hoveyda II 147 acetate pH 5 plus cutinase 18 
5 157 147 tris-HCl pH 8.5 - 
6 157 147 acetate pH 5 17 
7 156 158 acetate pH 5 <1 
8 157 158 Acetate pH 5 20 
a conditions: Catalyst (5 mol%), MgCl2(10 eq.), Buffer, CH2Cl2 5 %(v/v), 25 °C, 20h.  
 
An artificial metathase based on on human carbonic anhydrase II (hCA II) was reported 
by Ward et al.347 The hCA II protein has a strong affinity (typically nM - pM) toward 
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arylsulfonamides due to sulfonamide coordination to an active site zinc ion. Three 
different sulfonamide-substituted catalysts were prepared (159-161), and their activity 
toward ring closing metathesis of substrate 147 was evaluated. Catalyst 160, bearing 
ortho-isopropoxy groups at the NHC aryl groups, performed best. The ArM had similar 
activity to the free cofactor, but moderate turnover was observed even at pH 7.0, which 
may be relevant for in vivo applications (Table 20 and Scheme 52). 
Scheme 52. Human carbonic anhydrase as host for an artificial metathase.  
 
 
 
Table 20. Selected results for RCM with an artificial metathase based on hCA II.  
 
Entry Cat hCAII pH 
MClx  
mol/L 
TON Entry Cat hCAII pH 
MClx  
mol/L 
TON 
1 159 - 6.0 MgCl2 0.1 20 15 160 WT 8.0 - 21 
2 160 - 6.0 MgCl2 0.1 48 16 160 - 7.0 NaCl 1.5 32 
3 161 - 6.0 MgCl2 0.1 25 17 160 WT 7.0 NaCl 1.5 21 
4 159 WT 6.0 MgCl2 0.1 13 18 160 WT 7.0 NaCl 0.5 32 
5 160 WT 6.0 MgCl2 0.1 45 19 160 WT 7.0 NaCl 1.0 29 
6 161 WT 6.0 MgCl2 0.1 16 20 160 I91A 7.0 - 18 
7 160 WT 6.0 NaCl 0.2 40 21 160 F131A 7.0 - 16 
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8 160 WT 7.0 NaCl 0.2 28 22 160 L198F 7.0 - 18 
9 160 - 7.0 - 23 23 160 L198H 7.0 - 22 
10 160 WT 7.0 - 14 24 160 L198H 7.0 NaCl 0.15 28 
11a 160 WT 7.0 - 20 25 160 L198A 7.0 - 15 
12 160 - 5.0 MgCl2 0.5 85 26 160 L198Q 7.0 - 14 
13 160 WT 5.0 MgCl2 0.5 78 27 160 K170A 7.0 - 15 
14 160 WT 6.0 - 23       
a [substrate] = 5 mM, [catalyst] = 50 µM, [hCAII] = 60 µM;  
 
Okuda and Schwanenberg reported the first artificial metathase for ring opening 
metathesis polymerization (ROMP). In their original publication, the authors described a 
strategy to engineer the -barrel protein FhuA via modification of an internal cysteine 
mutant (K545C) of the protein (Figure 18).348 Two additional positions (N548V and 
E501F) were also mutated to ensure cysteine accessibility and improve catalyst 
performance. Both maleimide- and -bromoacetyl-functionalized GH-type catalysts 
reacted with the internal cysteine residue in the FhuA triple mutant to generate ArM 
metathases. Of the metathases evaluated, 166·FhuA, generated from maleimide 
functionalized GH-catalyst 166, provided the highest activity for polymerization of 7-
oxanorbornene 162, but higher activity was observed for the free catalyst. In a 
subsequent publication, the authors performed chemical optimization of the linker 
length.349 Gratifyingly, shortening the linker increased the efficiency of the metathase, 
and modest selectivity towards cis-double bonds was observed in the polymer product 
(Table 21, entries 1-8 and Scheme 53). 
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Figure 18. An artificial metathase349 and a Diels-Alderase350 were generated based on 
the FhuA scaffold (PDB code 1BY3). Metal catalysts were covalently tethered to the 
protein scaffold via mutation K545C.  
 
Scheme 53. Artificial metathase based on the FhuA barrel protein. 
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The same authors then examined a cysteine mutant of nitrobindin as a protein scaffold 
for their second generation metathases.199 Low bioconjugation yields were observed 
presumably due to the small size of the barrel interior relative to the sterically demanding 
GH-type catalysts. A cofactor bearing a longer linker 166, on the other hand, reacted to 
form the desired ArM 166·Nb1. Enlarging the cavity of the nitrobindin 1 scaffold led to 
higher bioconjugation yields. This mutant (nitrobindin 2) enabled formation of multiple 
metathases 164·Nb2, 165·Nb2 and 166·Nb2. The ArM generated using the cofactor 
bearing the longest linker 166·Nb2 again proved to be most active. The metathase also 
catalyzed ring closing metathesis with 2,2-diallyl-1,3-propanediol 167, but no protein 
acceleration was observed for this reaction (Table 21, entries 9-17 and Scheme 54).  
Scheme 54. Second generation metathase based on a nitrobindin scaffold. 
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Table 21. Selected results for the artificial metathase based on FhuA and Nitrobindin 
with substrates 162 and 167.  
 
Entry Catalyst Sub. 
Conversion 
(%) 
cis/trans TON Ref Entry Catalyst Sub. Conversion TON Ref 
1a 163 162 70 48/52 530 348 14c,e,f 163 167 >99 100 199 
2a 163 + FhuA 162 0 n.d. n.d 348 15d,e,f 165·Nb2 167 89 89 199 
3a 166·FhuA 162 37 56/44 365 348 16d,e,f 166·Nb2 167 >99 100 199 
4b 163 162 99 50/50 990 349 17d,e,g 166·Nb2 167 57 178 199 
5b 164·FhuA 162 41 58/42 555 349       
6b 165·FhuA 162 24 56/44 325 349       
7c 163 162 41 70/30 4100 199       
8d 163 162 <5 n.d. n.d 199       
9d 166·Nb1 162 10 40/60 1100 199       
10d 164·Nb2 162 <5 n.d. n.d. 199       
11d 165·NB2 162 19 42/58 2100 199       
12d 166·NB2 162 78 43/57 9700 199       
13d,e 166·NB2 162 80 48/52 9900 199       
a phosphate buffer pH 7.4, 10% THF, 0.125 mM PE-PEG; b phosphate buffer pH 5.8, 10% THF, 0.125 mM PE-PEG; c in THF, 12 h, 
0.01 mol% catalyst; d 0.008 mol% catalyst, MES buffer pH 6.0, 0.2 M NaCl, 25 °C, 12h; e performed at 40 °C; f [Sub] = 125 mM; [cat] 
= 1.25 mM; g 0.3 mol% catalyst.  
 
A breakthrough in the field of artificial metalloenzymes and metathases in particular was 
achieved in the groups of Ward and Panke.351 Relying on the biotin-streptavidin couple, 
they selectively assembled an ArM metathase within the periplasm of Escherichia coli. 
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The secretion of streptavidin into the periplasm was achieved by fusing Sav with the 
signal peptide OmpA. The E. coli strain combined a biotinylated GH-type catalyst 171 
and periplasmic streptavidin as the protein host. This approach offers several important 
benefits. First, the metathase is not exposed to metabolites that could potentially 
interfere with the reaction or poison the catalyst. Glutathione, for example, is known to 
inhibit many precious metal catalysts,261 but in the periplasm, this metabolite is only 
present in low concentrations and primarily in its oxidized form. The latter was shown to 
be significantly less harmful to d6-metal complexes. Second, conducting metathesis 
reactions in vivo substantially sped up genetic optimization of the ArM metathases. A 
screening protocol was designed using microtiter plates and substrate 168, which 
yielded fluorescent umbelliferone 169 upon RCM. Saturation mutagenesis libraries for 
twenty different amino acid positions were generated and over 3000 clones were 
screened. A quintuple mutant (47A-49K-114Q-119G-121R) with a cell-specific activity 
5.4 times higher than the wild type metathase was identified. The activity of the purified 
ArM was also evaluated on two additional water soluble RCM substrates. The evolved 
metathase had increased activity over free catalyst as well as two benchmark, 
commercial catalysts toward uncharged diol substrate 167. When the positively-charged 
diallylsulfonamide derivative 170 was tested with the quintuple mutant, however, a lower 
activity than the wild type was observed. The authors hypothesized that this may be due 
to electrostatic repulsion of the quarternary ammonium ion and the positively charged 
guanidinium group of arginine K121R. Consequently, a new round of saturation 
mutagenesis was performed at this position and a new clone (47A-49K/114Q-119G-
121L) was found with leucine as an apolar residue at the 121 position. Upon removing 
this charge, the new mutant brought a significant improvement for the positively charged 
substrate 170 (Table 22 and Scheme 55).  
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Scheme 55. In vivo directed evolution of an artificial metathase based on the biotin-
streptavidin technology.  
 
 
 
Table 22. In vitro performance of artificial metathases obtained by directed evolution.  
 
Entry Cat 
SAV 
mutant 
Sub TON 
1a 172 - 167 230 
2a 173 - 167 340 
3a 171 - 167 155 
4a 171 Wild Type 167 445 
5a 171 (47A/49K/114Q/119G/121R) 167 645 
6a 171 (47A/49K/114Q/119G/121L) 167 455 
7b 172 - 170 18 
8b 173 - 170 30 
9b 171 - 170 32 
10b 171 Wild Type 170 53 
11b 171 (47A/49K/114Q/119G/121R) 170 46 
12b 171 (47A/49K/114Q/119G/121L) 170 89 
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a conditions: deuterated acetate buffer pH 4, 1.5 % DMSO-d6, [cat] = 50 µM, [sub] = 50 mM; bconditions: 
acetate buffer pH 4, 1.5 % DMSO, [cat] = 50 µM, [sub] = 10 mM.   
 
However, when performing catalysis in the periplasm, the metathase’s activity droped by 
ca 1 order of magnitude (e.g. 89 TON in vitro vs 7 TON in cellulo for substrate 170). The 
authors speculate that this may be caused by several factors including: i) the very low 
concentration of ArM in the periplasm; ii) the gel-like medium present in the periplasm 
and iii) the presence of non-innocent metabolites in the periplasm. 
In conclusion, it has been shown that metathesis is a versatile reaction for ArMs. Within 
the past five years, the efficiency of metathases rose from a TON of 20 to hundreds of 
turnovers. Furthermore, all of the common metathesis reactions including cross-
metathesis, ring closing metathesis, as well as ring opening metathesis polymerization 
have been achieved by artificial metathases. It has also been shown that such 
metathases under certain conditions can also work inside cells, which raises fascinating 
perspectives for their potential use in vivo. Yet, some major hurdles have to be 
overcome for such hybrid catalysts to be applicable as real alternatives to their 
organometallic counterparts. Since these systems rely on GH-type cofactors, they 
remain fragile toward reactive cell metabolites, especially thiols including GSH. This 
problem could be solved by either chemical engineering of more stable metathesis 
catalysts or by biological engineering of highly shielded active sites. The second 
challenge is the modest reactivity, compared to established commercial catalysts. 
However, taking into account the powerful tools offered by enzyme engineering, it is only 
a matter of time until highly efficient metathases can be developed for in vivo 
applications.  
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5.6 Cyclopropanation  
As noted in section 5.4, several heme enzymes have been reported to catalyze olefin 
cyclopropanation via carbene insertion into olefin substrates. Metal substituted heme 
proteins also catalyze this reaction. Indeed, (PPIX)Ir(Me)-substituted myoglobin (see 
active site in Figure 15) catalyzed cyclopropanation reactions of an internal alkene 174 
and an unactivated aliphatic olefin 175, neither of which has been reported for natural 
heme enzymes (Scheme 56 a-b). To facilitate in vivo generation of ArMs containing 
heme cofactors, Brustad and Snow recently reported an orthogonal P450-Fe-DPIX pair 
and demonstrated that the resulting ArMs could catalyze carbene insertion into olefins to 
generate cyclopropanes (Scheme 56 c), Figure 19).352  
Scheme 56. Cyclopropanation reactions catalyzed by heme-substituted ArMs: a) 
aromatic olefins and b) aliphatic olefins catalyzed by myoglobin variants; c) styrene 
cyclopropanation catalyzed by P450BM3 variants. 
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Figure 19. Cytochrome P450BM3 (PDB code 2IJ2) was evolved (mutant P450BM3 
G265F-T269V-L272W-L322I-F405M-T268A) to preferentially bind a synthetic heme 
derivative, DPIX-Fe, which bears two methyl groups instead of the bulkier vinyl 
groups.352 The ArM is a cyclopropanation catalyst.  
 
Prior to any reported studies on carbene insertion chemistry using metal-substituted 
heme enzymes, Lewis reported that ArMs containing a dirhodium cofactor could 
catalyze cyclopropanation of 4-methoxystyrene and insertion into the Si-H bond of 
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diphenylmethylsilane using diazoacetate carbene precursors (Scheme 57). The 
dirhodium ArMs were constructed by genetically encoding a p-azidophenylalanine 
residue at different sites within tHisF and phytase scaffolds, followed by strain-promoted 
azide-alkyne cycloaddition (SPAAC) of bicyclononyne (BCN)-substituted dirhodium 
cofactor (177).10 Neither of the carbene insertion reactions investigated proceeded with 
significant enantioselectivity, likely as a result of the dirhodium center projecting out of 
the scaffolds investigated. Significant levels of formal carbene insertion into the O-H 
bond of water were also observed, but these ArMs accepted donor-acceptor carbenes, 
which has not yet been reported using heme protein scaffolds. 
To determine if a protein scaffold could be used to correct the chemo- and 
enantioselectivity problems encountered by initial dirhodium ArM constructs, 
bioconjugation of 177 to several additional scaffolds was pursued. Gratifyingly, 
incorporating 177 into a prolyl oligopeptidase (POP)353 scaffold from Pyrococcus 
furiosus, which has a large active site capable of completely encapsulating the bulky 
dirhodium cofactor, led to modest enantioselectivity for styrene cyclopropanation (38% 
ee).354 Targeted mutagenesis of residues in the POP active site led to dirhodium ArMs 
that catalyzed styrene cyclopropanation with up to 92% ee and improved selectivity for 
cyclopropanation over competing formal insertion into the O-H bond of water (Scheme 
57 b)). Key residues introduced into the POP scaffold included a histidine (H328), 
believed to coordinate to one of the Rh centers in 177, and two phenylalanines (F99, 
F594) across the active site relative to the coordinating histidine (Figure 20).  
Scheme 57. Bicyclononyne-substituted dirhodium cofactor a). Dirhodium ArMs 
catalyzed cyclopropanation b) and Si-H insertion reactions c). 
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Figure 20. Homology model of Pfu POP.355 The hydrolase domain is shown in green, 
the propeller domain is shown in grey and cofactor 177 linked at Z477 is shown in red. In 
magenta are highlighted alanine mutations introduced to widen the pore and thereby 
enabling access of the cofactor to the active site. Additional mutations introduced into 
Pfu POP are shown as coloured spheres. Adapted from ref.354, Rights Managed by 
Nature Publishing Group. 
 
5.7 Polymerization (non-ROMP) 
The stereochemistry, molecular weight (Mw), and polydispersity (Mw/Mn) of polymers are 
critical factors that can be influenced by the secondary coordination sphere of metal 
catalysts. Researchers have also explored the potential to control polymer properties 
using interactions provided by either a protein scaffold or a protein assembly. The well-
defined interiors of these systems could provide a hydrophobic environment to favor 
polymerization, orient substrates, and influence polymer size and polydispersity. ArM 
polymerases that lead to the formation of C–C bonds via a variety of mechanisms, 
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including ATRP, acetylene polymerization, and ROMP have been developed. The latter 
metathesis-type polymerization is presented in section 5.5. 
In 2009, Ueno and Watanabe et al. introduced [Rh(nbd)Cl]2 184 (nbd = norbornadiene)  
into apo-ferritin and evaluated Rh-loaded capsule as catalyst for the polymerization of 
phenylacetylene 182 (Scheme 58).313 The crystal structure of 184·apo-ferrtin revealed 
one rhodium ion at the threefold channel and two rhodium ions in the accumulation 
center (Figure 13) via coordination of histidine and cysteine residues. The 
polyphenylacetylene 183 produced by 184·apo-ferritin displayed an average molecular 
weight (Mw) = 13.1 ± 1.5 · 103 g/mol and a polydispersity (Mw/Mn) = 2.6 ± 0.3. For 
comparison, the polymer produced by free [Rh(nbd)Cl]2 184 had Mw = 63.7 ±4 · 103 
g/mol and Mw/Mn = 21.4 ± 0.4 (Table 23, entries 1 and 2). 
Hayashi and coworkers covalently linked a maleimide-substituted Cp*Rh(cod) complex 
(185) to the interior of apo-nitrobindin (Nb) to perform the polymerization of phenyl 
acetylene 182 (Scheme 58).200 Nb contains an Fe-protoporphyrin IX 222 cofactor in a 
cavity formed by eight β-strands. In order to covalently anchor the pianostool cofactor, 
Q96, located at the entrance of the cavity, was mutated to a cysteine. The resulting 
artificial metalloenzyme was tested for alkyne polymerization. The free cofactor, 185, 
yielded the thermodynamically preferred cis-poly(phenylacetylene) 183 with trans : cis = 
7 : 93. In contrast, 185·Nb (Q96C) afforded 183 with trans : cis = 53 : 47 (Table 23, 
entries 3 and 4).  
Next, they genetically optimized the artificial polymerase to improve the trans-selectivity 
(Scheme 58). They selected aminoacid residues within 6 Å from the computed position 
of the Rh center. Gratifyingly, 185·Nb (H76L-Q96C-H158L) produced 183 with trans : cis 
= 82 : 18 (Table 23, entry 5).356 Molecular dynamic simulations of 185·Nb variants 
suggested that mutations which lock the orientation of the Rh-moiety and guide the 
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access of the monomer enhance trans-stereoselectivity.  
Scheme 58. Polymerization of phenylacetylene catalyzed by Rh(I)-modified proteins. 
 
 
In 2011, Bruns and coworkers reported that horseradish peroxidase (HRP) was able to 
catalyze atom transfer radical polymerization (ATRP) using N-isopropyl acrylamide 
(NIPAAm, 187) as the monomer and alkylbromide (186) as initiator (Table 23, entry 6).357  
In 2014, Bruns and coworkers constructed an ArM ATRPase comprised of copper 
complex 189 and the group II chaperonin thermosome (THS) from the archaea 
Thermoplasma acidophilum as a protein scaffold.358 THS is a hexadecameric protein 
complex and can switch between an open and a closed state by consumption of ATP. In 
its closed state, the protein possesses two cavities of 130 nm2 each that can host a 
polymerization event. In its open state, the pores are large enough to allow the polymer 
to exit the capsule. The ATRPase, 189·THS C363A-K316C-C364A catalyzed the 
polymerization of 187 under ATRP conditions (Scheme 59). This ATRPase yielded Poly-
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NIPAAm (PNIPAAm, 188) with a lower Mw/Mn and Mn compared to the catalyst bound on 
the surface of bovine serum albumin, a globular protein (BSA-189). These results 
indicate that the protein cage not only improves the polymerization process, but also 
limits the diffusion of monomers into the active site of the polymerase (Table 23, entries 
7 and 8).  
Scheme 59. N-isopropyl acrylamide (NIPAAm) atom transfer radical polymerization 
(ATRP) catalyzed by 189 ArMs. 
 
 
 
Table 23. Selected results for the polymerization catalyzed by ArMs.  
 
Entry Cofactor Sub Protein 
T 
 (°C) 
t 
(h) 
[Metal]  
(μM) 
Mn 
(g/mol) 
Mw/Mn trans:cis Ref 
1 184 182 No Protein 25 3 30.0 63700 21.4 – 313 
2 184 182 Fr (WT) 25 3 28.8 13100 2.6 – 313 
3 185 182 No Protein 25 24 10.0 22900 2.6 7 : 93 200 
4 185 182 Nb (Q96C) 25 24 10.0 42600 2.2 53 : 47 200 
5 185 182 Nb (H76L-Q96C-H158L) 25 24 10.0 38900 2.4 82 : 18 356 
6 222 187 HRP r.t 2.5 16.2 99900 1.44 – 357 
7 189 187 THS r.t. 20 16.2 1500 1.11 – 358 
8 189 187 BSA r.t. 20 16.2 42600 1.94 – 358 
 
5.8 Diels-Alder Reaction 
Diels-Alder reactions are widely used for the construction of six-membered rings due the 
predictable regio- and stereospecificity of these reactions.359 Copper(II)-catalyzed Diels-
Alder reactions of azachalcones with cyclopentadiene (Scheme 60 a) have been 
extensively employed in fundamental studies on the design of a wide range of 
catalysts,360 including ArMs. An early example, particularly notable for its high 
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enantioselectivity, was reported by Reetz. ArM Diels-Alderases were constructed via 
non-covalent binding of a Cu(II) phthalocyanine complex (Figure 22, 190) to various 
serum albumins. Up to 91% conversion, 91:9 endo/exo ratio, and 98% ee could be 
obtained using this system (Table 24, entry 1-6), although the rate of the ArM-catalyzed 
reaction was slower than that catalyzed by cofactor alone. In a separate effort, Reetz 
also demonstrated that a His2Asp Cu(II) binding site could be introduced into tHisF, the 
thermostable synthase subunit of the glutaminase synthase enzyme complex from 
Thermotoga maritima, to generate an ArM Diels-Alderase.361 EPR spectroscopy was 
used to confirm Cu(II) binding in the designed site, and eliminating potential metal-
binding cysteine and histidine residues from the scaffold surface improved the 
enantioselectivity of this system (up to 46% ee, Table 24, entries 7-8 and Figure 21). 
 
Figure 21. Designed putative metal binding site in the thermostable protein tHisF for the 
evolution of Diels-Alderase at the top of the TIM barrel (based on the crystal structure 
PDB: 1THF). Highlighted are the existing aspartate residue in tHisF and the two 
histidines introduced to create the 2-His-1-carboxylate motif. The cysteine residue in the 
middle of the TIM barrel was replaced with alanine to prevent metal binding. 
 
Scheme 60. Model Diels-Alder reactions catalyzed by ArMs. 
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Scaffold-specific interactions have also been used to anchor catalysts into protein 
scaffolds to generate ArMs that catalyze the Diels-Alder reaction displayed in Scheme 
60 a. For example, Niemeyer reconstituted apo myoglobin using a heme cofactor 
substituted with both ssDNA and a Cu(II)-bipy complex (Figure 22, 191).362 The resulting 
ArM catalyzed the Diels-Alder reaction with improved enantioselectivity relative to the 
heme-ssDNA cofactor alone (18% ee for endo product and 10% for exo, Table 24, 
entries 9-10). More recently, Mahy and Ricoux demonstrated that a testosterone-
substituted Cu(II)-phenanthrene complex (Figure 22, 192) could be incorporated into a 
neocarzinostatin variant engineered to bind testosterone with improved affinity relative to 
the WT enzyme.363 The scaffold exhibited tighter binding affinity to the Cu(II)-
phenanthroline-testerone cofactor (Kd = 3 μM) than toward testosterone (Kd = 13 μM), 
and docking experiments suggested that the added phenanthroline ligand enhanced the 
complementarity of the cofactor to the protein. The resulting ArM catalyzed the reaction 
displayed in Scheme 60 a) with an increased endo : exo ratio compared to cofactor 
alone, but with lower conversion and no enantioselectivity (Table 24, entries 11-12).  
Several approaches to generate ArM Diels-Alderases via covalent modification of 
scaffold proteins have also been reported. For example, Salmain constructed a Diels-
Alderase by covalently linking a chloroacetamide-substituted [(η6-arene)ruthenium(II)]-
complex to papain via cysteine alkylation (Figure 22, 193).364 The TOF of the Diels-Alder 
reaction between cyclopentadiene and acrolein (a rare example not involving aza-
134 
chalcones, Scheme 60 b) was increased more than threefold with the ArM relative to the 
free cofactor. Kamer353 and later Okuda and Hayashi365 have demonstrated that 
bidentate and tridentate nitrogen ligands (Figure 23, 194-202) can be introduced into 
protein scaffolds to generate ArM Diels-Alderases for the reaction shown in Scheme 60 
a) following metallation with Cu(II). Modest enantioselectivity was observed in the former 
case (Table 24, entries 13-15)353 while improved conversion relative to free cofactor was 
observed in the latter (Table 24, entries 16-17)365. A similar tridentate ligand 196 was 
used to generate an improved ArM Diels-Alderase via bioconjugation to an engineered 
variant of the transmembrane protein ferric hydroxamate uptake component A (FhuA).350 
The endo-selectivity was improved to 98% by the 196·FhuA compared to 54% and 66% 
obtained for the free copper ion and 196 respectively (Table 24, entries 18-19).  
Filice showed that a similar approach could be used to generate immobilized ArM Diels-
Alderases. A lipase from G. thermocatenulatus (GTL) containing cysteine mutation in a 
cleft distal to the active site was immobilized on hydrophobic sepharose. A Cu(II) 
cofactor derived from ligand 200 was used to alkylate the distal cysteine in GTL to 
generate an ArM, which catalyzed the reaction shown in Scheme 60 a) with up to 92% 
ee (Table 24, entries 20-22). Both the support and immobilizing orientation had a large 
impact on the selectivity of the reaction, and the native activity of the lipase was 
maintained after cofactor incorporation in the distal site.366  
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Figure 22. Cofactors used to construct an artificial Diels-Alderase. 
 
 
Figure 23. Bidentate and tridentate nitrogen cofactors used to form ArM Diels-Alderases. 
 
Concurrent with much of this work, Roelfes conducted a number of studies on the 
development of Cu(II)-bipyridine and related ArMs that catalyze the Diels-Alder reaction 
and other Lewis Acid catalyzed processes. Initial studies showed that the lactococcal 
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multidrug resistance regulator (LmrR), a dimeric transcription repressor, could be 
alkylated with an haloacetamide-substituted bipyridine (199) and phenanthroline ligands 
201 at the dimer interface to generate Diels-Alderases following metallation with 
Cu(II).367 High conversion and enantiomeric excess (both > 90%) were observed for the 
reaction displayed in Scheme 60 a) (Table 24, entries 23-24). Point mutants of this ArM 
also catalyzed enantioselective hydration of azachalcones with a slightly lower 
conversion and enantiomeric excess (up to 84% ee) as discussed in chapter 7 (Scheme 
93).368  
Table 24. Selected results for the Diels-Alderase. 
 
Ent. Cof. Protein pH 
T 
(°C) 
[Cof] 
(µM) 
t 
(day) 
[Cof]/[Prot] 
Y. 
(%) 
Endo/Exo 
ee 
(%)b 
TONd Ref 
1 190 BSA 4.0 5 0.4 3 1:1.2 78 96:4 93 39 369 
2 190 HSA 4.0 5 0.4 3 1:1.2 89 91:9 85 45 369 
3 190 PSA 4.0 5 0.4 3 1:1.2 87 89:11 68 44 369 
4 190 RSA 4.0 5 0.4 3 1:1.2 69 88:12 7 35 369 
5 190 SSA 4.0 5 0.4 3 1:1.2 76 87:13 75 38 369 
6 190 CSA 4.0 5 0.4 3 1:1.2 72 78:22 1 36 369 
7 CuSO4 - 7.5 12 115 4 - 44 87:13 1 4 
361 
8 CuSO4 tHisF-HHD-4xAla 7.5 12 115 4 1:1.3 73 93:7 46 6
 361 
9 191 - 7.4 4 100 3 - 6 > 99:1 0 0.6 362 
10 191 apo-Mb 7.4 4 100 3 1:1 71 90:10 
18, 
10a 
7 362 
11 192 - 7.5 4 114 3 - 98 84:16 - 36 363 
12 192 NCS-3.24 7.5 4 114 3 1.1:1 83 81:19 - 33 363 
13 
202-
Cu2+ 
- 6.0 4 56 3 - 27 85:15 - 3 353 
14 
202-
Cu2+ 
SCP- 
2LV83C 
6.0 4 56 3 1:1.1 20 88:12 25 2 353 
15 
202-
Cu2+ 
SCP- 
2LA100C 
6.0 4 56 3 1:1.1 43 92:8 - 5 353 
16 
198-
Cu2+ 
- 7.0 4 100 3 - 11 85:15 - 1 365 
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17 
198-
Cu2+ 
Nb-Q96C/ 
M75L/M148L/H76L/H158L 
7.0 4 100 3 1:1.1 22 90:10 - 2 365 
18 
195-
Cu2+ 
- 7.4c 4 10 3 - 12 66:34 - 12 350 
19 
195-
Cu2+ 
FhuA 7.4c 4 10 3 1:1 64 98:2 - 64 350 
20 
200-
Cu2+ 
- 6.0 4 2.4 3 - 28 92:8 < 5 118 366 
21 
200-
Cu2+ 
GTL-S114C 6.0 4 2.4 3 1:1 99 99:1 18 416 366 
22 
200-
Cu2+ 
GTL-S196C 6.0 4 2.4 3 1:1 98 94:6 92 412 366 
23 
201-
Cu2+ 
- 7.0 4 30 3 - 20 93:7 0 7 367 
24 
201-
Cu2+ 
LmrR-M89C 7.0 4 30 3 1:1.1 93 95:5 97 31 367 
a For both endo and exo; b Positive and negative ee values correspond to the (R)- and (S)-enantiomers respectively; c Buffer contains 
0.125 mM polyethylene polyethylene glycol and 20%(v/v) THF. d TON calculated from original papers by reviewer. 
 
 
5.9 Huisgen [3+2] Cycloaddition 
Ueno and coworkers have explored the use of self-assembled protein scaffolds for ArM 
catalysis.370 For example, the tubular structure formed by the triple-stranded -helical 
assembly of three subunits of gene product 5, (gp5)3, from bacteriophage T4, was used 
to generate an ArM that catalyzes a Huisgen [3+2] cycloaddition.298 A protease resistant 
fragment from the C-terminal region of (gp5)3, termed (gp5β)3, was fused to a foldon (f) 
domain that promotes trimerization of bacteriophage T4 fibritin to generate a stable 
tubular scaffold. A succinimide moiety conjugated with flavin 204 was introduced at 
lysines located on the outer-surface of the [(gp5βf)3]2 (Scheme 61 and Figure 12). Upon 
addition of copper ions, the artificial metalloenzyme catalyzed the azide-alkyne [3 + 2] 
cycloaddition. The hybrid catalyst 204·[(gp5βf)3]2 catalyzed the "click reaction" reaction 
faster than 205 or of a mixture of 205 and [(gp5βf)3]2 (Table 25).  
Scheme 61. Cu(I)-catalyzed cycloaddition catalyzed by the copper-flavin complex 
conjugated to [(gp5βf)3]2. 
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Table 25. Selected results for the Cu(I)-catalyzed cycloaddition of substrate 182 and 
203 in the presence of [(gp5βf)3]2.a  
 
Entry Cofactor Proteina t (h) [Cof] (µM) [Ascorbic acid] (mM) TON Ref 
1 204 [(gp5βf)3]2 5 250 0.25 5.86 
298 
2 205 [(gp5βf)3]2 5 250 0.25 0.14 
298 
3 205 No Protein 5 250 0.25 0.62 298 
a Reactions were carried out in a solution of 1 : 1 tert-butylalcohol/MOPS (2mM, pH 7.5) at 5°C.  
 
5.10 Friedel-Crafts Reaction 
Although the Friedel-Crafts reaction was introduced more than 130 years ago, it still 
represents an attractive tool to alkylate aromatic compounds.371 Initially, it required ≥ 1.0 
equivalent of Lewis acid, and alkyl halides. Today however, alkyl alcohols, ethers, 
tosylamides, or styrenes can be used instead of alkyl halides, and catalytic asymmetric 
Friedel-Crafts reactions have been developed.371-373  
Artificial metalloenzymes that catalyze the Friedel-Crafts reaction have been developed 
by Roelfes et al. A BpyAla residue was genetically encoded into LmrR to eliminate the 
need for covalent modification of the scaffold.374 Metallation with Cu(II) provided an ArM 
that catalyzed the Friedel-Crafts alkylation of a variety of indoles (Scheme 62) with 
conversions as high as 94% and high enantioselectivity (up to 83% ee, Table 26, entries 
2-7). Interestingly, when the ligand was placed outside of the hydrophobic pocket, the 
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opposite enantiomer was formed (Table 26, entry 3). More recently, Roelfes 
demonstrated that the hydrophobic cavity of dimeric LmrR was capable of binding an 
unsubstituted Cu(II) phenanthroline cofactor directly to form ArMs through 
supramolecular assembly.375 The binding affinity of the cofactor was measured by 
tryptophan fluorescence quenching, which showed the dissociation constant (Kd) was 
much higher when an interfacial tryptophan residue (W96A) was removed (45 μM 
compared to 2.6 μM). Fluorescence decay also showed decreased lifetime when the 
scaffold was saturated with Cu(II), suggesting cofactor binding at the hydrophobic pore. 
The enantioselectivity of these ArMs toward Friedel-Crafts alkylations was significantly 
higher (up to 94% ee) (Table 26, entries 8-11) than the covalently linked systems noted 
above. These studies constitute one of the few cases in which covalent scaffold 
modification, metal binding to a scaffold residue (albeit an unnatural amino acid), and 
non-covalent scaffold binding have all be used to generate ArM catalysts, all of which 
provided high enantioselectivity. 
Scheme 62. Friedel-Crafts reaction catalyzed by LmrR-Cu ArMs. 
 
 
 
Table 26. Selected results for the asymmetric Friedel-Crafts reaction based on 
Cu(phen)-cotaining ArMs 
 
Entry Protein Sub. t (h) 
Ratio  
[Cof]/[Prot] 
Conversion (%) ee (%) TONc Ref 
1a - 206 72 - 98 0 10.9 374 
2 LmrR_LM (M89X) 206 72 1/1.25 27 49 (S) 3 374 
3 LmrR_LM (F93X) 206 72 1/1.25 36 22 (R) 4 374 
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4 LmrR_LM (M89XE107A) 206 72 1/1.25 22 66 (S) 2.4 374 
5 LmrR_LM (M89XF93W) 207 72 1/1.25 16 55 (S) 1.8 374 
6 LmrR_LM (M89XF93W) 208 72 1/1.25 3 50 (S) 0.3 374 
7 LmrR_LM (M89XF93W) 209 72 1/1.25 94 83 (S) 10.4 374 
8b LmrR_LM 206 16 1/1.33 90 84 (S) 5 375 
9b LmrR_LM 207 64 1/1.33 Full 94 (S) 11.1 375 
10b LmrR_LM 208 64 1/1.33 19 64 (S) 2.1 375 
11b LmrR_LM 207 64 1/1.33 Full 93 (S) 11.1 375 
12b LmrR_LM 206 16 1/1.33 53 <5  5.9 375 
a Cu(NO3)2 only. 
 b None covalent binding with Cu(phen).  cCalculated based on the concentration of the limiting substrate. 
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6. Oxygen Insertion Chemistry 
6.1 Peroxidation or Oxygenation 
Dioxygen is widely used as a terminal oxidant in biological processes. Although the 
reaction of organic compounds with dioxygen is generally thermodynamically favorable, 
kinetic barriers slow the oxidation of most organic compounds. This can be traced back 
to spin considerations: organic compounds exist mostly as spin-paired species whereas 
dioxygen has a triplet ground-state, thus rendering the reaction spin-forbidded.376 To 
overcome the high energetic barrier, nature typically generates metal–O2 species in the 
active site of metalloenzymes such as cytochrome P450, methane monooxygenase and 
tyrosinase etc. Inspired by these metalloenzymes relying on dioxygen for oxygenation 
and oxidation reactions, heme analogues or copper complexes have been exploited as a 
cofactors to create numerous artificial oxidases. This section summarizes oxidation 
reactions catalyzed by artificial oxidases using peroxides and molecular oxygen as 
oxidant. Oxygen-atom insertion reactions are described in the following sections.  
Shortly after the initial reports of catalytic antibodies, Schultz and Cochran described a 
class of metallo-catalytic antibodies which they coined “hemoabzymes”.133, 377 Shortly 
thereafter, Imanaka and Mahy joined these efforts.378-379 This term "hemoabzyme" stems 
from their composition: a porphyrin (“hemo-“), inserted into an anti-body (“-ab-”) that has 
been elicited in mice against a protein-conjugated heme hapten. Progress achieved 
relying on this strategy has been reviewed recently.62-63  
In 1990, Schultz and coworkers used N-methyl-mesoporphyrin IX (19) as the hapten. 
This molecule was selected as a transition-state analogue for porphyrin metalation. The 
metallation of the mesoporphyrin IX was accelerated by monoclonal anti-19 to afford the 
hemoabzyme 20·Ab-7G12. Peroxidase degradation catalyzed by this metallo-antibody 
was quantified using o-dianisidine oxidation (210) (Scheme 63).133, 377 The hemoabzyme 
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20·Ab-7G12 displayed saturation kinetics and was > 4 times more efficient than the 
[Fe(MPIX)] 20 (Table 27, entries 1 and 2). 
Scheme 63. Antibodies raised against 19 catalyze the oxidation of o-dianisidine 210 
upon loading with cofactor 20.  
 
 
In 1999, Kawamura-Konishi and coworkers also utilized the same set of hapten 19 and 
catalyst 20 to generate an ArM peroxidase.380 The affinity between 20 and the isolated 
antibody 2B4 was KD = 0.064 μM. In the presence of hydrogen peroxide, oxidation of 
ABTS 211, o-dianisidine 210, and pyrogallol 212 was investigated (Scheme 64). The 
ArM exhibited higher peroxidase activity for o-dianisidine 210 and ABTS 211 than the 
ferric mesoporphyrin itself, while such enhancement was not observed for pyrogallol 212 
(Table 27, entries 3 and 4). The authors hypothesize that the antibody imposed a certain 
degree of substrate preference to the cofactor. 
Scheme 64. Peroxidase activity of iron porphyrin derivatives in the presence of an 
antibody elicited against N-methylmesoporphyrin 19.  
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In 1995, the group of Imanaka immunized mice using TpCPP as a hapten (Scheme 
65).378 Both monoclonal antibodies as well as the light chain (L) of one of these 
antibodies (L-Ab-13-1) were isolated. Incorporating 213 into L-Ab-13-1 afforded an ArM 
that was more thermostable and displayed a higher peroxidase activity than the complex 
of 213 with the complete antibody. The peroxidase activity of 213·L-Ab-13-1 was 
significantly higher than other hemoabzymes, and remains among the highest reported 
to date (Table 27, entry 5). 
Scheme 65. Antibodies raised against TpCPP bind 213 to afford hemoabzymes with 
peroxidase activity. 
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In 1996, Mahy and coworkers selected the tetra-aryl porphyrin 214 as a hapten (Scheme 
66).379 Two IgG1 monoclonal antibodies, Ab-14H7 and Ab-13G10, bind 214 with a 
dissociation KD = 5.5 x 10-9 M and KD = 2.9 x 10-9 M respectively.379 These are the 
highest affinity values reported for porphyrin/Ab-antiporphyrin interactions.381 The protein 
pocket provided a beneficial effect on the peroxidase activity of 214. Indeed, both 
214·Ab-14H7 and 214·Ab-13G10 showed ~5 times higher kcat/KM than 214 alone at pH 
5.0 (Table 27, entries 6-8). 214·Ab-13G10 showed even higher activity at pH 4.6 (Table 
27, entry 9). 
Scheme 66. Supplementation of a synthetic o-carboxyphenyl-porphyrin 214 or 215 with 
their cognate antibodies affords artificial peroxidases. 
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Harada and coworkers elicited monoclonal antibodies 03-1 and 12E11G against the 
anionic porphyrin 213 and the cationic porphyrin 216, respectively (Scheme 67).134, 382 
The dissociation constant between the antibody 03-1 and Fe-meso-tetrakis(4-
carboxyphenyl)porphyrin (TCPP) 213 was 1.5 × 10–7 M and the antibody 12E11G bound 
to Fe-meso-tetrakis(4-N-methylpyridyl)porphyrin (TMPyP) 216 with Kd of 2.6 × 10–7 M. In 
the presence of hydrogen peroxide, the resulting ArMs catalyzed the oxidation of 
pyrogallol 212 with higher catalytic performance than the free cofactor (Table 27, entries 
10-13).  
Scheme 67. Oxidation of pyrogallol catalyzed by iron porphyrin derivatives in the 
presence of an antibody. 
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In 2002, Mahy and coworkers investigated the impact of added imidazole on the 
peroxidase activity of their hemoabzyme to mimic the histidine ligation found in natural 
peroxidases.383 The effect was deleterious in the case of hindered porphyrins: the 
peroxidase activity of 214·Ab-13G10 decreased by fifty percent upon addition of 50 mM 
imidazole. (Scheme 66) However, for 215·Ab-13G10, addition of 50 mM imidazole 
increased the kcat/KM by a factor ~15 (Table 27, entries 14 and 5). Under these 
conditions, 215·Ab-13G10 displayed higher kcat and kcat/KM than 214·Ab-13G10 (Table 
27, entries 8, 9 and 15). 
To further improve catalytic activity, microperoxidase 8 (MP8, 217), which contains an 
intramolecular imidazole-moiety, was also examined as a catalyst.384 MP8 is a digestion 
product of the horse cytochrome c and consists of a heme [Fe(PPIX)] linked to an 
octapeptide via two thioether linkages and provides a histidine ligated to iron. The IgG1 
monoclonal antibody Ab-3A3 binds 217 with a dissociation constant KD ~ 10-7 M. 217 
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alone catalyzes peroxide degradation as well as monooxygenation reactions; however, 
its performance is limited by dimerization and by its oxidative degradation during 
catalysis. Upon integration within the antibody, the authors hoped to alleviate these 
challenges and to improve catalytic efficiency by providing a well-defined second 
coordination sphere environment for enantioselective monooxygenation. They 
investigated 217·Ab-3A3 for peroxidase activity toward both o-dianisidine (210) and 
ABTS (211) (Scheme 68). The 217·Ab-3A3 showed a kcat/KM ~ 3.3 x 104 M-1·s-1 with 210 
as substrate. This corresponds to the highest catalytic efficiency reported to date for an 
hemoabzyme (Table 27, entry 17). This represents a ~50 % improvement over the free 
cofactor 217 (Table 27, entry 16). 
Scheme 68. Peroxidase activity of 217 is enhanced upon binding to Ab-3A3. 
 
 
In the presence of hydrogen peroxide and a nitrite anion, 217·Ab-3A3 also catalyzes the 
nitration of phenol 218 to yield in para-nitrophenol p-219 and ortho-nitrophenol o-219 
with an 11 : 8 regioselectivity (Scheme 69).385 Upon incorporation into the antibody Ab-
3A3, both the activity (36 TON vs. 19 TON) and the selectivity increased: the o-219 was 
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favored by a factor two over p-219. 
Scheme 69. Supramolecular assembly of 217 with Ab-3A3 yields an ArM for the nitration 
of phenol. (The catalyst loading is reported vs. the hydrogen peroxide concentration)  
 
 
In 2004, Mahy and coworkers reported a "Trojan Horse" strategy to assemble ArMs. In 
the previous hemoabzymes, antibodies were raised against a molecule that is directly 
involved in the reaction (e.g. the catalyst, a structural analog of a reaction intermediate 
or transition state). In the "Trojan Horse" strategy, an anchor moiety was used as 
hapten. This constitutes a versatile means to elicit an host-anchor couple for assembling 
ArMs, alleviating the requirement of natural protein-cofactor specific interactions. As 
proof of principle, they tethered a porphyrin to estradiol (220, Scheme 70) and 
incorporated this cofactor into Ab-7A3, an antibody raised against estradiol.386-388 The 
resulting antibody·porphyrin conjugate 220·Ab-7A3 had an affinity KD = 4·10-7 M and 
displayed peroxidase activity twofold improved compared to the free cofactor 220. 387 
Scheme 70. A Trojan Horse anchoring strategy affords an "Hemoabzyme" with 
peroxidase activity.  
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Table 27. Selected results for the peroxidase activity of “hemoabzymes”.  
 
Entry Cof. Protein Sub. pH 
T 
(°C) 
[Cof] 
(µM) 
[H2O2] 
(mM) 
KM 
(mM-1) 
kcat 
(s-1) 
kcat/KM 
(s-1.M-1) 
Ref 
1 20 – 210 8.0 10 0.5 5 43 2.77 64 133 
2 20 Ab-7G12 210 8.0 10 0.5 5 24 6.57 274 133 
3 20 – 210 b 8.0 10 0.3 
0.0103-
0.613 
43 5.5 128 380 
4 20 Ab-2B4 210 b 8.0 10 0.3 
0.0103-
0.613 
25 1.3 51 380 
5 213 L-Ab-13-1 212 8.0 37 0.5 5 2.3 11.12 4833 378 
6 214 – 211 5.0 20 0.2 1 42 0.85 21 379 
7 214 Ab-14H7 211 5.0 20 0.2 1 9 1.05 119 379 
8 214 Ab-13G10 211 5.0 20 0.2 1 16 1.67 105 379 
9 214 Ab-13G10 211 4.6 20 0.2 0.7 16 9.33 222 389 
10 213 – 212 9.0 – 0.5 5 – 0.15 – 134 
11 213 Ab-03-1 212 9.0 – 0.5 5 4.0 0.83 208 134 
12 216 – 212 9.0 r.t. 0.5 50 – 1.38 – 382 
13 216 Ab-12E11G 212 9.0 r.t. 0.5 50 8.6 11.3 1318 382 
14 215 Ab-13G10 211 5.0 19 0.3 0.7 34 0.53 15.7 383 
15 215 Ab-13G10 211 5.0 19 0.3 0.7 10 a 2.53a 253a 383 
16 217 – 210 7.4 20 0.1 0.1 0.4 9.83 24580 384 
17 217 Ab-3A3 210 7.4 20 0.1 0.1 0.45 14.75 32780 384 
a 50 mM imidazole added. b 0.3 mM 
 
Many hemoproteins, including myoglobin, cytochrome b5, horseradish peroxidase, and 
cytochromes P450 possess a Fe-protoporphyrin IX cofactor (FePPIX, 222). Since 
FePPIX is bound in the pocket of hemoproteins via only non-covalent and dative 
interactions, it can readily be removed under acidic conditions. The resulting apo-
hemoprotein can be reconstituted with synthetic FePPIX analogues to generate ArMs. 52 
Hayashi and coworkers varied the propionate side chain of PPIX, hypothesizing that this 
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could affect substrate-binding.331 A double-winged Fe-PPIX derivative (223) that 
possessed two aromatic rings and eight carboxylates (Figure 24) was synthesized and 
used to reconstitute apo-Mb. Compared to 222·Mb, 223·Mb displayed a higher kcat and a 
lower KM for the oxidation of guaiacol (221) with hydrogen peroxide (Table 28, entries 1 
and 2 and Scheme 71), suggesting that the dendridic wedges act as substrate-binding 
moieties. Further improvements to catalytic activity were realized using the Mb H64D 
variant.332 Reconstituting this scaffold with 222 and 223 led to ArMs that oxidized 221 
with kcat/KM 96- and 434-fold higher than the ArMs generated using the wt Mb scaffold 
(Figure 24, Table 28, entries 3-6). 
While reconstituting Mb with double-winged Fe-PPIX cofactors led to ArMs with reduced 
KM, the improvement for kcat was modest (Table 28, entries 3-6). Since the chemical 
modification of both propionates of 222 decreased the reactivity of the corresponding 
oxoferryl intermediate, the single-winged Fe-PPIX cofactor 224 was also prepared 
(Figure 24).390 When bound to Mb, 224 can form hydrogen bonds between its 
unmodified propionate and Mb R45 to lock the orientation of the cofactor. Accordingly, 
224·Mb (H64D) showed 20-fold higher kcat and 3.7-fold higher kcat/KM for guaiacol 221 
oxidation compared with 223·Mb (H64D) (Table 28, entries 6 and 7). 
Hayashi and coworkers also reconstituted Mb with Fe-porphycene 225, a constitutional 
isomer of Fe-PPIX (Figure 24).333 Fe-porphycene 225 binds to myoglobin (Mb) more 
tightly than Fe-PPIX due to a stronger interaction between the porphycene Fe center 
and with His93. This strong electron σ-donation also increases the peroxidase activity of 
the ArM. In the presence of hydrogen peroxide, the rate of guaiacol oxidation catalyzed 
by 225·Mb is eleven-fold higher than that observed with native Mb (222·Mb) (Table 28, 
entries 8 and 9). (see active site in Figure 15). The same group also reconstituted HRP 
with Fe-porphycene 225 since the active species responsible for the peroxidase activity 
has a longer lifetime in HRP compared to Mb (Figure 24).391 In the presence of hydrogen 
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peroxide, 225·HRP oxidized the guaiacol 221 with a comparable rate to native HRP 
(222·HRP). (Table 28, entries 10 and 11).  
Finally, Fe-corrole 226 was also used to reconstitute both Mb and HRP. Hayashi and 
coworkers hypothesized that the high-valent oxidation states of this cofactor might be 
better stabilized due to the trianionic character of the corrole (Figure 24). The resulting 
Mb- and HRP-based ArMs were used to catalyze guaiacol oxidation in the presence of 
hydrogen peroxide. The catalytic activity decreased in the following order: 222·HRP > 
226·HRP > 226·Mb >> 222·Mb (Table 28, entries 12-15).392 
Table 28. Selected results for the peroxidase activity by reconstituted hemoproteins with 
iron porphyrin derivatives. 
 
Ent. Cof. Proteina Sub. pH 
T 
(°C) 
[Cof] 
(µM) 
[H2O2] 
(mM) 
KM 
(mM -1) 
kcat 
(s -1) 
kcat/KM 
(s-1M-1) 
TOF 
(s-1) 
Ref 
1 222 Mb (WT) 221 7.0 20 1 9.7 32 
0.3
6 
11 – 331 
2 223 Mb (WT) 221 7.0 20 1 9.7 7.4 1.1 149 – 331 
3 222 Mb (WT) 221 6.0 25 2 100 54 2.8 53 – 332 
4 223 Mb (WT) 221 6.0 25 2 100 3.4 6.2 1800 – 332 
5 222 Mb (H64D) 221 6.0 25 2 15 1.8 9.0 5100 – 332 
6 223 Mb (H64D) 221 6.0 25 2 15 0.052 1.2 23000 – 332 
7 224 Mb (H64D) 221 6.0 25 4 100 0.29 24 85000 – 390 
8 222 Mb (WT) 221 7.0 20 1 20 – – – 0.021 333 
9 225 Mb (WT) 221 7.0 20 1 20 – – – 0.230 333 
10 222 HRP (WT) 221 7.0 25 0.1 4 – – – 40 391 
11 225 HRP (WT) 221 7.0 25 0.1 4 – – – 38 391 
12 222 Mb (WT) 221 7.0 20 2 5 – – – ~0 392 
13 226 Mb (WT) 221 7.0 20 2 5 – – – 0.43 392 
14 222 HRP (WT) 221 7.0 20 2 5 – – – 11 392 
15 226 HRP (WT) 221 7.0 20 2 5 – – – 1.6 392 
 
Scheme 71. Oxidation of guaiacol performed by myoglobin and horseradish peroxidae. 
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Figure 24. Cofactors used for the oxidation of guaiacol and thioanisole in the presence 
of apo heme proteins.  
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De novo designed proteins have also been used as scaffolds to generate ArM oxidases 
and oxygenases via metallation with both metal ions and metal porphyrin complexes. 
DeGrado and Kaplan, for example, designed a phenol oxidase based on DFtet, a four-
chain heterotetrameric helix bundle from the family of the dueferri (DF) proteins.393 The 
de novo-designed metalloenzyme contains two Fe-ions in its active site and its catalytic 
activity depends on the presence of dioxygen. Phenol oxidase activity occurs via 
formation of an oxo-bridged di-Fe(III) species (Scheme 72). Combinations of different 
monomeric units and introduction of mutations in the active site (i.e. increasing the size 
of cavity in the active site) led to highly active variants. The engineered metalloenzymes 
catalyze the oxidation of 4-aminophenol (227) to the corresponding benzoquinone 
monoimine (228). Catalytic efficiencies (kcat/KM) of up to 1540 M-1 · min-1 along with a 
~1000-fold rate enhancement relative to the background reaction were achieved, and 
the best variant (G4-DFtet) provided over 100 turnovers.  
Scheme 72. Oxidation of 4-aminophenol (227) using an engineered di-iron 
metalloenzyme G4-DFtet. 
 
Lombardi et al. also engineered an artificial oxidase using the DF1 scaffold (PDB entry 
1EC5), a well-characterized metalloprotein of the dueferri protein family.394 DF1 is a 
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dimeric protein in which each monomer adopts an helix-loop-helix structure.395 The 
active site consists of two Fe-ions coordinated by two glutamates and one histidine each 
(Figure 25). Introducing mutations beneficial for the catalytic activity of the G4-DFtet 
analogue led to a destabilization of the protein fold, but this issue was solved by 
mutating the interhelical turn. An NMR structure of the new DF3 variant was determined 
(PDB entry 2KIK), and the designed artificial metalloenzyme displayed oxidase activities 
towards various substrates (Table 29).  
Table 29. Oxidase activity of de novo-designed artificial di-iron oxo-proteins.  
 
Entry Protein Substrate 
KM 
(mM) 
kcat 
(min-1) 
kcat/KM 
(M-1 · min-1) 
TON Ref 
1 DF3 3,5-di-tert-butylcatechol 2.09 ± 0.31 13.2 ± 1.2 6315  394 
2 DF3 227 1.97 ± 0.27 2.72 ± 0.19 1380 >50 394 
3 DF3 p-phenylenediamine 8.87 ± 2.58 0.73 ± 0.03 83  394 
4 G4-DFtet 227 0.83 ± 0.06 1.30 ± 0.10 1540 >100 
393 
Reaction conditions: HEPES buffer (100 mM, pH 7.0), 100 mM NaCl.  
 
 
Figure 25. Cartoon representation of DF1 structures (PDB: 1EC5). Side view of the 
designed four helix bundles. Highlighted, in yellow, the amino acid mutations in the turn 
and in proximity of the active site, introduced to stabilize the protein scaffold and to allow 
substrates to approach the metal ions, respectively a). Zoom into the active site of Due 
Ferro protein. Iron centers are depicted in red. Coordinating residues (two His and four 
Glu) are represented as stick and coloured by element b). 
 
DeGrado et al. repurposed a de novo-designed metalloprotein originally designed to 
oxidize hydroquinones in order to catalyze selective N-hydroxylation of arylamines.396 
DFsc, a single-chain four-helix bundle protein from the dueferri family (PDB entry 2HZ8), 
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was selected as template for the redesign. Four Ala → Gly mutations (analogous to the 
G4-DFtet construct) afforded a highly active hydroquinone oxidase (G4DFsc). Inspection 
of the crystal structure of AurF (PDB entry 2JCD), an N-oxygenase containing a di-iron 
catalytic center, suggested the incorporation of a third metal-binding His residue in the 
scaffold. Following the introduction of three additional stabilizing mutations, a functional 
N-hydroxylase was created (3His-G4DFsc, PDB entry 2LFD). Both enzymes displayed 
high affinity for Fe(II) (Kd = 70 ± 3 μM and 30 ± 2 μM for G4DFsc and 3His-G4DFsc 
respectively). G4DFsc had a high catalytic activity towards the oxidation of 4-
aminophenol (227), whereas no N-hydroxylase activity was observed. The opposite 
trend was observed for 3His-G4DFsc. This construct showed high activity towards the 
selective N-hydroxylation of p-anisidine (229, Scheme 73) thus highlighting the flexibility 
of de-novo designed metalloproteins and the power to repurpose the reaction specificity 
by introduction of single mutations. Recently, DeGrado et al. identified the actual active 
species of the two due-ferri scaffolds (G4DFsc and 3His-G4DFsc) and suggested 
mechanisms explaining their different reactivities.397  
Scheme 73: Selective N-hydroxylation of p-anisidine 229 with the de-novo designed 
metalloprotein 3His-G4DFsc. The N-hydroxylated product 230 is thought to undergo 
disproportionation to form p-nitrosoanisole 231, which reacts with another molecule of p-
anisidine 229 via a nucleophilic aromatic substitution to yield 4-nitroso-4`-
methoxydiphenylamine 232.  
 
 
In 2008, Mahy and coworkers inserted the porphyrin [Fe(TpCCP)] (213) into xylanase A 
(Xln) via supramolecular interactions.398 This protein possesses a hydrophobic pocket 
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that may host a [M(TpCCP)]-complex. Even though modeling studies suggested that the 
porphyrin does not entirely fit into the cleft, the host-guest affinity was in the micromolar 
range (KD = 0.5 µM), ensuring a high concentration of the desired ArM during catayltic 
experiments. The peroxidase activity of this ArM was determined via its ability to 
promote the oxidation o-dianisidine 210, Scheme 63. Compared to 213 alone, 213·Xln 
displayed an 1.8 fold higher kcat but a 3-fold lower kcat/KM, due to a lower affinity for the 
substrate (i.e. KM 5 times higher) (Table 30, entries 1 and 2). 
Table 30. Selected results for the peroxidase activity by 213·Xln.  
 
Entry Cof. Protein Sub. pH 
T 
(°C) 
[Cof] 
(µM) 
[H2O2] 
(mM) 
KM 
(mM -1) 
kcat 
(s -1) 
kcat/KM 
(s-1M-1) 
Ref 
1 213 – 210 7.5 20 1.2 2.4 0.16 0.49 3041 398 
2 213 Xln 210 7.5 20 1.2 2.4 0.8 0.87 1083 398 
 
In 2012, Itoh and Fujieda et al. prepared artificial dicopper oxidase by substitution of the 
di-zinc moiety of β-lactamase.399 This artificial metalloenzyme catalyzed the oxidation of 
catechol under aerobic conditions. Based on molecular dynamics simulations, they 
redesigned the copper binding site to more closely mimic the dicopper active site of 
natural catechol oxidases (Figure 26). The resulting triple mutant displayed 87-fold 
higher kcat/KM values for the 4-tert-butylcatecol 233 oxidation compared to the wild type 
β-lactamase (Scheme 74 and Table 31).  
Table 31. Selected results for catechol oxidation by dicopper reconstituted β-lactamase.  
 
Entry Cofactor Proteina Sub. pH T (°C) 
[ArM] 
(µM) 
KM 
(mM -1) 
kcat 
(s -1) 
kcat/KM 
(s-1M-1) 
Ref 
1 Copper ion β-lactamase (WT) 233 7.0 25 20 7.7 1.1 1.4 399 
2 Copper ion 
β-lactamase 
(D88G-S185H-P224G) 
233 7.0 25 20 3.2 40 125 399 
 
Scheme 74. Oxidation of catechol derivatives catalyzed by dicopper-reconstituted β-
lactamases. 
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Figure 26. Active site structure of copper-substituted metallo β-Lactamase (PDB: 2FU7). 
Highlighted, in yellow, the amino acid position mutated to convert β-lactamase in 
catechol oxidase (D88G, S185H, P224G). In magenta, the five coordinating histidine 
residues (displayed as spheres). 
 
In 2015, Ward and coworkers constructed an artificial copper oxidase by mining the pdb 
to identify proteins containing latent facial triad motifs, i.e. proteins would contain a metal 
binding site following a single point mutation. Following mutagenesis and metallation, 
the resulting ArMs might be expeted to possess radically different catalytic activity 
compared to the wild-type proteins. The algorithm “Search of Three-dimensional Atom 
Motifs in Protein Structure” (STAMPS)400 was used to identify thirteen proteins with a 
putative facial triad motifs.401 Among the identified proteins, only 6-
phosphogluconolactonase (6-PGLac hereafter), afforded peroxidase activity toward o-
dianisidine in the presence of H2O2 upon metallation CuSO4 (Scheme 75). Using 
glucose oxidase with glucose and O2 in the presence of Cu6-PGLac led to slightly 
improved activity. A dramatic increase in activity was observed using t-BuOOH as 
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oxidant. Michaelis-Menten kinetics were determined KM = 11 µM, kcat = 78103·s-1, and 
the kcat obtained was four orders of magnitude lower than natural horseradish 
peroxidase (7.7107 M-1s-1). Although the authors anticipated that the copper binding 
sites was the predicted triad (His67, His104, Asp131), it was unambiguously 
demonstrated that the catalytically active copper center was bound to only two histidine 
residues (i.e. H67 and H104). These results were validated by X-ray, EPR and 
mutagenesis studies.  
Scheme 75. A single point mutation of 6-phosphogluconolactonase yields a facial triad 
(H67-H104-N131D). Addition of CuSO4 leads to an artificial peroxidase.401 a) A 
colorimetric assay was applied to quantify the peroxidase activity of Cu-PGLac in the 
presence of t-BuOOH; b) the crystal structure of the artificial peroxidase (PDB code 
4tm7) highlights copper coordination to only two histidines H67 and H104; c) 
mutagenesis highlights the requirement of both histidines but not of the aspartate D121.  
 
 
In addition to supramolecular anchoring and dative anchoring, a non-natural ligand was 
directly introduced into the amino acid sequence. In 2008, Schultz and Lee incorporated 
159 
the unnatural amino acid (2,2’-bipyridine-5-yl)alanine (Bpy-Ala, 237, Figure 27) into the 
catabolite activator protein (CAP), a dsDNA binding protein of E. coli (Figure 27).402 The 
engineered construct (CAP K26Bpy-Ala) showed a high affinity towards a 50-bp double-
stranded DNA containing the 22-bp CAP recognition sequence (Kd = 1.90 nM vs. 0.85 
nM for the wild type CAP). In the presence of Cu(II) or Fe(II), cAMP and 3-
mercaptopropionic acid or ascorbic acid as a reducing agent, site specific DNA cleavage 
activity was observed. Thus, a DNA binding protein was repurposed into an artificial 
metalloenzyme. Additional DNA-cleaving ArMs are summarized in section 6.8.  
 
 
Figure 27: The unnatural metal binding amino acid (2,2’-bipyridine-5-yl)alanine (Bpy-Ala 
237) was introduced in artificial zinc-finger domains. a) Structure of Bpy-Ala. b) 
Catabolite activator protein CAP (PDB code 2CGP) was mutated to bear Bpy-Ala in 
position 26. Upon addition of Cu2+ or Fe2+ and a reducing agent cleavage of the DNA 
substrate was achieved. 
 
6.2 Sulfoxidation 
Enantiopure sulfoxides are important building blocks for organic synthesis and have 
found applications as chiral auxiliaries and ligands in enantioselective catalysis.403-405 
Enantioselective oxidation of sulfides has gained considerable attention as an easy way 
of generating enantiopure sulfoxides.404, 406-407 Most commonly used sulfoxidation 
catalysts rely on titanium, manganese, iron, or vanadium.404, 408-409 The mechanism of 
asymmetric induction in these processes resembles that of several natural enzymes as 
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the prochiral sulfide does not coordinate to the metal prior to oxidation. Instead, a metal-
activated oxygen moiety (e.g. a metal-oxo, -peroxo, etc.) is delivered to a suitably-
positioned sulfide. Accordingly, sulfoxidation is an attractive reaction to scrutinize the 
role of second coordination sphere interactions that could be imparted by a host protein 
containing a suitable sulfoxidation catalyst. In this context, the asymmetric sulfoxidation 
of thioanisole-type substrates has become a benchmark reaction to evaluate the 
performance of artificial sulfoxidases, Scheme 76. Most of the ArMs previously 
described for their peroxidase activity have also been tested as sulfoxidases.  
Scheme 76. Thioanisole 27 is used as a benchmark substrate to evaluate the 
performance of artificial sulfoxidases. For reaction conditions and results, please refer to 
Table 32. 
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The first examples of ArM sulfoxidases were reported by the groups of Sheldon in 1998 
and Keinan in 1999 (see chapter 3 and Table 32, entries 1-2), and a similar antibody-
based strategy was later used by Mahy and coworkers. Among the hemoabzymes that 
were investigated, 217·Ab-3A3 displayed the highest peroxidase activity, Scheme 68. 
Mahy and coworkers later showed that this ArM catalyzes the sulfoxidation of thioanisole 
27 in the presence of H2O2.410 The ArM 217·Ab-3A3 performed better than 217 alone, 
with 82 and 38 TON respectively (Table 32, entries 3-4). The ArM was also more 
enantioselective, with 45 % ee vs. 23 % ee in favor of the (R)-28. Those results were 
obtained in presence of 5 % t-BuOH, which significantly improved both activity and 
enantioselectivity of 217, with and without Ab-3A3. 
The hemoabzymes with anti-estradiol antibodies were also tested for the sulfoxidation of 
thioanisole 27 in presence of H2O2. First, 220·Ab-7A3 was twice as active as 220 alone, 
and afforded (S)-28 with 8 % ee. (Table 32, entries 5-6).386 Substitution of the N-
methylpyridinium groups by p-sulfonatophenyl groups yielded an 25% less active 
artificial peroxidase affording similar enantioselectivity: up to 10 % ee for (S)-28.411 Upon 
incorporation of the sulfonated cofactor within neocarzinostatin (NCS), the 
enantioselectivity slightly increased (i.e. 13 % ee), but was accompanied with a 
decrease in activity (i.e. 6 TON).412 
Better results were obtained with the ArM resulting from incorporation of an iron 
porphyrin within xylanase, 213·Xln. Upon addition of exogeneous imidazole, 213·Xln 
afforded (S)-28 with up to 145 TON and 40 % ee (Table 32, entries 7-8).413-414 The 
authors speculate that the added imidazole mimics the effect of an axial histidine on 
catalysis, reminiscent of the activity observed with 217·Ab-3A3. In summary, 213·Xln 
and 217·Ab-3A3 are the most active and enantioselective artificial sulfoxidases reported 
by the Mahy group and display enantioselectivities of 40 % ee  (S)- 28 and 45 % (R)-28, 
respectively. 
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Watanabe, Ueno and coworkers reported the formation of an ArM sulfoxidase by 
incorporating an Fe-porphyrin cofactor into a (gp27-gp5)3 (gp = gene product) scaffold 
from bacteriophage T4. The structure of this protein consists of a β-helical needle made 
of the gp5 trimer and a cup-shaped structure composed of the gp27 trimer. A cysteine 
residue was introduced at the bottom of the cup to react with a maleimide moiety of Fe-
PPIX 252 (Scheme 76 and Figure 12).415 The oxidation of the thioanisole 27 was 
investigated in the presence of hydrogen peroxide. The catalytic efficiency was 
enhanced tenfold in the presence of (gp27-gp5)3, compared to the free cofactor 252 
(Table 32, entries 9-10), which was attributed to the hydrophobic environment of the cup 
structure.  
ArM sulfoxidases have also been generated using metal-salen and -salophen cofactors. 
For example, Watanabe and coworkers reconstituted myoglobin (Mb) with various 
Schiff-base complexes,328 including Cr-salophen 243, which has a similar size and 
shape to the native Fe-PPIX cofactor (222) of Mb. The reconstituted Mb ArM catalyzed 
the enantioselective oxidation of thioanisole 27 (Scheme 76). Mutations H64D and A71G 
were introduced into the Mb scaffold to improve substrate access to the active site and 
to improve the affinity for 243, respectively. The resulting ArM oxidized thioanisole 27 in 
the presence of hydrogen peroxide to afford 28 with 13% ee (Table 32, entries 11-12). A 
crystal structure of 244·Mb A71G was obtained, and based on this structure, the 
salophen ligand was replaced with a salen ligand to create a larger substrate access 
pathway.416 Modeling suggested that the location of the metal complex in Mb depends 
on the nature of the 3,3'-substituents of the salen moiety. Gratifyingly, the 
enantioselectivity for the thioanisole 27 oxidation was indeed influenced by the nature of 
the complexes 245-247. The highest ee (32%) was obtained with 245·Mb (Table 32, 
entry 13).  
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Lu later reported on a dual anchoring strategy to fix the orientation of a Mn(salen) 
cofactor bearing two methane thiosulfonate groups (248, Scheme 76) within an apo 
myoglobin scaffold containing two cysteine mutations L72C-Y103C (Figure 15). The 
resulting ArM catalyzed the sulfoxidation of thioanisole with higher enantioselectivity (51% 
ee) than an analogous system with only one anchoring point Mb(Y103C) (Table 32, 
entries 14-15).329 In both of these systems, sulfoxidation was accompanied by 
overoxidation to the corresponding sulfone 242. By selecting alternate anchoring sites 
within Mb T39C-L72C, Lu also showed that the chemoselectivity of the ArMs could be 
enhanced.330 Increased activity (52% yield), enantioselectivity (60% ee), and 
chemoselectivity (100% sulfoxide) were obtained for reactions catalyzed by 248·Mb 
T39C-L72C (Table 32, entry 16). Subsequent studies on this system suggested that 
polar residues in the ArM active site led to its improved activity, and the need for 
substrates to enter the active site via a hydrophobic region of the scaffold was believed 
to favor entry of sulfide over sulfoxide to impart chemoselectivity. In addition, residues in 
the secondary coordination sphere of the ArM active site were shown to impact the pH 
dependence of ArM catalysis relative to cofactor alone.417  
In 2009, Ménage and coworkers inserted Mn−salen complexes (250, Scheme 76) into 
human serum albumin (HSA hereafter) to catalyze the oxidation of sulfide 27 to the 
corresponding sulfoxide 28.418 Serum albumins have been used in the past as host to 
catalyze a variety of reactions.27, 91, 93 The choice of HSA as a host for ArM formation 
was based on its ability to bind a variety of small hydrophobic molecules. Indeed, facile 
ArM formation was realized by incubating HSA with one equivalent of cofactor 250, and 
1:1 HSA:250 binding stoichiometry was observed (KD = 8 µM). The resulting ArM 
catalyzed the oxidation of 27 in the presence of aqueous NaOCl (2 eq) at pH 5.2 to 
provide a mixture of sulfoxide 28 (7%) and sulfone 242 (31 %). The free Mn−salen 
complexes afforded almost exclusively the sulfone 242 (60 %). When combined with 
165 
HSA, however, the resulting ArM (250·HSA) led to formation of sulfoxide 28 exclusively 
(97 %, i.e. 97 TON) (Table 32, entry 17), although racemic product was obtained. No 
catalysis was observed when hydrogen peroxide was used instead of hypochlorite, and 
addition of excess 250 relative to BSA led to decreased chemoselectivity. Interestingly, 
the ArM remained efficient (i.e. 95 % conversion) and chemoselective (i.e. 92 : 3 ratio for 
28 : 242) upon recycling the ArM up to four times. In contrast, HSA alone lost its 
selectivity upon recycling. In the absence of cofactor, HSA is unspecifically oxidized by 
HOCl as confirmed by SDS-PAGE, which led to a gradual erosion of the 
chemoselectivity.  
Liang and coworkers also developed an artificial sulfoxidase by incorporating a cobalt-
salen cofactor into a serum albumin scaffold,.419 251·BSA (Scheme 76) achieved 98 
TON  for the sulfoxidation of thioanisole 27 with up to 50 % ee in favor of the (R)-28 
(Table 32, entry 18). Improved enantioselectivity was obtained with substrate 238: up to 
87 % ee was obtained for (R)-240 (Table 32, entry 19). Unfortunately, the increase in 
enantioselectivity was accompanied with a loss of activity and chemoselectivity 
(sulfoxide vs sulfone). 
Mn–corroles have also been combined with serum albumins to afford ArM sulfoxidases. 
In 2005, Gross and coworkers inserted a sulfonated manganese corrole 253 within 
various serum albumins, Scheme 76. Human serum albumin was shown to bind 253 
with a dissociation constant in the nanomolar range. In terms of catalysis, however, the 
best results were obtained with bovine serum albumin (BSA). In presence of hydrogen 
peroxide, 253·BSA achieved 42 TON for thioanisole 27 sulfoxidation, with up to 52 % ee 
in favor of the (S)-28 (Table 32, entry 20). The enantioselectivity increased with o-
halogen-bearing substrates albeit at the cost of reduced activity: sulfoxidation of 2-
bromo-thioanisole 239 proceeded in 74 % ee (S)-241 but only 8 TON (Table 32, entry 
21). The iron-containing corrole was also tested, but the corresponding ArMs had lower 
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activity and selectivity. These same authors later evaluated ArMs generated from 
incorporation of metal-corrole complexes into other serum albumins. Interestingly, 
253·RSA (rabbit serum albumin) was used to complete the synthesis of armodafinil 257, 
a FDA-approved eugeroic drug: up to  70 % ee (R)-257 could be achieved (Scheme 77 
and Table 32, entry 22).420 
Scheme 77. Binding of a Mn-corrole to various serum albumins afford an artificial 
sulfoxidases for armodafinil synthesis. 
 
 
Building on the 253·BSA ArM reported by Gross and coworkers, Mahy and Gross later 
reported an ArM sulfoxidase that used water as an oxygen source.421-422 Upon irradiation, 
a [Ru(bpy)3]2+–photosensitizer sequentially abstracts two electrons from 
[Mn(III)(Corrole)(OH2)] 253 to yield [Mn(V)(Corrole)(O)] in the presence of 
[Co(III)(NH3)5Cl]2+ as an electron acceptor. The active [Mn(V)(Corrole)(O)] transfers its 
oxygen to thioanisole 27. Isotope-labeling confirmed that water is indeed the oxygen 
source in the sulfoxide 28 (21 TON 16 % ee (R)-28, Table 32, entry 23). Strinkingly, 
when H2O2 was used as oxidant in the presence of 253·BSA, the opposite enantiomer 
(S)-28 was produced. This clearly demonstrates that, depending on the oxidant,  that the 
active species are not identical.421  
Ward and coworkers investigated the propensity of vanadyl-loaded Sav to promote the 
asymmetric sulfoxidation of aryl-alkyl thioethers.423 In the presence of the Sav scaffold 
(twofold excess of biotin-binding sites vs. VO2+), vanadate sulfoxidase activity increased 
from 28 to 50 TON for thioanisole 27 (Scheme 78 and Table 32, entries 24 and 26). The 
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Sav scaffold a 46 % ee in favor of (R)-28. While the VO2+ source did not influence the 
reaction, the oxidizing agent had a dramatic influence on the observed enantioselectivity. 
Only t-BuOOH afforded high activity and enantioselectivity, while H2O2 afforded (rac)-28 
and cumylhydroperoxide yielded the opposite enantiomer (S)-28 (15 % ee). Electron-rich 
aromatic thioethers yielded good to very good enantioselectivities: (R)-258 and (R)-259 
were produced in 90 and 93 % ee respectively (Table 32, entries 27-28). Dialkyl 
thioethers 260 and 261 afforded moderate ee. In the presence of biotin, no 
enantioselectivity was obtained, suggesting that the vanadyl moiety is located within the 
biotin-binding site. This assumption was confirmed upon mutation of biotin-binding key 
residue Sav D128A to afford rac-28. The X-band EPR signal obtained with complex 
VO(H2O)5·Sav is very similar to the free VO(H2O)5, suggesting that the protein interacts 
with the complex only via second coordination sphere interactions. It is interesting to 
note that, despite the poorly defined localization of the vanadyl moiety within Sav, the 
resulting sulfoxidase affords very good enantioselectivities, highlighting the flexibility of 
this facinating protein scaffold. 
Scheme 78. Incorporation of VOSO4 within Sav affords an artificial sulfoxidase. Adapted 
with permission from ref.423 Copyright 2016 American Chemical Society. 
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Artificial sulfoxidases based on non-porphyrin iron complexes have been investigated by 
Ménage and coworkers. For example, Fe complexe 268 (Scheme 79) was incorporated 
into NikA, a periplasmic nickel-binding protein.424 Ménage and coworkers had previously 
reported on the incorporation of small iron complexes into the pocket of NikA: they 
characterized the complex·protein assembly as well as investigated the iron-mediated 
oxygen insertion in an aromatic C-H bond of the ligand.425-426 The affinity of these 
complexes for NikA lies in the µM range. Based on the structure of the ArM, docking 
simulations of various substrates into the cofactor-loaded cavity were performed. The 
substrates evaluated all contained an R1-S-CH2-X moiety. The main selection criterion 
was the Fe·····S distance, to favour an Fe····O····S transition state. The docking 
revealed that a family of molecules, containing an R1-S-CH2-C(O)-NH-R2 motif (R1, R2 
aromatic groups), met this criterion. The simplest molecule, with R1 = 3-amino-phenyl 
and R2 = α-naphthyl, was selected as the starting point for substrate design. This 
skeleton is reminiscent of omeprazole and modafinil, drugs containing an enantiopure 
sulfoxide moiety (Scheme 79). In the absence of protein, oxidation of 262 yielded neither 
sulfoxide 264 nor sulfone. Instead, the dichlorinated sulfoxide species 265 was isolated. 
When 268·NikA was added to a reaction mixture containing sulfide 262 (in a ratio 
ArM:substrate:NaOCl  1:255:600), it afforded 173 TON in 4 h and a selectivity of 87 % in 
favor of sulfoxide 264 of (Table 32, entry 29). 268·NikA displayed the highest TOF (43 h-
1). Under similar conditions, sulfide 263 was selectively converted into sulfoxide with 
TON = 199 (Table 32, entry 30). Unfortunately these ArMs displayed only very modest 
enantioselectivity (i.e. ≤ 10 %).  
 
Scheme 79. Inserting iron complexes 268 into NikA yields an artificial sulfoxidase. 
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The same group subsequently reported another artificial sulfoxidase based on the 
supramolecular anchoring of 254 in human serum albumin (HSA).427 To ensure a more 
defined localization within HSA, a “Trojan horse” known to interact specifically with HSA 
was used. The authors functionalized the abiotic cofactor [Fe(BPHMEN)Cl2] with an 
ibuprofen anchor, resulting in 254, Scheme 76. Ibuprofen is known to bind to HSA 
preferentially in its “drug site 2” (IIIA domain). Correspondingly, 254 binds HSA with a 
~27 µM affinity to afford 254·HSA. When thioanisole 27 was dissolved in an acetate-
buffered solution (pH 5.2, 2.4 equ. NaOCl), no oxidation was detected. If 254 alone was 
used, the sulfone 242 was produced exclusively (97% yield). When HSA alone was used 
as catalyst, a mixture of sulfoxide 28 and sulfone 242 were produced in 45 % and 12 % 
yield respectively. In the presence of 254·HSA, the sulfoxide 28 and the sulfone 242 
were produced in 62% and 10% yield respectively. Upon lowering the temperature to 
4°C, 1367 TON were obtained with 254·HSA, (TOF = 459 min-1, Table 32, entry 31). The 
main advantage brought by the incorporation of the cofactor into HSA was the stability 
and recyclability of the ArM: after four rounds of catalysis, 254·HSA maintained its 
chemoselectivity for 28. In contrast, HSA gradually lost its activity and selectivity upon 
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recycling.418 Despite the better defined localization of the cofactor within HSA, no 
enantioselectivity was observed for the sulfoxidation.  
Finally, the groups of Mahy and Banse explored a covalent anchoring strategy for the 
generation of an artificial non-heme ArM sulfoxidase. β-lactoglobulin (β-LG) was used as 
a scaffold to covalently anchor the iron-cofactor 255 to Cys121, Scheme 76.428 This ArM 
catalyzed the sulfoxidation of thioanisole, with a TON = 2.8. Starting at 20 % ee in favour 
of (R)-28, the selectivity eroded over the course of the reaction, suggesting a 
denaturation of the ArM.  
 
Table 32. Selected results for artificial sulfoxidases. 
 
Ent. Cof. Protein Sub. Ox. pH 
T 
(°C) 
[Cof] 
(µM) 
[Ox.] 
(mM) 
ee 
(%) 
TON 
(t / h) 
TOF 
(s-1) 
Ref 
1 269 Phytase 27 H2O2   10  66 (S) 550 (3)  
148 
2 
TCPP-
Ru(II)-
CO 
Ab-SN37.4 27 PhIO 9.0 4 0.5 0.5 43 (S) ~750  155 
3 217 – 27 H2O2 7.5 r.t. 0.3 0.05 23 (R)
 a 38 (1.5) a  410 
4 217 Ab-3A3 27 H2O2 7.5 r.t. 0.3 0.05 45 (R)
 a 82 (1.5) a  410 
5 220 Ab-7A3 27 H2O2 4.4 r.t. 5 0.25 – 5.6 (2.6)  
386 
6 220 Ab-7A3 27 H2O2 4.4 r.t. 5 0.25 8 (S) 12 (2.6)  
386 
7 213 – 27 H2O2 7.4 r.t. 20 3.5 – 162 (2.3)
b  414 
8 213 Xln 27 H2O2 7.4 r.t. 20 3.5 40 (S) 145 (2.3)
b  414 
9 252 – 27 H2O2 8.0 18 2 0.5 –  0.0006 
415 
10 252 (gp27-gp5)3 27 H2O2 8.0 18 2 0.5 –  0.0062 
415 
11 243 – 27 H2O2 5.0 35 10 1 –  0.0002 
328 
12 243 
Mb (H64D-
A71G) 
27 H2O2 5.0 35 10 1 13 (S)  0.001 
328 
13 245 
Mb (H64D-
A71G) 
27 H2O2 5.0 35 10 1 32 (S)  0.008 
416 
14 249 – 27 H2O2 7.0 4 500 10 – 1.9 (0.17)  
330 
15 248 
Mb(L72C/ 
Y103C) 
27 H2O2 5.1 4 130 6.5 51(S)  0.007 
329 
16 248 
Mb(T39C/ 
L72C) 
27 H2O2 7.0 4 500 10 60 5 (0.17)  
330 
17 250 HSA 27 NaOCl 5.2 r.t. 12.5 2.5 – 97 (0.17)  418 
18 251 BSA 27 H2O2 5.1 0 2.7 0.4 50 (R) 98 (20)  
419 
19 251 BSA 238 H2O2 5.1 0 2.7 0.4 87 (R) 19 (20)  
419 
20 253 BSA 27 H2O2 7.0 24 200 15 52 (S) 42 (1.5)  
421 
21 253 BSA 239 H2O2 7.0 24 200 15 74 (S) 8 (1.5)  
421 
22 253 RSA 256 H2O2 7.0 r.t. 200 40 70 (R) 45 (1)  
420 
23 253 BSA 27 PS/hν c 7.4 r.t. 50 – 16 (R) 21 (0.2)  422 
24 – WT Sav 27 tBuOOH 2.2 r.t. 200 50 4 (R) 3.5 (4)  423 
25 [VO]2+ – 27 tBuOOH 2.2 r.t. 200 50 – 27.5 (4)  423 
26 [VO]2+ WT Sav 27 tBuOOH 2.2 r.t. 200 50 46 (R) 47 (4)  423 
27 [VO]2+ WT Sav 258 tBuOOH 2.2 r.t. 200 50 90 (R) 50 (4)  423 
28 [VO]2+ WT Sav 259 tBuOOH 2.2 r.t. 200 50 93 (R) 26.5 (4)  423 
29 268 NikA 262 NaOCl 7.0 r.t. 37 22.2 ≤10 173 (4) 0.012 424 
30 268 NikA 263 NaOCl 7.0 r.t. 37 22.2 ≤5 199 (4)  424 
31 254 HSA 27 NaOCl 5.2 r.t. 38 45.7 – 1367 7.65 427 
a with 5 % t-BuOH. b with 100 equivalents of imidazole. c irradiation at 450 nm in the presence of 0.4 mM [Ru(bpy)3]
2+ and 12 mM 
[Co(III)(NH3)5Cl]
2+ as electron acceptor. 
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6.3 Alcohol Oxidation 
Numerous natural enzymes, including laccases, glucose oxidases, and alcohol 
dehydrogenases, catalyze the oxidation of alcohols.429 Alcohol dehydrogenases are 
highly active and enantioselective NAD(P)H-dependent enzymes, but they often 
possess a narrow substrate scope. NAD(P)H cofactor recycling is an important 
economic issue and can be achieved by enzymatic and non-enzymatic systems. 
Homogenous catalysts are of course widely used for alcohol oxidation.430 Transition 
metal complexes of ruthenium, palladium, or copper in combination with 
TEMPO/dioxygen or a peroxide such as H2O2 or t-BuOOH are typically used for alcohol 
oxidation. Artificial metalloenzymes are potentially an attractive alternative for 
enantioselective alcohol oxidation. As elegantly demonstrated by Noyori, a pianostool-
based asymmetric transfer hydrogenation catalyst, can act either in the reduction- or in 
the oxidation-direction, depending on the hydride donor : hydride acceptor ratio.431 This 
is reminiscent of natural alcohol dehydrogenases. 
To mimic such systems, Ward and coworkers investigated whether biotinylated 
transition metal pianostool complexes anchored within Sav could catalyze the 
(asymmetric) oxidation of primary and secondary aromatic alcohols.432 Of the four 
biotinylated piano stool transition metal complexes tested [η6-(benzene)Ru(70)Cl] 
displayed highest activity for the oxidation of phenethyl alcohol into acetophenone (200 
TON) upon incorporation into WT Sav. On the other hand, no hydride acceptor (electron-
deficient ketones, quinones etc.) proved efficient for the oxidation of phenetyl alcohol: 
only t-BuOOH led to oxidation, suggesting an alternative mechanism, different from the 
widely accepted concerted proton and hydride transfer via a six-membered transition 
state.431  
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6.4 Epoxidation 
Olefin epoxidation is a powerful approach for introducing oxygen atoms into organic 
compounds due the stereospecificity of this reaction and the potential for subsequent 
ring opening reactions of epoxides.433 While a wide range of olefin epoxidation catalysts 
have been developed,434 high levels of enantioselectivity remain challenging for a 
number of olefin classes.435 Several different ArMs have therefore been explored with 
the hope of controlling epoxidation selectivity.  
For example, Kazlauskas436 and Soumillion437 independently reported that the active site 
Zn of carbonic anhydrase could be replaced with Mn to generate artificial epoxidases. 
Specifically, incubating apo hCA II with Mn(II) salts (chloride or acetate) led to the 
formation of an hCA·Mn ArM that catalyzed the epoxidation of styrenes in the presence 
of hydrogen peroxide with a moderate conversion and enantioselectivity (up to 67% ee). 
The Kazlauskas system also provided modest enantioselectivity (52% ee) on an 
aliphatic olefin, albeit with low conversion (Scheme 80). 
Scheme 80. Epoxidation catalyzed by Mn-substituted hCA II. 
 
 
Manganese complexes with multidentate nitrogen ligands are robust catalysts for a 
range of oxygenation reactions. Reetz incorporated a maleimide-substituted Mn-salen 
cofactor 272 into papain via cysteine alkylation; the resulting ArM catalyzed the olefin 
epoxidation, but low enantioselectivity was observed (< 10% ee, data not shown in the 
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paper).165 Lewis and coworkers also generated Mn-terpyridine ArMs by linking a 
maleimide-substituted terpyridine cofactor (273) to cysteine residues in nitrobindin and 
tHisF. Both benzylic oxidation and olefin epoxidation were catalyzed by these ArMs 
(Scheme 81).201 
Scheme 81. Benzyl oxidation and olefin epoxidation catalyzed by Mn(salen) and 
Mn(terpy) ArMs. 
 
 
Ab-7A3, an antibody that was raised against estradiol has been used as a scaffold for 
incorporating estradiol-substituted Mn(III)-porphyrins (Scheme 82) by Mahy.411 The 
affinities of Ab-7A3 for 274 and 283 (KD = 9.0 · 10-6 M and KD = 1.9 · 10-6 M, 
respectively) were lower by approximately 3 orders of magnitude compared to the 
estradiol alone (KD = 9.5 · 10-10 M). Spectroscopic data suggested that the metal centers 
in these cofactors are not coordinated to any residues of the antibody scaffold. 
Nonetheless, 274·Ab-7A3 and 283·Ab-7A3 catalyzed the epoxidation of styrene, 
affording 425 and 100 turnovers respectively within one hour, in the presence of 0.2% 
ArM vs. the oxidant. Additional products 277 and 278 were also formed, however, and 
the chemoselectivity favored production of phenylacetaldehyde 277: 25 % and 45 % 
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using 274·Ab-7A3 and 283·Ab-7A3, respectively. As both cofactors were mostly located 
outside of the protein, the presence of the antibody only modestly influenced the 
catalytic performance of the resulting ArMs. 
Mahy and coworkers demonstrated that Xylanase A (Xln hereafter) can host, deep in its 
pocket, the synthetic iron porphyrin [Fe(TpCPP)] 213 (KD = 0.5 · 10-6 M).398 The resulting 
ArM displays peroxidase and sulfoxidase catalytic activity (sections 6.1 and 6.2). 
Incorporation of [Mn(TpCPP)] 284 into Xln (KD = 1.5 · 10-6 M) affords an ArM for the 
epoxidation of styrene.438 The olefins 275 and 279 were converted to the aryloxiranes 
276 and 280 in 17% and 16% yield respectively (i.e. 23 and 21 TON). The 
chemoselectivity of the reaction was not affected by the protein scaffold, favouring the 
epoxide 276 for styrene (65%). For the electron-rich styrene derivative 279, the carbonyl 
products 281 and 282 were formed preferentially (70%). Importantly, the Xln host protein 
was responsible for enantioselectivity in the 284·Xln-catalyzed epoxidation, resulting in 
ee = 8.5% for (S)-276 and 80% for (R)-280. In addition, an increase of yield was also 
observed when comparing 284 to 284 · Xln.  
Scheme 82. Styrene epoxidation catalyzed by ArMs assembled with synthetic Mn(III)-
porphyrins via a Trojan horse anchoring strategy and supramolecular incorporation. The 
catalyst loading is reported vs. the oxidant.  
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6.5 Dihydroxylation 
Catalytic asymmetric dihydroxylation of olefins with osmium tetroxide and chiral ligands 
was discovered by Sharpless in the 1980s. As presented in the historical perspective, an 
ArM dihydroxylase was reported Kokubo.116 Inspired by this report, Ward and coworkers 
envisaged that the classic cinchona alkaloid ligands typically used for asymmetric 
dihydroxylation could be replaced with amino acid side chain functionality provided by 
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Sav. X-ray analysis of a Sav crystal soaked with excess K2[OsO2(OH)4] revealed metal 
binding on surface-exposed basic amino acid residues, including H87 and H127.439 
Incubating WT Sav with 1-2 eq. K2[OsO2(OH)4] yielded a highly enantioselective catalyst 
for the dihydroxylation of vinyl substrates, Table 33 and Scheme 83. (R)-1,2-dihydroxy-
2-phenyl propane was obtained from -methylstyrene 10 with 95 % ee. To identify the 
position of the catalytic site, residues that had osmium-bound in the crystal structure 
were mutated to alanine. Surprisingly, none of these mutants displayed a significantly 
eroded ee suggesting that the active osmium is not bound to any of these residues. In 
stark contrast, mutations within the biotin binding vestibule (e.g. S112, K121) and deep 
within the biotin binding pocket (e.g. D128) had a significant impact on the 
enantioselectivity of the artificial dihydroxylase. The ee for 1,2-dihydroxy-3-thiophenyl 
propane increased from 2 % (R)- to 71 % (S)-product when catalysis was performed 
with mutant S112Y. Mutant D128A afforded the same product with 71 % (R)-selectivity, 
Table 33.  
Table 33. Incubation of Sav with K2[OsO2(OH)4] affords an asymmetric dihydroxylase.  
 
Entry Substrate Sav mutant 
K2[OsO2(OH)4] 
(mol%) 
ee 
(%) 
TONa 
1 10 S112M 5.0 97 (R) 16 
2 285 S112Y 5.0 82 (S) 14 
3 285 D128A 2.5 77 (R) 21 
4 286 S112Y 5.0 71 (S) 7 
5 286 D128A 2.5 71 (R) 10 
6 287 S112M 5.0 41 (1R, 2S) 12 
7 288 WT 2.5 90 (1R, 2S) 26 
8 288 S112T 2.5 92 (1R, 2S) 16 
9 289 D128A 2.5 45 (1R, 2S) 13 
10 290 S112T 2.5 68 (3R, 4R) 6 
aBased on the amount of K2[OsO2(OH)4] employed.  
 
Scheme 83. Incubation of Sav with K2[OsO2(OH)4] affords an asymmetric dihydroxylase. 
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One of the most stringent requirements for ArMs is the preferred use of water as a 
reaction medium.27 A few reports, however, outline efforts to create ArMs that operate in 
the presence of large amounts of organic solvents.20, 175, 438, 440-441 To overcome the 
inherent tendency of proteins to denature in the presence of organic solvents, Tiller and 
co-worker have investigated the potential of organosoluble polymer enzyme conjugates 
(PECs hereafter, 294) using poly(2-oxazoline) 291 for the creation of ArMs.442-443 PEC 
formation was achieved by coupling anhydride intermediate 293 with the amino groups 
present on the surface of host proteins, Scheme 84. The resulting ArMs are soluble in 
apolar solvents and display activity in both organic- and aqueous media. 
Scheme 84. The terminal amino group of poly(2-oxazoline) 291, reacts with pyrometillic 
dianhydride 292 to afford the oligomer intermediate poly(2-oxazoline) anhydride 293. 
PECs 294 are generated upon coupling of the anhydride 293 with the amino groups on 
the surface of the protein scaffold.  
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Building on the work of Kokubo116 and Ward439 on osmate-catalyzed dihydroxylation 
employing ArMs, Tiller and coworkers reported on the use of PECs 294 as chiral 
scaffolds for the dihydroxylation of alkenes in organic solvents.444 The amphiphilic nature 
of PECs allowed formation of the osmate-PEC ArMs in fairly apolar media. PEC-
derivatives from various proteins were evaluated in the asymmetric dihydroxylation of 
styrene 176 in water-saturated chloroform using hexacyanoferrate (III) as co-oxidizing 
agent. (Table 34 and Scheme 85).  
Table 34. Selected results for the catalytic dihydroxylation of styrene 176 with PECs in 
chloroform.  
 
Entry Protein co-oxidant base T (d) 
Ratio  
[Os] / [Prot] 
ee 
(%) 
TONa 
1 Lysozyme K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 4.2 rac. < 1 
2 BSA K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 18 rac. < 1 
3 α-chymotripsin K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 7.5 19 (S) < 1 
4 Proteinase-K K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 6 8.3 6 (S) < 1 
5 Lipase (C. rugosa) K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 16.7 12 (S) < 1 
6 peroxidase K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 12.5 12 (S) < 1 
7 ADH K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 11 12 (S) < 1
 
8 laccase K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 7.7 15 (R) < 1
 
9 laccase K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 1.9 93 (R) 7
 
10b laccase K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 7 1.9 98 (R) 42
 
11 laccase K3[Fe(CN)6] (300 mM) K2CO3 (300 mM) 3 3.8 99.4 (R) <1 
12c laccase t-BuOOH (110 mM) K2CO3 (300 mM) 7 2 98 (R) 232 
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13d laccase t-BuOOH (110 mM) KOHe 7 1 99.4 (R) 501 
a Based on the amount of K2[OsO2(OH)4] employed.
 b PEC was dialyzed against 10mM EDTA for 24 h followed by further dialysis 
against water. c 26 M K2[OsO2(OH)4]. 
d 13 M K2[OsO2(OH)4]. 
e 10 L / mL of a saturated methanolic solution. BSA: bovine serum 
albumin, ADH: Alcohol dehydrogenases (ADH).  
 
Scheme 85. Immobilized artificial dihydroxylase obtained as polymer enzyme conjugate 
using various protein hosts. 
 
 
1-phenylethane-1,2-diol 295 was obtained in racemic form with enzyme conjugates 
derived from lysozyme or BSA (Table 34, entries 1 and 2). All other polymer-enzyme 
conjugates afforded enantioenriched product with (S)-configuration (Table 34, entries 3 
and 7) except for laccase (Table 34, entry 8). Varying the osmate : laccase ratio from 7.7 
to 1.9 improved the yield and ee substantially (7 TON and 93%) (Table 34, entry 9). 
Laccase contains four copper ions in its active site. Dialysis against EDTA and 
subsequent loading with osmate led to a further improvement in yield and ee for the 
dihydroxylation of styrene (98 % ee (R)-295, Table 34, entry 10). 
In a subsequent study, alternative reaction conditions were investigated to overcome the 
poor solubility of the co-oxidant K3[Fe(CN)6] in CHCl3. t-BuOOH in combination with 
methanolic KOH as a base led to excellent results for dihydroxylation of styrene with a 
TON of 501 and even outcompeting the Sharpless system in terms of enantioselectivity 
(> 99 % ee (R)) (Table 34, entries 12-13).445 KMnO4 and FeCl2, respectively, were 
tested in the same study as alternatives to K2[OsO2(OH)4], but resulted in a sharp drop 
in TON (51 for KMnO4 and 20 for FeCl2) and enantioselectivity (26% ee (R) for KMnO4 
and 11% ee (R) for FeCl2).  
More challenging substrates were also tested with the K3[Fe(CN)6] / K2CO3 system: 1-H 
indene 289, 1,2-dihydronaphthalene 287, and (allyloxy)benzene 285 yielded the 
corresponding vicinal diols in moderate to good ee. (Table 35, entries 1, 3 and 4 and 
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Figure 28) The enantiomeric excess observed for substrates 289 and 287 is, the highest 
ever reported for the osmium catalyzed dihydroxylation to the best of our knowledge. 
Strikingly, neither the styrene derivative 10 nor 297 afforded the corresponding diol.444 
These results stand in contrast with those obtained by Ward and coworkers, relying on 
streptavidin as host protein.439 Although selectivities of protein-osmium hybrids are 
promising, the turnover numbers are modest, with the exception of styrene. 
Table 35. Substrate scope for the catalytic dihydroxylation of alkenes with laccase 
based PEC.a,b  
 
Entry Protein Sub. T (d) ee c (%) TONd 
1 laccase 289 7 71 (R)e 3 
2 laccase 10 7 - - 
3 laccase 285 7 87 (R) < 1 
4 laccase 287 6 75 (R)e 11 
5 laccase 296 7 - - 
6 laccase 297 7 rac. 1 
a See Scheme 85 for reaction conditions,b Ratio [Os] / [Prot] = 1.9, c positive ee values correspond to the (R)-enantiomer. d Based on 
the amount of K2[OsO2(OH)4] employed. 
e ee values of 1R,2S calculated by comparison of the amounts of the cis enantiomer (1R,2S 
and 1S,2R). 
 
 
Figure 28. Substrates tested by Tiller in the catalytic dihydroxylation of alkenes with 
laccase based PEC. 
 
6.6 Cco Oxidase 
Lu designed and engineered a biosynthetic model of cytochrome c oxidase (CcO) by 
introducing a heme-copper center into Mb (CubMb).292 A tyrosine mutant in the active 
site (CubMb F33Y or CubMb G65Y) enabled its catalytic activity for the reduction of O2 to 
H2O and different reactive oxygen species (ROS) with high activity (TON > 1000).446 
Multiple approaches were used to fine-tune the ArM and thus increase the 
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corresponding reduction rates. A point mutation (S92A) was introduced into CubMb 
F33Y; this removed hydrogen bonds to the proximal His ligand and a heme propionate, 
created a more hydrophobic heme pocket, and increased the heme Eo from 95 to 123 
mV. Reconstituting the scaffold with different heme derivatives (Figure 29, 222, 298-301) 
led to the identification of ArMs with even higher Eo (up to 320 mV with 300) and better 
activity (more than threefold TONs after 9 h compared to CubMb F33Y).447 A series of 
different tyrosine analogs (Figure 30, 302-306) were also introduced into the enzymes in 
E. coli via stop codon suppression methodology. Unnatural aminoacid 302 mimicked the 
Tyr-His crosslink in CcO, and the resulting ArM catalyzed the reduction of oxygen to 
water with eightfold more selectivity and threefold higher TON than CubMb F33Y.448 
Tyrosine residues bearing different halogen substituents with decreased pKa also 
improved the selectivity and TON (up to 1200) of the ArM, suggesting the enhancement 
of proton donating ability of the phenol ring of the Tyr was beneficial.449 More recently, 3-
methoxytyrosine (306), a tyrosine analog with similar pKa but lower Eo, was incorporated 
into the ArM, the resulting ArM also showed higher oxidase activity (15.0 vs 6.5 μM min-
1) and selectivity (82% vs 51% to water).450 
 
Figure 29. Various heme derivatives used to fine-tune the redox potential of the ArMs.  
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Figure 30. Various tyrosine analogs incorporated in the artificial oxidase to optimize the 
activity. 
 
6.7 C-H oxidation 
As noted in section 5.4, selective functionalization of C-H bonds remains a key 
challenge in catalysis, and ArMs have great potential to improve control over such 
processes. Toward this end, a Mn(terpy) cofactor (307) was covalently linked to the 
nitrobindin (Nb) scaffold, a heme protein with a β-barrel structure, as noted in section 5.5 
(Scheme 81) to generate an ArM that catalyzed the oxidation of a broad range of 
hydrocarbons with good to excellent yields (up to 97%). Hoyever, selectivity identical to 
that of the free cofactor was observed (Scheme 86).201  
Scheme 86. Selected results for Mn(terpy) ArM catalyzed C-H oxidation. 
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In order to scrutinize the role of both the tetradentate ligand and the metal in Mb, 
Hayashi and coworkers tested the hydroxylation of ethylbenzene 308 by Mb 
reconstituted by Fe-porphycene 225 by Mn-protoporphyrin IX 309 and a Mn-porphycene 
310, Scheme 87.451 Using hydrogen peroxide as oxidant, only 224·Mb yielded 
phenylethanol 50 with TON = 13 and an ee = 14% (S)(Table 36, entries 1-4). No 
overoxidation to the corresponding acetophenone could be detected.  
Table 36. The oxidation reaction by reconstituted Mbs with M-porphyrinoids 
 
Entry Cofactor Protein Sub. pH [Cof] (µM) [H2O2] (mM) TON TOF (h
-1) Ref 
1 222 Mb (WT) 308 8.0 20 10 0 0 451 
2 225 Mb (WT) 308 8.0 20 10 0 0 451 
3 309 Mb (WT) 308 8.0 20 10 0 0 451 
4 310 Mb (WT) 308 8.0 20 10 13 33 451 
          
 
Scheme 87. Hydroxylation of ethylbenzene catalyzed by Mb reconstituted with 
metalloporphyrinoids. 
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6.8 Protein and Nucleic Acid Cleavage 
ArMs have also been designed to catalyze site-selective cleavage of proteins and 
nucleic acids. Indeed, many of the earliest ArMs developed via covalent modification of 
protein scaffolds involved modification of protein- and DNA-binding scaffold proteins for 
this purpose. Unlike most of the systems described above, surface modification of the 
scaffold is sufficient for selective biopolymer cleavage since the scaffold needs only to 
maintain cofactors proximal to bound DNA. For example, following iminothiolane 
treatment, the surface lysine residues on the E. coli Trp repressor protein (trp) were 
used to install an iodoacetamide-substituted phenanthroline cofactor (Figure 23, 200) 
that was metallated to generate an ArM nuclease.125 Substrate DNA that contained the 
aroH transcription unit naturally recognized by the trp scaffold was selectively cleaved in 
the presence of tryptophan and 3-mercaptopropionic acid. A similar approach was used 
to link an Fe(III)-EDTA cofactor (311) to the σ70 subunit of E. coli RNAP complex. The 
resulting ArM catalyzed cleavage of nucleic acid and protein components of the RNAP 
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complex near the σ70 binding sites.452 Haloacetamide-substituted phenanthroline (Figure 
23, 200)453 or EDTA ligands454 and an Fe(III)-EDTA cofactor (Figure 31 311)455 have 
been used to generate ArMs for selective biopolymer cleavage via alkylation of cysteine 
residues on scaffold proteins.15 Related systems have been generated via disulfide 
exchange456 and transesterification.457 Finally, in order to bypass the need for the 
covalent scaffold modification, BpyAla was genetically encoded into catabolite activator 
protein (CAP) near the the DNA binding site of this scaffold.402 The BpyAla 237 residue 
was selectively metallated with Fe(II) and Cu(II) to generate ArM nucleases. 
Building on these studies, Nolte recently constructed an ArM containing a Mn-porphyrin 
cofactor (Figure 31, cofactor 312) that selectively and processively oxidized tri-adenine 
sites in double stranded DNA (dsDNA).458 A trimeric, ring-shaped, DNA-binding clamp 
protein (gp45) was used as scaffold, and cysteine residues on the clamp were alkylated 
with a maleimide substituted manganese-phorphyrin complex (312). Supercoiled DNA 
was quantitatively oxidized by 312 and the reactive position of dsDNA was turned into 
an aldehyde after oxidation, which was further modified with hydroxylamine-derived 
biotin. Relying on a biotin-streptavidin pulldown, the reaction site was then visualized by 
AFM. When the gp45 was closed with an octapeptide, the activity of the ArM was 
decreased (55% conversion) and the modification-pattern was changed dramatically, 
indicating the binding of gp45 to the DNA was the key to processive catalysis. The 
reaction direction of the ArM could also be guided by clamper-loader complex (gp44/62) 
like the native polymerase.  
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Figure 31. Selected cofactors used for construction of nucleic acid cleaving ArMs. 
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7. Hydration 
A wide range of natural enzymes catalyze an equally diverse range of hydration 
reactions. Around one-third of the enzymes classified are involved in the addition- or 
removal of a water molecule from a specific substrate, thus illustrating their importance 
in nature. Most of these enzymes are hydrolases (E.C. 3), but examples can also be 
found among the lyases (carbon-oxygen bond cleavage, E.C. 4.2).459 Some of these 
enzymes (e.g. carbonic anhydrase, acetylcholinesterase and fumarase) belong to the 
fastest and most efficient enzymes known today, operating at the limit of 
substrate/product diffusion (with kcat/KM ≈ 108-109 M-1· s-1).460  
In addition to the large variety of natural hydrolytic (metallo)-enzymes, researchers have 
created ArMs to hydrolyze small model compounds (4-nitrophenyl acetate/phosphate), 
antibiotics (cefotaxime, ampicillin), or an analogue of the nerve agent cyclosarin. ArMs 
have also been applied for the hydration of CO2 or α,β-unsaturated 2-acyl pyridines and 
were engineered to catalyze epoxide ring-opening reactions, Kemp eliminations, 
transesterifications, and RNA ligations. The applied metalloenzymes were created by 
placing a catalytically active metal center (often Zn(II)) either in existing proteins or in de 
novo-designed scaffolds. The catalytic performance and the selectivity of the constructs 
were subsequently improved by means of genetic engineering. Artificial hydrolases are 
presented below.  
 
7.1 Hydrolytic Cleavage 
In 2006, Kim and Benkovic et al. engineered an artificial β-lactamase for the hydrolysis 
of the antibiotic cefotaxime (313).461 They repurposed the catalytic activity of an existing 
protein scaffold by applying the SIAFE approach (simultaneous incorporation and 
adjustment of functional elements) in conjunction with directed evolution. Insertion, 
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deletion, and substitution of active site loops led to β-lactamase activity in the αβ/βα 
metallo-hydrolase scaffold of glyoxalase II. Subsequent modification of the protein by 
point mutations resulted in a highly active engineered β-lactamase (evMBL8, PBD entry 
2F50). The designed enzyme completely lost its native activity (hydrolysis of the 
thioester bond of (S)-D-lactoylglutathione), in favor of the hydrolysis of cefotaxime 313, 
Scheme 88. The engineered enzyme, whose metal content was 1.63 ± 0.43 mol Zn and 
0.46 ± 0.14 mol Fe per mol of enzyme, displayed a catalytic efficiency (kcat/KM) of 184 M-
1·s-1.  
Scheme 88. An engineered β-lactamase evMBL8 catalyzes the hydrolysis of cefotaxime 
313.  
 
 
Beside antibiotics, small model compounds have also been examined as substrates for 
designed ArM hydrolases. For example, Pecoraro has engineered a variety of ArMs that 
catalyze hydrolysis of 4-nitrophenyl acetate 315.462 The de novo-designed scaffolds 
consist of a coiled-coil motif with an engineered His3 Zn(II) binding site. Metallation of 
this scaffold with Zn(II) led to an ArM that hydrolyzed ester 315 with a catalytic efficiency 
only ~100-fold lower than that of the natural hCAII, Table 37. More generally, the ArM 
hydrolase ([Hg(II)][Zn(II)(H2O/OH-)](TRIL9CL23H)3n+) consists of a three-stranded 
coiled-coil motif based on the TRI peptide family. The α-helical monomers display the 
general amino acid sequence Ac-G(LKALEEK)4G-NH2 in which two leucine residues 
were mutated to either histidine or cysteine. Upon metallation, this scaffold harbors a 
catalytically active tetrahedral Zn(II)(His)3OH2 site (mutation L23H) and a structure 
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stabilizing trigonal planar Hg(II)(Cys)3 site (mutation L9C) are formed (crystal structure of 
an analogue: PBD entry 3PBJ, Figure 32). 
 
Figure 32. Cartoon representation of de novo-designed three helix bundle proteins. Side 
view of the trimer found in the asymmetric unit of the crystal structure in TRI peptide 
structure analogs (PDB:3PBJ). The three helix bundles contain Zn(II) (red) and Hg(II) 
(grey) metal centers coordinated with three His and three Cys, respectively. 
 
Table 37. Saturation kinetic constants for the artificial metallohydrolase 
[Hg(II)][Zn(II)(H2O/OH-)](TRIL9CL23H)3n+ and hCAII for the hydrolysis of 4-nitrophenyl 
acetate 315.a  
 
Entry Protein pH KM (mM) kcat (s
-1) kcat/KM (M
-1 · s-1) Ref 
1 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ 
7.5 1.6 ± 0.4 2.2 ± 0.5 · 10-3 1.38 ± 0.04 462 
2 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ 
8.0 1.7 ± 0.5 5.4 ± 1.5 · 10-3 3.1 ± 0.1 462 
3 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ 
8.5 1.9 ± 0.6 12 ± 4 · 10-3 6.0 ± 0.1 462 
4 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ 
9.0 2.1 ± 0.6 38 ± 10 · 10-3 17.6 ± 0.3 462 
5 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ 
9.5 1.7 ± 0.5 40 ± 12 · 10-3 23.3 ± 0.3 462 
6 hCAII 7.4 30.5 ± 2.1 n.d. 2607 ± 85 463 
7 hCAII 8.0 20.7 53 ± 10 2550 464 
8 hCAII 9.0 23.9 56 ± 10 2320 464 
a Reaction conditions: 10 μM [Hg(II)][Zn(II)(H2O/OH
-)](TRIL9CL23H)3
n+ in 50 mM buffer (HEPES or CHES), 25°C.  
 
Zastrow and Pecoraro subsequently investigated the influence of the active site location 
on the catalytic activity of TRI-based ArM hydrolases.465 Four coiled-coil motifs were 
designed in which i) the positions of the Zn(II)-site and the Hg(II)-site were inverted 
(TRIL9CL23H and TRIL9HL23C, Table 38, entries 1-2 and 3-4), ii) the Zn(II)-site was 
moved closer to the N-terminus (TRIL9CL19H, Table 38, entries 5-6), iii) the Hg(II)-site 
was omitted (TRIL2WL23H, Table 38, entries 7-8). Analysis of these constructs revealed 
that the maximal rate, the metal binding affinity and the substrate access depended on 
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the position of the Zn(II)-site, whereas all designs showed similar maximal catalytic 
efficiencies for the hydrolysis of 315.  
Table 38. Kinetic analysis of four artificial metallohydrolases catalyzing the hydrolysis of 
4-nitrophenyl acetate 315.a  
 
Entry Protein pH 
kcat 
(s-1) 
KM 
(mM) 
kcat/KM 
(M-1 · s-1) 
Kd,app 
(μM) 
(kcat)max 
(s-1)b 
(kcat/KM)max 
(M-1 · s-1)b 
1 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ c 
7.5 0.0022 1.6 1.38 0.8 
~0.053 31 
2 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL23H)3
n+ c 
9.0 0.038 2.1 17.6 0.22 
3 
[Zn(II)(H2O/OH
-)] 
[Hg(II)](TRIL9HL23C)3
n+ 
7.5 0.0005 0.9 0.6 ~8 
~0.030 24 
4 
[Zn(II)(H2O/OH
-)] 
[Hg(II)](TRIL9HL23C)3
n+ 
9.0 0.011 1.1 9.7 0.8 
5 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL19H)3
n+ 
7.5 0.0014 4.2 0.33 3.7 
~0.076 27 
6 
[Hg(II)][Zn(II)(H2O/OH
-)] 
(TRIL9CL19H)3
n+ 
9.0 0.010 2.3 4.5 0.4 
7 [Zn(II)(H2O/OH
-)](TRIL2WL23H)3
n+ 7.5 0.0011 2.7 0.41 0.6 
~0.055 25 
8 [Zn(II)(H2O/OH
-)](TRIL2WL23H)3
n+ 9.0 0.016 1.8 8.9 0.24 
a Reaction conditions: 10−20 μM active Zn(II)-bound peptide complex; values at pH 7.5 determined in 50 mM HEPES; values at pH 
9.0 determined in 50 mM CHES; 25°C. The error range of the kinetic parameters is not displayed for clarity. b Determined at 
optimized pH. c Data reported by Pecoraro et al.462  
 
Efficient and selective hydrolysis of organophosphates, especially those in nerve agents, 
has become increasingly important due the serious biological threat that these 
compounds pose. In 2012, Baker et al. repurposed a mouse adenosine deaminase to 
catalyze the hydrolysis of such an organophosphate.466 A coumarinyl analogue 314 of 
the nerve agent cyclosarin was efficiently hydrolyzed by the engineered zinc dependent 
enzyme PT3.3 (Scheme 89), and a catalytic efficiency (kcat/KM) of ~104 M-1·s-1 was 
determined. This ArM was engineered via a combination of computational design and 
directed evolution. Initially, the PDB was screened for enzymes containing mononuclear 
zinc sites. These enzymes are known to catalyze hydrolysis in nature. A calculated 
model of the transition state for phosphate hydrolysis was subsequently docked into 
these scaffolds, beneficial hydrogen bonds in the active sites were engineered, and 
steric clashes were minimized. Out of a set of 12 designed enzymes, one showed a 
moderate catalytic activity (kcat/KM = 4 M-1·s-1). Saturation mutagenesis of 12 residues 
surrounding the active site led to the identification of a variant with a ~40-fold improved 
catalytic efficiency (PT3.1, PDB entry 3T1G). Random mutagenesis using error-prone 
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PCR and a point mutation in the active site (based on analysis of the crystal structure) 
further increased the activity. Overall, the catalytic efficiency towards the hydrolysis of 
diethyl 7-hydroxycoumarinyl phosphate 314 was improved by a factor of 107. The 
designed artificial metalloenzyme (PT3.3) exceeded 140 turnovers. Based on a similar in 
silico design strategy relying on the Rosetta algorithm, Baker et al. have created artificial 
Diels-Alderases467, Retro-Aldolases468 and Kemp-Eliminases.469 These engineered 
enzymes do not contain any catalytically active metal, are thus not included in this 
review. They do, however, demonstrate the huge potential of computational enzyme 
design combined with directed evolution. 
Scheme 89: Hydrolysis of a coumarinyl analogue of cyclosarin 314 catalyzed by an in 
silico designed artificial metallo-hydrolase PT3.3.  
 
 
In 2012, Kuhlman reported an Zn(II)-dependent ArM that catalyzed hydrolysis of 4-
nitrophenyl acetate or phosphate (315 or 316 respectively).470 A 5 kDa helical hairpin 
monomer (Rab4-binding domain of rabenosyn) was used as a starting point to engineer 
a zinc-mediated homodimer (MID1-zinc). The construct bears two Zn(II)-binding sites at 
the protein interface. Analysis of the crystal structure (PDB entry 3V1C) revealed that 
only three out of the four designed histidine residues coordinate to zinc, thus suggesting 
a possible coordination site that may promote esterase activity. The Zn(His)3 motif, 
located in a 6·4 Å protein cavity, indeed displayed hydrolase activity towards 4-
nitrophenyl acetate (315, kcat/KM = 630 M-1·s-1, max. TON = 50) and 4-nitrophenyl 
phosphate 316 (kcat/KM = 14 M-1·s-1), Scheme 90. Mutagenesis of the three zinc-
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coordinating histidines to alanines led to a complete loss of esterase activity, suggesting 
that indeed the Zn(His)3 motif is required for catalysis.  
Scheme 90: Hydrolytic activity of MID1-zinc towards 4-nitrophenyl acetate (315) and 4-
nitrophenyl phosphate (316).  
 
 
Similar to the previous report from Kim and Benkovic et al., Tezcan engineered an ArM 
β-lactamase to hydrolyze an antibiotic. The Tezcan system, however, involved Zn(II)-
mediated self-assembly of four engineered cytochrome cb562 units, Figure 33.471 To 
stabilize the resulting D2 symmetric tetramer, a total of 16 surface mutations including 
the introduction of zinc-coordination sites, hydrophobic interactions, and disulfide bonds 
were introduced. The designed supramolecular protein assemblies harbor eight Zn(II)-
ions (4 structural zinc sites and 4 catalytic zinc sites). Saturation mutagenesis of four 
individual amino acid positions surrounding the catalytic zinc sites led to the 
identification of a highly active variant (Zn8:A104/G57AB34, PDB entry 4U9E). This ArM β-
lactamase catalyzed the hydrolysis of ampicillin 317 and 4-nitrophenyl acetate 315 with 
catalytic efficiencies (kcat/KM) of 35090 M-1·min-1 and 296 M-1·s-1 respectively, Scheme 
91. In vivo β-lactamase activity was demonstrated by expression and secretion of this 
construct into the periplasm of E. coli. Colonies successfully grew on LB-agar plates 
containing ampicillin (0.8 mg/l).  
Scheme 91. An evolved artificial metallo β-lactamase Zn8:A104/G57AB34 catalyzes the 
hydrolysis of ampicillin 317 and 4-nitrophenyl acetate 315.  
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Figure 33. Cytochrome cb562 was engineered (PDB code 4U9E) to accommodate two 
structural and two catalytic zinc-binding sites affording -lactamase activity.471  
 
7.2 Ligation Reaction 
In 2007, Szostak and Seelig introduced de novo RNA-ligase activity into human retinoid-
X-receptor (hRXRα).472 mRNA display-based screening of more than 1012 randomized 
two zinc-finger domains revealed highly active mutants towards the ligation of a 5’-
triphosphorylated RNA with the terminal 3’-hydroxyl group of a second RNA, Scheme 
92.473 After 17 rounds of evolution, ligases performing several turnovers accompanied 
with a more than 2·106 fold rate enhancement were identified. Importantly, no initial 
catalytic activity or knowledge of the reaction mechanism was required to engineer this 
ligase activity. Structure determination of a highly active variant (ligase 10C, PDB entry 
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2LZE) revealed substantial differences compared to the initial protein (hRXRα).474 The 
helical DNA recognition domain was replaced by a long unstructured loop and the 
protein adopted a cyclic structure, Figure 34. The artificial ligase still contained two zinc-
finger domains, although four of the eight initial cysteine coordination sites were 
replaced by aspartate, glutamate or histidine. The enzyme maintained its high activity 
even at temperatures up to 65°C.475  
 
Figure 34. Cartoon representation of changes resulting from directed evolution of hXRXα (PDB: 
1RXR) to the ligase C10 (PDB: 2LZE). a) Comparison of the 3D structure of hRXRα and b) the 
artificially evolved ligase. N and C termini omitted for clarity; the two zinc finger regions (Zn-I and 
Zn-II), in each scaffold, are highlighted in blue and green, respectively. Zinc-coordinating 
residues are shown as stick. 
 
Scheme 92. In vitro selection of artificial ligase enzymes by mRNA display. A DNA 
library is transcribed and the corresponding mRNA modified with puromycin (P) followed 
by in vitro translation. The zinc-finger proteins (linked to their genotype) catalyze the 
ligation of a 5’-triphosphate-activated RNA (PPP-substrate) with the terminal 3’-hydroxyl 
group of a second RNA (HO-substrate) bearing a biotin anchor (B). The mRNA is 
reverse-transcribed and the linked strands (Product) are immobilized on streptavidin 
(Sav)-coated beads. After selection, the constructs are released from the beads by UV-
irradiation of a photocleavable linker (PC). DNA is amplified/mutated by PCR and 
subjected to the next round of selection. Adapted with permission from ref.472 Copyright 
Macmillan Publishers Limited 2007.  
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7.3 Hydration of C=C and C=O Double Bonds 
In 2013, Roelfes et al. applied their previously designed LmrR-Cu(phen) Diels-Alderase 
(section 5.8) in the hydration of α,β-unsaturated 2-acyl pyridine (Scheme 93).368 Slightly 
lower conversion and enantiomeric excess (up to 84% ee) were observed compared to 
the Diels-Alder reaction. The point mutants of this ArM also suggested that the two 
residues (F93, D100) at the front entrance had a crucial impact on both the activity and 
the selectivity.  
Scheme 93. Selected results for hydration of α,β-unsaturated 2-acyl pyridines.  
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A similar strategy was applied by Pecoraro et al. The previously designed ArM 
[Hg(II)][Zn(II)(H2O/OH-)](TRIL9CL23H)3n+ (section 7.1), a highly active hydrolase for 4-
nitrophenyl acetate 315, displayed CO2 hydration activity (Table 39, entry 1). In order to 
generalize their approach of de novo-designed ArMs, they switched from a three-
stranded coiled-coil motif to a single-stranded antiparallel three-helix bundle (α3D-motif, 
originally designed by DeGrado et al.476). Being single-stranded, this 73 amino acid 
protein allows the introduction of unique mutations (rather than mutations that are 
repeated with three-fold symmetry). The potential to improve the catalytic performance 
of ArMs derived from this scaffold is therefore expected to be higher. Indeed, Pecoraro 
et al. engineered CO2 hydration activity into this scaffold by mutagenesis (4 mutations) 
and elongation of the C-terminus (4 residues).477 Three leucine residues were replaced 
by histidines to form the catalytically active Zn(II)(His)3O-site and an existing histidine 
was replaced by valine to avoid undesired Zn(II)-binding. The engineered protein 
(α3DH3) bound Zn(II) with nanomolar affinity (Kd = 59 ± 9 nM at pH 9.0) to form a highly 
active ArM (Table 39, entries 2-5 and Figure 35).  
 
Figure 35. Side view of α3DH3 model built on α3D peptide structure (PDB: 2A3D). 
Highlighted, in each single chain of the three helix bundle, the His introduced for the 
coordination with Zn(II) ion (not displayed). Coordinating residues are represented as 
stick and coloured by element. 
 
Table 39. Kinetics for CO2 hydration by natural and artificial metalloenzymesa  
 
Entry Protein pH KM (mM) kcat (s
-1) kcat/KM (M
-1 · s-1) Ref 
1 [Hg(II)][Zn(II)(H2O/OH
-)](TRIL9CL23H)3
n+ 9.5 10.0 ± 2.4 (1.8 ± 0.4) · 103 (1.8 ± 0.3) · 105 462 
2 [Zn(II)]α3DH3 9.5 3.5 ± 0.6 134 ± 8 (3.8 ± 0.5) · 10
4 477 
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3 [Zn(II)]α3DH3 9.0 4.9 ± 1.0 103 ± 8 (2.1 ± 0.3) · 10
4 477 
4 [Zn(II)]α3DH3 8.5 7.2 ± 1.1 82 ± 6 (1.1 ± 0.1) · 10
4 477 
5 [Zn(II)]α3DH3 8.0 6.2 ± 1.7 39 ± 4 (0.63 ± 0.1) · 10
4 477 
6 hCAII 8.8 8.9 8.2 · 105 9.2 · 107 478 
7 hCAIII 9.0 20 8 · 103 4 · 105 479 
a Reaction conditions: 100 μM [Zn(II)]α3DH3, 50 mM buffer / 25 μM indicator (TAPS/m-cresol purple (pH 8.0 and 8.5), AMPSO/thymol 
blue (pH 9.0), CHES/thymol blue (pH 9.5), 0.1 M ionic strength with Na2SO4, 25°C.  
 
7.4 Lyases 
In 2011, DeGrado et al. engineered Kemp-eliminase activity into the C-terminal domain 
(last 75 residues) of calmodulin (CaM), a Ca2+ binding EF-hand regulatory protein.480 
Although the artificial enzyme does not contain a catalytically active metal center, its 
activity is allosterically regulated by the addition of Ca2+ ions. Upon binding of Ca2+, CaM 
undergoes a structural rearrangement and opens a hydrophobic pocket. De Grado et al. 
placed a general base (mutation F92E) at the bottom of the hydrophobic pocket (Figure 
36), guided by computational design. This mutation afforded an active Kemp-eliminase 
(cCaM-F92E, PDB entry 2KZ2, Scheme 94). A catalytic efficiency (kcat/KM) of 5.8 ± 0.3 
M-1·s-1 was determined for cCaM-F92E, whereas the natural CaM showed no activity. 
The engineered protein exceeded 40 turnovers.  
Scheme 94. Kemp elimination catalyzed by an engineered calmodulin variant cCaM-
F92E.  
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Figure 36. The C-terminal domain of calmodulin (PDB code 2KZ2) is a Ca2+-dependent 
Kemp-Eliminase.480 
 
Beside Kemp-eliminases, researchers have also designed ArMs to catalyze epoxide 
ring-opening reactions. In 2012, for example, Ueno et al. engineered such an artificial 
construct by covalently linking maleimide-substituted bipyridine cofactor 319 to a 
cysteine residue in [(gp5βf)3]2 (sections 5.9 and 6.2).299 Metallation of this scaffold via 
addition of scandium ions led to the formation of 319·[(gp5βf)3]2, which catalyzed the 
ring-opening of epoxide 316 with aniline as nucleophile. The reaction efficiency 
depended on the position of the bipyridine ligand 319 (Table 40). The ArM 
319·[(gp5βf)3]2 (G18C) gave the highest TON (8.4) and ee (17%). In contrast, trace 
amounts of racemic aminoalcohol 318 were produced by the mixture of [(gp5βf)3]2 
lacking the critical cysteine residue and cofactor 320, Scheme 95. 
Table 40. Selected results for the epoxide ring-opening reaction catalyzed by a Sc(bpy) 
complex anchored to [(gp5βf)3]2.a  
 
Entry Cofactor1 Protein [Cof] (µM) Sub1. Sub2. ee (%) TON Ref 
1 319 [(gp5βf)3]2 (G18C) 200 316 317 17 (1R, 2R) 8.4 
299 
2 319 [(gp5βf)3]2 (L47C) 200 316 317 9 (1S, 2S) 2.6 
299 
3 319 [(gp5βf)3]2 (N51C) 200 316 317 1 (1S, 2S) 1.6 
299 
4 320 [(gp5βf)3]2 200 316 317 – trace 
299 
a Reactions were carried out in solution of 1 : 9 acetonitrile/MOPS (10 mM, pH 7.5) at 40°C; [[(gp5βf)3]2] = 33 μM; reaction time: 48 h.  
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Scheme 95. Epoxide ring-opening reaction catalyzed by a Sc(bpy) complex covalently 
anchored to [(gp5βf)3]2. 
 
 
As previously noted (section 4.1), Kamer has shown that a cysteine residue of 
photoactive yellow protein (PYP) can be selectively acylated with acylimidazole-
substituted reagents, and this approach has been used to incorporate phosphine ligands 
into PYP (Figure 37 a).441 The analogous reaction could also be achieved using the 
corresponding [PdCl(3-C3H5)]2 complexes of phosphines 234 and 235 (Figure 37 b), 
and the resulting ArMs catalyzed allylic amination of 1,3-di-phenylprop-2-enyl acetate 
with benzylamine (Figure 37 c). No enantioselectivity was observed in this 
transformation, but the authors also noted that no conversion was observed using PYP 
lacking phosphine modification in the presence of [PdCl(3-C3H5)]2, showing that the 
observed amination reactions results from intact ArM. Denaturation of the PYP scaffold 
in the presence of the organic solvent required for substrate solubility was suggested as 
an explanation for the lack of enantioselectivity in this transformation. These authors 
later reported a two-step procedure for incorporating phosphines into proteins, though 
no catalysis was reported.481 
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Figure 37. a) Covalent modification of PYP using acylimidazole reagents. b) Acyl-
imidazole-substituted phosphine ligands used to generate Pd-allyl ArMs. c) Allylic 
amination catalyzed by PYP-phosphine Pd-allyl ArMs.441 
 
In addition to the 20 natural amino acids, researchers have also incorporated a variety of 
unnatural amino acids81 into designed ArM hydrolases. In 2013, Baker et al. designed an 
ArM relying on the unnatural amino acid (2,2’-bipyridin-5yl)alanine (Bpy-Ala, 237, Figure 
26, see also the work of Schultz et al. in section 6.1).482 The engineered constructs 
bound divalent metal ions Co2+, Zn2+, Fe2+ and Ni2+. The highest affinity was determined 
for Zn2+ (Kd ~ 40 pM). Analysis of the crystal structures of the nickel and cobalt-bound 
variants revealed an octahedral coordination provided by Bpy-Ala, a bidentate glutamate, 
an aspartate, and a water molecule. These constructs however do not display any 
catalytic activity.  
Finally, an ArM transesterase that mimics the catalytic activity of an RNAse was 
generated by Mahy and coworkers using a “Trojan horse” strategy. The affinity of 
testosterone for variant 3.24 of neocarzinostatin (NCS hereafter) was previously 
exploited to anchor testosterone-linked metal cofactors to NCS.412 A testosterone-
substituted Zn complex, [Zn(N,N-(2-pyridylmethyl)2)Cl] 323, was prepared and used to 
201 
generate an ArM transesterase upon binding to NCS (KD = 4.0 µM).483 The zinc-moiety 
of cofactor 323 is rapidly aquated and the Zn(II) ion reduces the pKa of the bound water, 
leading to hydrolase activity. Docking studies suggest that the testosterone-moiety of 
323 could bind the site 2 of NCS in a fashion that is reminiscent to the interaction in the 
(unsubstituted) testosterone-NCS complex. The lowest-energy docked 323 structure 
suggests that the catalytic-moiety is located in the site 1 of NCS, thus exerting a 
significant influence on the catalytic performance and paving the way for improvement 
through mutagenesis. 
Scheme 96. Supramolecular anchoring of a [N(CH2Py)2ZnCl]-moiety, via a testosterone 
"Trojan Horse", into neocarzinostatin (NCS) affords an artificial metalloenzyme 
displaying RNAse-like activity. 
 
 
The ArM 323·NCS did not hydrolyze common DNA model compounds, such as bis(p-
nitrophenyl)phosphate. It did, however, catalyze the transesterification of phosphate 321 
into 322, Scheme 96. The involvement of a vicinal hydroxy-moiety is reminiscent to the 
activity of RNAse enzymes. The highest activity achieved was TOF = 3·10-4 s-1, at pH 
7.0. This is ~800 fold faster than the cofactor 323 alone, highlighting the positive 
influence of the NCS host protein. Saturation kinetics were determined for 323·NCS: KM 
= 22 µM and a kcat = 3 · 10-4 s-1 resulting in an efficiency kcat/KM = 13.6 M-1·s-1. 
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Unfortunately, the protein rapidly denatures in solution, thus limiting the lifetime of 
323·NCS.  
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8. Outlook 
The studies highlighted in this review showcase the wide range of metal complexes, 
protein scaffolds, and linkage strategies that have been used to generate ArMs to date. 
This diversity of components and methodologies has led to systems that catalyze an 
impressive range of challenging chemical reactions, many of which are not found in 
nature. Moreover, a range of approaches has been developed to optimize ArMs for 
chemo-, regio-, site-, and enantioselective catalysis. Early efforts toward this end 
involved altering cofactor linkage sites within scaffold proteins,145 altering cofactor 
structure,154 and exploring different scaffold/cofactor combinations to enable 
chemogenetic ArM optimization.177 Point mutations were later introduced into putative 
ArM active sites of scaffold proteins to improve ArM selectivity,173, 416 and iterative 
targeted mutagenesis was subsequently reported.484 We anticipate that, despite the 
more pronounced effect of chemical variation of the cofactor on both activity and 
selectivity, the genetic optimization and the possibility to apply directed evolution 
schemes may be the method of choice for the optimization of ArMs in the close future, 
thanks to its ease of parallelization. 
Despite these advances and many more since,39 ArM catalysis remains rather 
underdeveloped when compared to homogeneous transition metal catalysis or enzyme 
catalysis. Because of this, Whitesides' pronouncement regarding the practicality of 
ArMs2 remains true to this day. As noted in the introduction, fundamental advances in 
protein engineering485 and aqueous organometallic chemistry486 contributed to a 
resurgence in ArM research around the year 2000. Further improvements in ArM 
efficiency will require innovations that specifically address and exploit the hybrid 
structures of ArMs.87 For example, while many studies have demonstrated the potential 
for protein scaffolds to control the selectivity of organometallic catalysts, the catalysts 
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used are typically well-known from the organometallic literature and remain unmodified 
upon incorporation into protein scaffolds. The activity and selectivity of cofactors 
designed to interact synergistically with scaffold proteins via ligand exchange,321 electron 
transfer,296 or other means could be more extensively tuned or even uniquely activated 
via incorporation into proteins. Similarly, while a range of bioconjugation techniques 
have been used for cofactor incorporation, only a handful of these are compatible with 
complex media, including cell lysate (in vitro) or cytosol (in vivo). Transitioning to 
efficient bioorthogonal methods354, 487 for covalent354, non-covalent351, dative471, and 
substitutive352 cofactor incorporation will ensure that ArM libraries can be readily 
generated as efficiently as for natural enzymes.  
Just as methodology must be adapted to suit different aspects of the unique composition 
or ArMs, so too must our understanding of the structure and function of these catalysts, 
which currently lags far behind that of transition metal catalysts and enzymes. ArM 
characterization typically involves a battery of spectroscopy, mass spectrometry, and, in 
some cases, X-ray crystallography to ensure the desired composition. Evidence for 
specific scaffold-cofactor interactions (e.g. dative ligation of metal centers) is often 
presented,257, 354 and many examples in which scaffold accelerated catalysis have been 
reported.44, 321 On the other hand, the exact contributions to catalysis of the former and 
the origins of the latter remain unclear. Substrate binding interactions within ArM active 
sites remain almost completely unexplored. These are precisely the types of phenomena 
that natural enzymes have evolved to harness,488 so understanding how they have 
emerged in ArMs (albeit to only a primordial extent at this point) could improve our ability 
to design and evolve comparably efficient systems. Given the importance of protein 
scaffolds to the activity of natural metal cofactors,489 it is reasonable to hypothesize that 
large improvements in the activity and selectivity of synthetic catalysts could be 
achieved using properly designed protein scaffolds. Toward this end, far deeper 
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biophysical studies into the nature of ArM catalysis, mirroring efforts in enzymology, are 
required. Similarly, significant improvements in computational approaches to design and 
simulate the structure and conformational dynamics or proteins containing synthetic 
metal catalysts will be required to provide insight into the molecular level events that 
occur during ArM catalysis.274, 482, 490 
Advances in cofactor design, activation, and bioconjugation, along with improved 
understanding of ArM catalysis would facilitate development of what is perhaps the most 
important methodological hurdle limiting ArM catalysis: directed evolution.491 It is difficult 
to overstate the impact that directed evolution has had on biocatalysis in industry using 
natural enzymes (see also the introduction to this issue of Chemical Reviews.),163 and 
yet such efforts toward ArMs remain in their infancy. Reports to date have demonstrated 
that iterative targeted mutagenesis of residues proximal to metal cofactors (or at least 
their presumed location during catalysis) can improve ArM selectivity and activity.7 While 
similar approaches have of course been used to optimize natural enzymes, the true 
power of directed evolution and the great improvements and surprises in the activity of 
evolved enzymes have been realized not solely via mutation of active site residues but 
from functional screens and selections conducted on diverse populations of enzymes 
containing mutations throughout their structure.491  
Unfortunately, random mutagenesis methods remain unexplored in part due to the small 
ArM library sizes that can be generated using existing cofactor incorporation methods,492 
while targeted mutagenesis (outside of the putative ArM active site) is hindered by a lack 
of fundamental understanding of how distal scaffold mutations impact cofactor 
selectivity. Toward the latter point, for example, it is not obvious that phylogenetic tools 
used to generate targeted "smart libraries" of natural enzymes are applicable to ArMs 
given that the function of the two are completely unrelated.163 Nonetheless, adapting the 
full arsenal of library methodologies that are available for enzyme evolution, ranging 
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from random mutagenesis and gene shuffling485 to combinatorial codon mutagenesis493 
and chimeragenesis494, to ArMs will ensure that the latter can be evolved with the 
efficiency of the former. Genome mining to identify diverse homologues of relevant 
scaffolds and computations tools to identify new scaffolds based on sequence but 
(predicted) structural homology could also be highly beneficial for identifying new ArM 
scaffolds.495-496 Based on the success of evolved enzymes for practical applications, this 
would go a long way to establish whether ArMs can in fact have practical utility. 
Despite the need for significant advances in our ability to engineer and understand 
ArMs, hints of their potential utility have already begun to emerge. The many 
enantioselective transformations highlighted above have certainly proven their worth for 
fine chemical synthesis. The few studies reported on the activity of immobilized ArMs 
suggest that significant improvements in the practicality of ArM catalysis could be 
realized using different immobilization procedures.259, 262, 316, 334 A key goal of future ArM 
research must be to develop such transformations that cannot be accomplished using 
small molecule or enzyme catalysts. In such cases, the added complexity of ArM 
formation relative to other systems might be offset by savings in other aspects of a 
process. Tandem processes involving enzyme and ArM catalysis have also been 
developed,263 and these illustrate the unique ability of ArMs to shield transition metals 
from species that would otherwise lead to catalyst death. Taking this possibility to the 
extreme, ArM catalysis in vivo351, 497 could ultimately be used to augment metabolic 
pathways with synthetic reactions to expand the scope of biosynthesis498. Obviously 
much work remains before these possibilities can be realized, but recent progress in 
ArM catalysis and other areas of protein engineering and organometallic chemistry 
should encourage those willing to take on the challenges that lie ahead. 
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